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The structural integrity of the white matter is required for neuronal communication 
within the brain which is essential for normal cognitive function. Post-mortem and 
clinical imaging studies of elderly individuals have demonstrated that white matter 
integrity is weakened with increasing age which is proposed to underlie age-related 
cognitive decline. Whilst the exact mechanisms are unknown it is thought that 
modest age-related reductions in cerebral blood flow, termed chronic cerebral 
hypoperfusion, may contribute to white matter disruption and impaired cognition 
with ageing. Investigating the effects of white matter integrity in humans is limited 
as it is difficult to definitively ascertain a cause and effect relationship. Indeed, 
elderly individuals with cerebral hypoperfusion often have co-existing disease such 
as hypertension thus the effects of hypoperfusion in isolation cannot be determined. 
This has led to the development of a mouse model of chronic cerebral hypoperfusion 
which provides the opportunity to directly assess whether cerebral hypoperfusion 
results in disruption to white matter and cognitive impairment. This is achieved by 
applying small wire coils around both common carotid arteries of the mouse 
resulting in a global reduction in cerebral blood flow. Importantly the extent of blood 
flow reduction is dependent on the internal diameter of the coils meaning that 
differing severities of hypoperfusion can be studied. Previous studies using this 
model have demonstrated diffuse white matter pathology in white matter tracts 
including the corpus callosum, internal capsule and optic tract following 1 month of 




This thesis sought to test the hypothesis that chronic cerebral hypoperfusion would 
influence the structural integrity of nodal and paranodal domains of myelinated 
axons of the white matter and result in decreased numbers of oligodendroglial cells. 
It was additionally hypothesised that treatment with the anti-inflammatory and 
antioxidant drug dimethyl fumarate (DMF) would ameliorate structural and 
functional alterations to white matter following hypoperfusion. 
 
Aim 1 – To determine the impact of chronic cerebral hypoperfusion on the 
structural integrity of nodal and paranodal domains of myelinated axons 
The first aim of this thesis was to investigate the effects of chronic cerebral 
hypoperfusion on the structural integrity of nodal and paranodal domains of 
myelinated axons. This was addressed by examining key myelin and axonal proteins 
found at nodal, paranodal and internodal domains. This revealed significant 
alterations to the distribution of voltage-gated sodium (Nav1.6) channels at nodes of 
Ranvier which were differentially altered in response to increasing durations of 
chronic cerebral hypoperfusion. Specifically an increase in the Nav1.6
+ domain 
length was observed in the corpus callosum following 3 days (p < 0.0001) and 1 
month (p < 0.001) of chronic cerebral hypoperfusion but was not significantly 
different from sham controls following 6 weeks of hypoperfusion (p = 0.066). A 
significant decrease in Nav1.6 domain length was observed following 3 months of 
hypoperfusion (p = 0.003). Assessment of paranodal integrity was carried out by 
measuring nodal gap length and by ultrastructural analysis of paranodal domains. 




like junctions and abnormal morphology of paranodal loops. Furthermore this study 
revealed a significant loss of myelin associated glycoprotein, a key protein involved 
in the maintenance of axon-glial integrity, as early as 3 days following the onset of 
hypoperfusion. A further aim of this study was to examine potential mechanisms 
underlying the observed alterations to nodal and paranodal domains following 
cerebral hypoperfusion. It was hypothesised that increased inflammation and 
accumulation of mitochondria at nodes of Ranvier would be observed following 
hypoperfusion. The extent of inflammation was assessed by counting numbers of 
microglia which revealed no significant difference between groups following 3 days 
of hypoperfusion (p = 0.425) but a significant increase in microglial number was 
observed following 1 month of hypoperfusion (p = 0.001). In addition, assessment of 
mitochondrial distribution along myelinated axons revealed decreased numbers of 
nodes containing mitochondria following 6 weeks of hypoperfusion (p = 0.03) with 
no difference between groups observed following 3 months (p = 0.742). Taken 
together the results from this study provide evidence that chronic cerebral 
hypoperfusion results in dynamic alterations in the localisation of Nav1.6 channels 
which are accompanied by disruption to paranodal domains and impaired axon-glial 
integrity. Furthermore microglial number does not appear to mediate nodal and 
paranodal disruption following 3 days but may contribute to ongoing pathology 







Aim 2 – To determine the effects of chronic cerebral hypoperfusion on 
oligodendroglial populations 
The second aim of this thesis was to determine the effect of chronic cerebral 
hypoperfusion on numbers of mature oligodendrocytes and oligodendrocyte 
precursor cells (OPCs). This revealed a significant decrease in numbers of both 
populations following 3 days of cerebral hypoperfusion however following 1 month 
numbers of OPCs were restored and a significant increase in mature oligodendrocyte 
number was observed. Assessment of OPC proliferation demonstrated low numbers 
of proliferating cells but revealed that a proportion of newly generated cells had 
differentiated into mature oligodendrocytes. To determine a potential mechanism 
involved in OPC differentiation following cerebral hypoperfusion the expression of 
the GPR17 receptor was examined which has recently been reported to mediate OPC 
differentiation in response to injury. The results demonstrated decreased expression 
of GPR17 following 3 days of hypoperfusion (p = 0.007) with no difference between 
groups observed following 1 month (p = 0.362) indicating that this receptor is not 
involved in differentiation of OPCs following hypoperfusion. Taken together the 
results from this study show that mature oligodendrocytes and OPCs are lost early in 
response to hypoperfusion but that these cells recover over time, highlighting the 






Aim 3 – To investigate whether modulation of inflammation and oxidative stress 
could ameliorate alterations to white matter structure and function following 
severe chronic cerebral hypoperfusion 
The third and final aim of this thesis was to determine whether treatment with the 
anti-inflammatory and antioxidant drug DMF could ameliorate structural and 
functional alterations to white matter following severe chronic cerebral 
hypoperfusion. This was achieved by examining myelin and axonal integrity in 
addition to numbers of oligodendrocytes and OPCs following 7 days of severe 
chronic cerebral hypoperfusion. This revealed that myelin integrity was significantly 
decreased in vehicle-treated hypoperfused animals as compared to shams (p = 0.005). 
However no differences in myelin integrity were observed between sham and 
hypoperfused mice treated with DMF (p = 0.312). In contrast to the previous study, 
numbers of oligodendrocytes and OPCs were not altered following severe 
hypoperfusion however DMF treatment led to significantly increased numbers of 
oligodendrocytes in sham animals (p = 0.003). Assessment of white matter function 
using electrophysiology revealed that the conduction velocity of myelinated axons 
was significantly increased in DMF-treated hypoperfused animals as compared to 
those treated with vehicle (p = 0.04). Taken together the results of this study 
demonstrate that modulation of inflammation and oxidative stress may improve 








The results presented in this thesis demonstrate that chronic cerebral hypoperfusion 
results in structural alterations to myelinated axons and to oligodendroglial 
populations within the white matter which are accompanied by impaired spatial 
working memory. Whilst previous studies using the model have reported that 
cerebral hypoperfusion results in diffuse white matter pathology, this study has 
highlighted the vulnerability of nodal and paranodal domains of myelinated axons as 
regions which are altered early in response to hypoperfusion. Furthermore, 
characterisation of oligodendroglial populations has revealed that these cells are 
replaced over time despite ongoing hypoperfusion which demonstrates the 
regenerative capacity of the white matter following cerebral hypoperfusion. 
Critically the results presented in this thesis demonstrate that treatment with DMF 
improved the function of myelinated axons in response to severe reductions in 
cerebral blood flow and thus may represent an appropriate therapeutic strategy for 
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 1. Introduction  
 
The white matter of the brain is essential for neuronal communication and therefore 
plays a critical role in normal cognitive function. Post-mortem and magnetic 
resonance imaging (MRI) studies of elderly individuals have demonstrated that white 
matter integrity is weakened with increasing age which is thought to contribute to 
cognitive decline (Brant-Zawadzki et al., 1985; Awad et al., 1986a; Breteler et al., 
1994a; de Leeuw et al., 2001). Whilst the exact mechanisms underlying white matter 
disruption with ageing are unknown it is thought that modest age-related decreases in 
cerebral blood flow, termed chronic cerebral hypoperfusion, may be an important 
factor (Brun and Englund, 1986; O'Sullivan et al., 2002; Fernando et al., 2006). 
Studying the effects of cerebral hypoperfusion on white matter integrity in human 
brain is limited as elderly individuals often have co-morbid disease such as 
hypertension making it difficult to directly ascertain a causal relationship. This has 
led to the development of animal models of chronic cerebral hypoperfusion which 
can be used to directly determine the effects of cerebral hypoperfusion, in isolation, 
on white matter integrity and cognition. The studies described in this thesis sought to 
determine the impact of cerebral hypoperfusion on white matter structure and 






1.1 White matter 
The human brain consists of grey and white matter which both account for around 
50% of total brain volume (Zhang and Sejnowski, 2000). The white matter consists 
primarily of myelinated axons and associated glial cells including oligodendrocytes, 
astrocytes and microglia (Figure 1.1). The white matter also contains blood vessels 
which are essential for the delivery of oxygen and glucose to resident cells. 
 
1.1.1 Cellular components of white matter 
The glial cells of the white matter each have specific roles in the maintenance of 
white matter integrity but signalling mechanisms exist between glial cell types and 




Oligodendrocytes are the most abundant cells within the white matter, comprising 
around 70% of the total cell population (Ling and Leblond, 1973). Oligodendrocytes 
extend processes composed of myelin which wrap around neighbouring axons 
providing an insulating myelin sheath (Figures 1.1A and 1.1B). It has been estimated 
that a single oligodendrocyte can myelinate between 30-50 segments on individual 
axons (Hildebrand et al., 1993; Rivers et al., 2008), which are termed internodes 
(outlined in Section 1.1.2.2). The process of myelination is tightly regulated and 




surrounding compact myelin sheath which is called the g-ratio. In rodents the optimal 
g-ratio (axonal diameter divided by total fibre diameter) is reported to be 
approximately 0.64-0.77 (Smith and Koles, 1970; Little and Heath, 1994; Chomiak 
and Hu, 2009). 
 
In addition to myelin production, oligodendrocytes are also involved in the clustering 
of axonal ion channels (Kaplan et al., 1997; Dupree et al., 2004) and provide trophic 
and metabolic support to the axons they ensheath (Nave, 2010a; Lee et al., 2012). It 
has additionally been reported that oligodendrocytes can directly modulate the 
conduction velocity of the axons they myelinate (Yamazaki et al., 2007). 
 
1.1.1.2 Oligodendrocyte precursor cells 
Oligodendrocytes are derived from oligodendrocyte precursor cells (OPCs; Figures 
1.1A and 1.1C) which are abundant during late embryonic and early postnatal 
development but persist in the adult brain (Nishiyama et al., 2002). OPCs represent 
an intermediary stage in the oligodendrocyte lineage and differentiate into pre-
myelinating oligodendrocytes which then undergo further differentiation into mature 
myelinating oligodendrocytes (Figure 1.2; Nishiyama et al., 2009). It has been 
estimated that OPCs comprise around 8-9% of all cells within adult rat white matter 
(Dawson et al., 2003) and as such they are considered to be a major glial cell type 
(Peters, 2004). Furthermore, studies have revealed that OPCs are the most abundant 
proliferating cell type in both adult mouse (Dawson et al., 2003) and human (Geha et 




oligodendrocyte-type 2 astrocyte (O-2A) progenitor cells based on in vitro studies 
demonstrating that they could generate both oligodendrocytes and astrocytes (Raff et 
al., 1983; Ffrench-Constant and Raff, 1986). A growing number of studies have since 
characterised the fate of these precursor cells in vivo and have revealed that these 
cells exclusively belong to the oligodendrocyte lineage (reviewed by Richardson et 
al., 2011) and thus are now referred to as OPCs. Phenotypically, OPCs are identified 
based on expression of the neuron-glial antigen 2 (NG2) protein (Stallcup and 
Beasley, 1987) and are therefore also termed ‘NG2 cells’.  
 
The finding that OPCs with the ability to proliferate and differentiate are present in 
the adult brain has important implications both for myelin remodelling in the normal 
brain and repair following injury. Indeed, a recent study has shown that OPC 
proliferation and differentiation in healthy adult mouse brain are tightly co-ordinated 
to maintain a constant cell density throughout life (Hughes et al., 2013). 
Furthermore, it has been demonstrated that in response to white matter injury such as 
demyelination and ischaemia, OPCs can proliferate and differentiate into mature 
oligodendrocytes thus replacing any cells which may have been lost as a result of the 
insult (Mandai et al., 1997; Keirstead et al., 1998). Additionally, it has been reported 
that OPCs possess a variety of receptors, and that a subset of OPCs can generate 
action potentials (Karadottir et al., 2008) suggesting that they may have critical roles 






The second most abundant cells are astrocytes which comprise approximately 15-
20% of cells within the white matter (Ling and Leblond, 1973). Astrocytes have 
many and varied roles including intercellular signalling and repair following injury. 
Astrocytes make direct contact with blood vessels within the white matter (Figures 
1.1A and 1.1D) allowing regulation of local blood flow and modulation of energy 
supply and metabolism (reviewed by Sofroniew and Vinters, 2010). In the normal 
brain, astrocytes are usually ‘resting’ but upon CNS injury they can become activated 
which can have both beneficial and detrimental consequences (Sofroniew, 2009). 
 
1.1.1.3 Microglia/macrophages 
Microglia are the resident immune cells of the CNS (Figures 1.1A and 1.1E) and it is 
estimated that microglia comprise approximately 5% of all cells within the white 
matter (Lawson et al., 1990). Microglia are considered to be a subpopulation of 
macrophages however these populations of cells differ in that macrophages are found 
in organs throughout the body whereas microglia are only found in brain (reviewed 
by Saijo and Glass, 2011; Cronk and Kipnis, 2013). Despite this difference, both 
microglia and macrophages are observed in the brain and due to a lack of markers to 
distinguish microglial and macrophage populations these terms are often used 





Like astrocytes, microglia are normally found in a ‘resting’ state but can be rapidly 
activated in response to injury and disease. Resting microglia perform active 
surveillance of the local microenvironment allowing them to react rapidly to injury. 
Upon activation, microglia become phagocytic and release a battery of inflammatory 
mediators in addition to reactive oxygen species (Kreutzberg, 1996). Thus microglial 
activation is thought to exert both protective and damaging effects in the injured 
CNS.  
 
1.1.1.5 Blood vessels 
In addition to glial cells, the white matter also contains blood vessels which are 
essential for the delivery of oxygen and glucose to the cells of the white matter.  
Blood vessels are lined by endothelial cells which release a variety of mediators both 
to regulate local blood flow and to signal to glial cells (Faraci and Heistad, 1998; 





Figure 1.1: Cellular components of white matter. (A) The white matter consists of 
myelinated axons and associated glial cells including oligodendrocytes, astrocytes, 
microglia and oligodendrocyte precursor cells (OPCs). (B-E) Confocal images 
showing immunolabelled glial cells in mouse brain sections. (B) In this image a 
single oligodendrocyte can be seen forming internodal segments on multiple axons. 
(C) OPCs labelled using an anti-NG2 antibody. (D) In this image astrocyte processes 
can be seen outlining a blood vessel. (E) Resting microglia are shown in this image. 
Image A taken and adapted from The McGraw-Hill Company (www.mhhe.com). 
Image B was acquired at 40x magnification and images C-E were acquired at 20x. 
The following antibodies were used to label cells (B) myelin oligodendrocyte 
glycoprotein (MAG), (C) NG2, (D) glial fibrillary acidic protein (GFAP), and (E) 








Figure 1.2: The oligodendrocyte lineage. Oligodendrocyte precursor cells are 
derived from multipotent neural stem cells during late embryonic and early postnatal 
development. OPCs persist in the adult brain and represent around ~9% of cells 
within the white matter. OPCs first differentiate into pre-myelinating 
oligodendrocytes which then further differentiate into mature myelinating 




1.1.2 Structure and function of myelinated axons 
1.1.2.1 Myelin 
The presence of a myelin sheath around an axon is essential for fast and efficient 
axon potential conduction (outlined in Section 1.1.2.4). Myelin is comprised of 
approximately 70% lipids including phospholipids, glycolipids, cholesterol and 
glycosphingolipids which are commonly found in other cellular membranes 
(Baumann and Pham-Dinh, 2001). The lipid-rich composition of myelin gives the 
white matter its white appearance and provides myelin with its electrically insulating 
properties.  
 
In addition to high lipid content, myelin is also composed of approximately 30% 
protein. The major myelin proteins are myelin basic protein (MBP) and proteolipid 
protein (PLP), which constitute 30% and 50% of total myelin protein respectively 
(Baumann and Pham-Dinh, 2001). Two other proteins, 2',3'-Cyclic-nucleotide 3'-
phosphodiesterase (CNPase) and myelin-associated glycoprotein (MAG) are also 
present within the myelin sheath but represent minor proportions (4% and 1% 
respectively). Despite the relatively low proportion of MAG within the myelin 
sheath, this protein plays a key role in the maintenance of axon-glial connection (Li 





1.1.2.2 Domain structure of myelinated axons 
Myelinated axons have a defined domain structure (Figure 1.3A). The regularly 
spaced, non-myelinated nodes of Ranvier are flanked either side by the paranodal 
domains where myelin forms its terminal loops. The paranodes are adjacent to the 
juxtaparanodes which in turn are found beside the internodal domains. Each domain 
is characterised by a unique protein architecture (Figure 1.3B) which is specialised to 
allow efficient axon potential propagation along the length of the axon. 
 
1.1.2.3 Protein architecture of nodes, paranodes and juxtaparanodes  
Nodes of Ranvier are non-myelinated regions of myelinated axons which are 
approximately 1 µm in length (in both human and rodent) and contain a high density 
of voltage-gated sodium (Nav) channels (approximately 1000 channels per µm
2; 
(Waxman and Ritchie, 1993). The main sodium channel isoform present at adult 
nodes of Ranvier is Nav1.6 (Caldwell et al., 2000) however Nav1.2 has been 
demonstrated to be the predominant isoform during development (Kaplan et al., 
2001). The high density clustering of Nav1.6 channels is mediated by interactions 
with other nodal proteins, and through protein interactions at the paranodes (outlined 
below). At nodes of Ranvier Nav1.6 channels are associated with Ankyrin G, a large 
protein which tethers the channels to the node through its interaction with the actin-
binding protein βIV spectrin, which in turn anchors the complex to the axonal 
cytoskeleton (Figure 1.3B; Srinivasan et al., 1988). Nav1.6 channels also interact 
with the cell adhesion molecule neurofascin 186 (Nfasc186) at nodes of Ranvier 




extracellular matrix (Figure 1.3B; Hedstrom et al., 2007). Thus the interactions 
between Nav1.6 channels and other nodal proteins help to maintain the high density 
clustering of channels at nodes of Ranvier. 
 
The nodes of Ranvier are flanked either side by the paranodes which are the primary 
sites of axon-glial connection in the CNS. At the paranodes, the axonal proteins 
contactin and contactin-associated protein (Caspr) form a trimeric complex with the 
myelin protein neurofascin 155 (Nfasc155; Figure 1.3B). Together these proteins 
form the paranodal septate-like junctions which act as physical barriers to prevent the 
diffusion of Nav1.6 channels away from nodes of Ranvier. Studies using transgenic 
mice lacking Contactin (Boyle et al., 2001), Caspr (Bhat et al., 2001) and Nfasc155 
(Pillai et al., 2009) have shown that each of these proteins is essential for the 
maintenance of paranodal septate-like junctions. 
 
The juxtaparanodal domains are found adjacent to the paranodal domains (Figures 
1.3A and 1.3B) and are characterised by a high density of voltage-gated potassium 
(Kv) channels, including Kv1.1 and Kv1.2 isoforms (Wang et al., 1993). Similar to 
Nav1.6 channels at nodes of Ranvier, Kv channels are part of a larger protein 
complex including Caspr2 and TAG-1 (Poliak et al., 2003) however many 
components of the juxtaparanodal complex remain unidentified (Rasband, 2004). It 
is thought that the interaction between Caspr2 and TAG-1 plays an important role in 
restricting Kv channels to juxtaparanodes (Poliak and Peles, 2003) in addition to the 




juxtaparanodes and into the neighbouring paranodes. The internodal domains of 
myelinated axons are found adjacent to juxtaparanodes and are the sites at which 
compact myelin is present. MAG is found within internodal myelin and plays an 
important role in maintenance of axon-glial connection through associations with 






Figure 1.3 Myelinated axons consist of highly specialised domains. (A) Schematic 
diagram showing the domains of myelinated axons. Nodes of Ranvier are 
unmyelinated regions flanked either side by paranodal domains. The juxtaparanodes 
separate paranodal and internodal domains. (B) Nodes of Ranvier contain a high 
density of voltage-gated sodium channels (Nav1.6) which are anchored to the 
cytoskeleton via interactions with Ankyrin G and βIV spectrin. Additionally, an 
association with Nfasc186 tethers these channels to the extracellular matrix. The 
paranodal septate-like junctions found either side of the nodes of Ranvier are formed 
by the trimeric protein complex between the glial protein Nfasc155 and the axonal 
proteins Caspr and Contactin. At juxtaparanodal domains, clusters of Kv1.1 and 
Kv1.2 channels are present in addition to TAG-1 and Caspr2 which are thought to 
play an important role in the localisation of Kv channels at juxtaparanodes. Images 





1.1.2.4 Action potential conduction along myelinated axons 
The highly organised domain structure of myelinated axons and the presence of an 
intact myelin sheath are essential for saltatory conduction of action potentials along 
axons and are thus essential for neuronal communication within the brain. Saltatory 
conduction is the process by which action potentials are regenerated at nodes of 
Ranvier (Huxley and Stampfli, 1949; Hodgkin and Huxley, 1952) due to the fast 
influx of Na+ ions through Nav1.6 channels. The high density clustering of Nav1.6 
channels at nodes of Ranvier is essential for rapid Na+ entry and subsequent axonal 
depolarisation. Additionally, the segregation of Kv channels at juxtaparanodal 
domains is thought to play an important role in repolarising the axonal membrane 
allowing the return to resting membrane potential (Waxman and Ritchie, 1993). The 
insulating myelin sheath around myelinated axons is also important for action 
potential conduction as it acts to prevent internodal current leakage and increase 
resistance (reviewed by Hartline and Colman, 2007). It has been estimated that 
myelination of axons can increase conduction velocity by up to 100x compared to 
values of non-myelinated axons (Nave, 2010a).  
 
Measurement of action potential conduction along axons can be used to examine 
white matter function in experimental models and is assessed using 
electrophysiological approaches in brain slice preparations or teased nerve fibres. In 
such studies, the compound action potential (CAP) is typically measured which 
represents the combined action potential by all axons within the fibre bundle. This 




matter disruption on action potential conduction. Such studies have demonstrated 
that disruption to the myelin sheath or to the localisation of Nav1.6 channels at nodes 
of Ranvier can impair action potential conduction (McDonald and Sears, 1970; Ritter 
et al., 2013) and therefore may impact on cognition.  
 
1.1.3 The impact of ageing on white matter integrity and cognition  
The growing use of imaging techniques such as magnetic resonance imaging (MRI) 
in neurological research has helped advance our understanding of the role of white 
matter in the pathogenesis of brain disease but also during the normal ageing process. 
Early studies using T2-weighted MRI revealed the presence of white matter ‘lesions’, 
appearing as areas of hyperintense signal, in periventricular and deep subcortical 
white matter of elderly individuals (Brant-Zawadzki et al., 1985; Awad et al., 
1986b). Another study demonstrated that approximately 55% of individuals aged 
between 60 and 70 years old had white matter hyperintensities, the prevalence of 
which increased to 95% of subjects aged between 80 and 90 (de Leeuw et al., 2001). 
Additional studies have utilised diffusion tensor imaging (DTI) to visualise the 
directionality of white matter fibre tracts and have similarly reported age-related 
decreases in white matter integrity (Head et al., 2004; Bastin et al., 2009), with some 
studies demonstrating that this decline begins at approximately 40 years of age 





In addition to MRI, post-mortem studies have been carried out to study the 
pathological changes underlying white matter hyperintensities. These have revealed 
that areas of hyperintense signal correspond to areas in which there is a loss of 
myelinated fibres, myelin vacuolation and a marked increase in numbers of 
astrocytes and microglia (Awad et al., 1986a; Scarpelli et al., 1994; Simpson et al., 
2007a). Furthermore a significant decrease in white matter volume has also been 
reported in aged brains as compared to younger brains in both humans (Tang et al., 
1997) and primates (Peters and Sethares, 2002).  
 
Importantly, parallel MRI and cognitive testing in the same individuals has shown a 
direct association between white matter lesions and poorer performance in cognitive 
tests of executive function (Breteler et al., 1994a; O'Sullivan et al., 2001) and 
memory recall (de Groot et al., 2000; O'Brien et al., 2002). It has been proposed that 
reduced myelin integrity in ageing results in ‘disconnection’ within the brain which 
subsequently leads to cognitive decline (O'Sullivan et al., 2001). It has similarly been 
hypothesised that this disconnection initially affects executive cognitive function and 
aspects of memory as these processes involve a high degree of signalling between 
neurons and therefore are more susceptible to impaired action potential propagation 
as a result of myelin disruption (Bartzokis et al., 2004). Importantly, longitudinal 
study in a large cohort of elderly individuals has demonstrated that periventricular 
white matter lesion volume can predict the rate of cognitive decline over a 7 year 
period (De Groot et al., 2002). Furthermore, periventricular white matter 
hyperintensities are also observed in individuals with Alzheimer’s disease (AD) and 




Scheltens et al., 1995; Barber et al., 1999), suggesting that white matter disruption 
may contribute both to ‘normal’ age-related cognitive decline and to clinical 
dementia. Taken together, the evidence from MRI and pathology studies demonstrate 
age-related alterations in white matter integrity which may underlie cognitive decline 
in ageing. The exact causes of white matter disruption in ageing are unknown but it 
is thought that reduced cerebral blood flow (CBF) may be an important contributing 
factor.  
 
1.2 Blood supply to the brain and chronic cerebral hypoperfusion 
1.2.1 Blood supply to the brain 
Normal functioning of the brain requires a constant blood supply. In most mammals, 
including humans and rodents, the brain receives its blood supply primarily through 
the internal carotid arteries which supply the forebrain and the vertebral arteries 
which supply the hindbrain. These arteries enter the circle of Willis, a circular 
network of arteries which provides a uniform blood supply to the brain. This vascular 
network creates redundancies in the cerebral circulation such that perfusion remains 
constant in the event of blockage or stenosis of one of the arteries supplying or 
forming the circle of Willis. The integrity of the circle of Willis varies between 
species and individual strains of animals which can influence the ability of the brain 





1.2.1.1 Blood supply to the white matter 
The white matter receives its blood supply from deep penetrating arteries that run 
along the cortical surface and travel at right angles through the cortex into the 
subcortical white matter (Pantoni and Garcia, 1997; Nonaka et al., 2003). 
Microvessels branch from these penetrating arteries to form a three dimensional 
network supplying the white matter (Blinder et al., 2013). The periventricular white 
matter receives its blood supply from ventrofugal vessels arising from the base of the 
brain (Pantoni and Garcia, 1997). Anatomical studies have revealed that the vascular 
network supplying the white matter is less extensive than that of grey matter (Klein 
et al., 1986) and it has been estimated that capillary density is around one third to one 
quarter of that in the cortex (Klein et al., 1986; Nonaka et al., 2003). Similarly, MRI 
studies in humans have estimated that white matter CBF (~33.6 ml/min ± 11.5 per 
100g) is approximately half of that of grey matter (~69.7 ml/min ± 29.7 per 100g 
Rempp et al., 1994). It has been proposed that this relatively low blood supply may 
render the white matter more susceptible to reductions in CBF (Pantoni and Garcia, 
1997; Holland et al., 2008). 
 
1.2.2 Cerebral energy metabolism 
Although the brain accounts for only 2% of body weight, it is estimated to consume 
approximately 20% of total oxygen and 25% of total glucose (Edvinsson et al., 
1993). This high requirement of oxygen and glucose is essential for the generation of 
adenosine triphosphate (ATP), the main energy substrate of all cells within the brain 




therefore any disruption to cerebral blood flow can alter the balance between ATP 
production and usage, resulting in disturbed cellular function or cell death. ATP is 
generated as a product of the oxidation of glucose to water and CO2 through the 
sequential processes of glycolysis, which occurs in the cytosol, and the citric acid 
cycle and oxidative phosphorylation which occur within mitochondria. Together 
these processes yield approximately 30-36 molecules of ATP per molecule of 
glucose (reviewed by Magistretti and Allaman, 2013), the majority of which is 
generated from mitochondrial oxidative phosphorylation.  
 
ATP can also be generated in the absence of oxygen as a result of anaerobic 
glycolysis however this process is inefficient, generating two molecules of both ATP 
and lactate per molecule of glucose (Magistretti and Allaman, 2013). Interestingly, a 
number of studies have revealed that the brain can utilise lactate as an alternative 
energy source in the absence of glucose. Electrophysiological study has 
demonstrated that the evoked synaptic response in rat hippocampal slices was not 
significantly different when supplied with lactate as compared to glucose (Schurr et 
al., 1988). In addition it has been shown that lactate released by astrocytes can be 
used as a neuronal energy substrate during times of increased energy demand 
(Pellerin and Magistretti, 1994; Magistretti and Pellerin, 1999; Tarczyluk et al., 
2013). It is estimated that 1 molecule of lactate can generate approximately 15 
molecules of ATP (Schurr, 2006). Thus while the brain preferentially utilises glucose 
as the main energy source it has the capability to use alternatives in the event of 




1.2.2.1 Energy metabolism in white matter 
Given that white matter CBF is approximately 50% of that of grey matter it is not 
surprising that estimates of white matter oxygen and glucose consumption are 
similarly reported to be around half of grey matter values in both rodent (Sokoloff et 
al., 1977; Nishizaki et al., 1988) and human (Baron et al., 1984; Pantano et al., 
1984). Despite this, myelinated axons and glial cells of the white matter are critically 
dependent on an uninterrupted supply of oxygen and glucose. Interestingly, 
electrophysiological assessment of adult rat optic nerve preparations has shown that 
whilst 60 minutes of glucose deprivation results in irreversible failure of the CAP 
(Wender et al., 2000), the CAP is maintained in the absence of glucose for between 
30-40 minutes (Fern et al., 1998; Wender et al., 2000). Furthermore, the CAP is 
maintained for up to 15 minutes in the absence of both glucose and oxygen (Fern et 
al., 1998). Taken together these studies indicate that there are alternative energy 
stores within the white matter.   
 
Within myelinated axons the vast majority of ATP is generated from axonal 
mitochondria which are dynamically transported along the length of the axon to areas 
of increased energy demand (reviewed by Hollenbeck and Saxton, 2005). Growing 
evidence indicates that in addition to axonal mitochondria, the energy requirements 
of myelinated axons may be met in part by metabolic support from myelinating 
oligodendrocytes (Nave, 2010b; Saab et al., 2013). This theory proposes that 
myelinating oligodendrocytes can metabolically support axons by the transfer of 




the myelin sheath around an axon physically prevents axonal uptake of glucose from 
the extracellular environment (Nave, 2010a, b) therefore it has been postulated that 
oligodendrocyte metabolites such as lactate and pyruvate may be transferred to axons 
via ‘channels’ within non-compact myelin (Nave, 2010b; Saab et al., 2013). In 
support of this it has recently been demonstrated that the lactate transporter 
monocarboxylate transporter 1 (MCT1) is enriched along the myelin sheath and that 
loss of this transporter results in axonal damage (Lee et al., 2012). Furthermore, 
another recent study sought to determine the ability of myelinated axons to utilise 
oligodendrocyte-derived lactate and generated mutant mice in which oligodendrocyte 
mitochondria were disrupted and gradually lost the ability to generate ATP from 
oxidative phosphorylation (Funfschilling et al., 2012). In this model, 
oligodendrocytes were required to generate ATP through glycolysis leading to the 
production of lactate. Critically these mice did not exhibit any myelin or axonal 
pathology suggesting that both mature oligodendrocytes and myelinated axons could 
utilise lactate in the absence of glucose (Funfschilling et al., 2012). These recent 
findings confirm earlier studies which revealed that the rate of glycolytic metabolism 
is higher in white matter than grey matter (Morland et al., 2007) and that the CAP of 
optic nerve axons is unchanged when nerves are incubated in lactate as compared to 
glucose (Brown et al., 2001). It has additionally been reported that astrocytes also 
express MCT1 and that astrocyte-derived lactate can maintain the CAP in mouse 
optic nerve preparations, indicating a further energy source within the white matter 
(Tekkok et al., 2005). Taken together these studies demonstrate that in the absence of 
glucose, the energy requirements of oligodendrocytes and myelinated axons of the 




is of particular importance for conditions in which CBF is reduced such as chronic 
cerebral hypoperfusion.  
 
1.2.3 Chronic cerebral hypoperfusion 
A common feature of ageing is a modest age-related reduction in CBF, termed 
chronic cerebral hypoperfusion. Studies have shown that from age 20 to 80 years, 
CBF is reduced by approximately 0.5% per year (Leenders et al., 1990; Scheel et al., 
2000). This modest and chronic decrease in CBF with ageing should not be confused 
with ischaemic stroke which is a very acute and severe reduction (>70%) in CBF 
resulting in irreversible tissue damage with often debilitating consequences (Astrup 
et al., 1981; Baron, 2001).  
 
1.2.3.1 The impact of cerebral hypoperfusion on white matter integrity and cognition 
A growing number of studies have highlighted the association between chronic 
cerebral hypoperfusion and white matter disruption. Early MRI investigations 
revealed a strong correlation between white matter hyperintensities and 
cerebrovascular or cardiovascular disease (Awad et al., 1986b; Breteler et al., 
1994b). Furthermore, post-mortem investigation of individuals with clinical 
dementia revealed areas of myelin pallor characterised by loss of myelinated axons 
and oligodendrocytes in addition to thickening of cerebral arterioles. This finding, 
together with a strong history of cardiovascular disease in many of the cases 




due to hypoperfusion (Brun and Englund, 1986). This was later confirmed by parallel 
post-mortem MRI and pathology studies of ageing brains which revealed that 
periventricular white matter ‘lesions’ showed an increased expression of markers of 
hypoxia (Fernando et al., 2006) in addition to cerebrovascular pathology (Young et 
al., 2008). Additionally, a strong correlation between the presence of white matter 
hyperintensities and local blood flow has been reported (DeCarli et al., 1995; 
O'Sullivan et al., 2002). Furthermore it has been demonstrated that white matter 
hyperintensities often occur in regions in which blood flow is normally relatively 
lower compared to other white matter areas, namely the deep periventricular white 
matter (Holland et al., 2008). As indicated in Section 1.2.1.1, this low blood supply 
may render the periventricular white matter more susceptible to reductions in blood 
flow than other regions (Pantoni and Garcia, 1997; Holland et al., 2008). 
 
Additional studies have reported an association between reduced CBF, increased 
white matter hyperintensity volume and poorer performance upon 
neuropsychological testing of executive function in elderly individuals (Appelman et 
al., 2010). Similarly it has been demonstrated that elderly individuals with dementia 
have lower CBF than age-matched controls (Ruitenberg et al., 2005). Taken together 
these studies indicate that chronic cerebral hypoperfusion may underlie white matter 





1.2.3.2 Animal models of chronic cerebral hypoperfusion 
Investigating the effects of cerebral hypoperfusion on white matter integrity in 
human brain is limited as it is difficult to ascertain a cause and effect relationship 
through clinical imaging or post-mortem approaches. Indeed, many individuals with 
cerebral hypoperfusion often have co-existing disease states such as hypertension 
and diabetes mellitus and therefore it is difficult to study the effects of hypoperfusion 
on white matter integrity in isolation. This has led to the development of animal 
models which typically involve modulation of CBF through occlusion or stenosis of 
the common carotid arteries. The degree of hypoperfusion induced is dependent on 
the integrity of the circle of Willis which varies amongst species and strains (Figure 
1.4).  
 
1.2.3.2.1 Common carotid artery occlusion models  
Many investigators studying cerebral hypoperfusion have utilised the bilateral 
common carotid artery occlusion (BCCAO) model in rat (Pulsinelli and Brierley, 
1979). In this model both carotid arteries of Wistar or Sprague-Dawley rats are 
permanently occluded using nylon sutures, resulting in an approximate 60-70% 
decrease in CBF which recovers to around 50% of baseline within one month 
(reviewed by Farkas et al., 2007). Studies using this model have reported myelin 
disruption and vacuolation in the optic tract as early as 3 days after surgery with 
similar damage evident in the corpus callosum from 7 days (Wakita et al., 2002). 
This myelin pathology worsens over time such that disruption to other white matter 




2002). In addition, increased numbers of activated microglia and astrocytes have 
been reported in this model after 2 weeks (Cho et al., 2006; Lee et al., 2006), and 
persist until over 4 months following surgery (Ohta et al., 1997). Behavioural 
assessment has revealed that these rats commit more revisiting errors in the 8-arm 
radial arm maze task than sham controls when assessed 3 days and 4 months 
following surgery (Ni et al., 1994). Similarly a significantly increased escape latency 
in the Morris water maze task has been reported as early as 7 days following surgery 
(Pappas et al., 1996). Whilst these mice exhibit characteristic features of human age-
related white matter disruption (namely white matter damage, increased 
inflammation and cognitive decline) one limitation of this model is that due to the 
severity of the reduction in cerebral blood flow these animals often show pronounced 
ischaemic neuronal damage in the hippocampus (Farkas et al., 2004; Farkas et al., 
2007). In addition, extensive damage to the optic nerve is also reported (Farkas et al., 
2007) which may influence the ability of these animals to respond to visual cues 
during behavioural testing. The effects of decreased blood flow on white matter 
integrity and cognition can therefore not be studied in this model without the 
confounding presence of ischaemic neuronal damage.   
 
Whilst the rat BCCAO model is useful for studying the effects of severe 
hypoperfusion, mouse models are advantageous as they can be easily genetically 
modified. Permanent BCCAO cannot be studied in mouse as many strains are unable 
to tolerate the procedure due to an incomplete circle of Willis (Figure 1.4; Barone et 
al., 1993; Fujii et al., 1997; Yang et al., 1997; Kitagawa et al., 1998). This is 




mouse and is often used as a background strain for transgenic animals. These mice 
exhibit poorly developed or absent posterior communicating arteries which results in 
compromised collateral blood flow and a greater susceptibility to reductions in CBF 
(Figure 1.4; Yang et al., 1997; Kitagawa et al., 1998; Majid et al., 2000). A transient 
BCCAO model of global ischaemia, resulting in severe hypoperfusion, has been 
described in mouse through occlusion of the carotid arteries for 20 minutes (Yang et 
al., 1997). A disadvantage of this model however is that ischaemic neuronal damage 
is induced in the hippocampus (Yang et al., 1997), again confounding the study of 
hypoperfusion on white matter integrity. A model of permanent unilateral common 
carotid artery occlusion has more recently been described in mouse (Yoshizaki et al., 
2008). In this model, occlusion of the right common carotid artery induces white 
matter rarefaction and loss of myelinated fibres in the corpus callosum together with 
an increase in microglial number and levels of pro-inflammatory cytokines following 
1 month of hypoperfusion (Yoshizaki et al., 2008). These mice also exhibit impaired 
performance in object recognition tests (Yoshizaki et al., 2008) however this model 







Figure 1.4: The anatomy of the Circle of Willis. (A) Schematic diagram showing 
the anatomy of the Circle of Willis. Blood is delivered to the forebrain via the 
internal carotid arteries and to the hindbrain via the vertebral arteries. The posterior 
communicating arteries connect these two supplies to provide collateral flow such 
that if there is a blockage or stenosis of one of the arteries supplying or forming the 
Circle of Willis, CBF will remain constant. (B) Schematic diagram showing the 
incomplete Circle of Willis in C57Bl/6J mice. This strain of mice typically have an 
absence of either one or both posterior communicating arteries (PComA) resulting in 
insufficient collateral flow and an increased vulnerability to reductions in CBF. ACA 
– anterior communicating artery, MCA – middle cerebral artery, PCA – posterior 
cerebral artery, BA – basilar artery, SCA – superior cerebellar artery. Image A taken 
and adapted from Wikipedia (www.wikipedia.org). Image B taken and adapted from 





1.2.3.2.2 Bilateral common carotid artery stenosis 
Bilateral common carotid artery stenosis was first described as a model of cerebral 
hypoperfusion in gerbil (Kudo et al., 1990; Hattori et al., 1992). In this model, 
hypoperfusion is achieved through application of small wire coils to the carotid 
arteries resulting in stenosis (rather than complete occlusion) of the vessels and a 
reduction in CBF. A key advantage of this approach is that the level of 
hypoperfusion induced is dependent on the internal diameter of the microcoils which 
provides the opportunity to study the effects of increasing severity of hypoperfusion. 
Pathologically these animals exhibit widespread white matter rarefaction and 
increased astrocyte reactivity, together with ischaemic neuronal damage in the 
hippocampus and cortex from 1 week after surgery (Hattori et al., 1992). The extent 
of white and grey matter pathology induced in gerbil is a consequence of this 
species’ incomplete circle of Willis which renders the brain highly vulnerable to 
reductions in CBF (Yoshizaki et al., 2008). These animals also display an impaired 
learning ability in the passive avoidance test after 6 weeks of hypoperfusion (Kudo et 
al., 1990).  
 
Another bilateral carotid artery stenosis model has been developed using C57Bl/6J 
mice and similarly uses wire microcoils around the carotid arteries to reduce CBF 
(Shibata et al., 2004). The initial characterisation of the model studied the extent of 
white and grey matter pathology induced by microcoils of varying internal diameters 
(0.22mm, 0.20 mm, 0.18 mm and 0.16 mm). The authors reported that microcoils 




days which steadily recovered to around 15% of baseline values after one month 
(Shibata et al., 2004). Pathological assessment demonstrated diffuse white matter 
damage together with increased numbers of microglia and astrocytes evident from 14 
days after surgery and persisting for up to 1 month (Shibata et al., 2004; Coltman et 
al., 2011). Critically, this white matter damage occurred in the absence of ischaemic 
neuronal damage. In contrast, mice in which hypoperfusion was induced using 0.16 
mm diameter microcoils exhibited ischaemic neuronal damage in the cortex and 
hippocampus, together with cortical microinfarcts (Shibata et al., 2007). This 
highlights that the internal diameter of the microcoils can directly influence the 
extent of white and grey matter pathology, and indicates that the 0.18 mm microcoil 
is optimal for studying the effects of chronic cerebral hypoperfusion on white matter 
integrity. Furthermore, behavioural studies of mice fitted with 0.18 mm coils have 
demonstrated that hypoperfused mice commit significantly more revisiting errors that 
sham controls in the 8-arm radial arm maze assessment of spatial working memory 
(Shibata et al., 2007; Coltman et al., 2011). Thus this model provides the opportunity 
to study the effects of chronic cerebral hypoperfusion on white matter integrity and 
the downstream cognitive changes in the absence of ischaemic neuronal damage.  
 
A modification of the bilateral carotid stenosis model has more recently been 
described (Miki et al., 2009). In this study the authors applied a 0.18 mm microcoil 
to the right carotid artery and a 0.16 mm microcoil to the left common carotid artery 
in order to induce a more severe reduction in CBF whilst limiting the excessive 
mortality (75%) associated with applying 0.16 mm microcoils to each carotid 




initially to between 20 - 50% following six days which recovers to around 60% 
following 1 month. Pathologically these mice show myelin damage and glial 
activation following 1 month of cerebral hypoperfusion in addition to ischaemic 
neuronal damage, primarily in the hippocampus (Miki et al., 2009). Behavioural 
assessment using the Morris water maze has also demonstrated a significant increase 
in escape latency as compared to shams following 1 month of hypoperfusion (Miki et 
al., 2009). This modified model is therefore a useful tool to study the effects of more 
severe cerebral hypoperfusion.  
 
1.2.4 Mechanisms of white matter damage following cerebral hypoperfusion 
An understanding of the mechanisms underlying white matter disruption with 
hypoperfusion is essential for the development of future therapeutic strategies. 
Damage to myelinated axons and loss of oligodendrocytes is commonly observed in 
disease states such as cerebral ischaemia (Dewar et al., 2003) and multiple sclerosis 
(MS) (Lucchinetti et al., 2000). It has been demonstrated both in vitro and in vivo 
that oligodendrocytes are vulnerable to increased inflammation (Merrill and 
Scolding, 1999; Mabuchi et al., 2000) and oxidative stress (Bongarzone et al., 1995; 







White matter disruption associated with cerebral hypoperfusion in humans and in 
mouse models is accompanied by a pronounced inflammatory response. Post-mortem 
study of aged human brains has shown that periventricular white matter disruption is 
associated with a significant increase in microglial activation as compared to control 
brains (Simpson et al., 2007b). In addition, microarray analysis of white matter 
extracted from mice following 3 days of chronic cerebral hypoperfusion has revealed 
upregulation of several genes associated with inflammatory responses (Reimer et al., 
2011). Furthermore, increased production of the pro-inflammatory cytokine tumour 
necrosis factor α (TNFα) has been shown in rat following 14 days of BCCAO (Lee et 
al., 2006) and in mouse following 30 days of chronic cerebral hypoperfusion 
(Washida et al., 2010). Colocalisation of macrophages and apoptotic 
oligodendrocytes has also been reported following focal cerebral ischaemia in rat, 
suggesting that cytokine release from nearby macrophages may directly lead to 
oligodendrocyte death (Mabuchi et al., 2000). Additionally administration of the 
microglial inhibitor minocycline to rats following BCCAO has been reported to 
significantly ameliorate myelin loss in the corpus callosum as compared to controls 
(Cho et al., 2006). Taken together these studies indicate that increased inflammation 
may contribute to white matter disruption following chronic cerebral hypoperfusion.  
 
1.2.4.2 Oxidative stress 
The vulnerability of myelinated axons and oligodendrocytes to severe reductions in 




using models of cerebral ischaemia (Pantoni et al., 1996; Dewar et al., 2003). As 
outlined in Section 1.2.2, cells require glucose and oxygen for the generation of ATP 
through mitochondrial oxidative phosphorylation. Reactive oxygen and nitrogen 
species are generated as bi-products of normal oxidative metabolism, and are 
scavenged by endogenous antioxidant enzymes (Yu, 1994). In conditions of 
decreased oxygen and glucose, axonal mitochondria are unable to meet the energy 
requirements to maintain ionic gradients, resulting in an influx of Ca2+ which itself 
causes damage to mitochondria resulting in a substantial release of reactive oxygen 
species (Brookes et al., 2004; Waxman, 2006). This increased free radical generation 
results in damaging lipid, protein and nucleic acid oxidation and can perpetuate the 
release of further free radical species (Finkel and Holbrook, 2000). Furthermore it 
has also been demonstrated that activated microglia can release nitric oxide and 
superoxide radicals (Colton and Gilbert, 1987; Block et al., 2007) highlighting a link 
between inflammation and oxidative stress.  
 
It has been proposed that oligodendrocytes are particularly vulnerable to increased 
oxidative stress due to their high metabolic rate as compared to other cells (Hyden 
and Pigon, 1960) which is attributed to the high energy cost of myelin synthesis 
(McTigue and Tripathi, 2008), however this remains a contentious issue. In addition 
is has been demonstrated that oligodendrocytes and OPCs have a high iron content 
and low levels of the endogenous antioxidant enzyme glutathione (Connor and 
Menzies, 1996; Thorburne and Juurlink, 1996; Merrill and Scolding, 1999). Together 
these features of oligodendrocytes are thought to render them particularly vulnerable 




Studies in mouse have demonstrated increased oxidative stress within cerebral 
capillaries (Washida et al., 2010) and increased protein oxidation in white matter 
following 1 month of chronic cerebral hypoperfusion (Miyamoto et al., 2013b). In 
addition, increased lipid peroxidation and oxygen radicals have been demonstrated as 
early as 3 days following BCCAO in rat (Watanabe et al., 2006). Furthermore, an 
association between white matter hyperintensities and biochemical markers of 
oxidative stress has been reported in a recent human post-mortem study (Back et al., 
2011). Critically, it has been demonstrated that oxidative stress results in decreased 
differentiation of OPCs (Miyamoto et al., 2013b) suggesting that in addition to the 
damaging effects on oligodendrocytes and myelin, oxidative stress may also impair 
white matter repair processes.  
 
1.2.5 Mechanisms of white matter repair 
A number of studies have identified key receptors and signalling pathways involved 
in the regulation of OPC proliferation and differentiation, and modulation of 
inflammation and oxidative stress which may provide the opportunity to modulate 
white matter disruption following hypoperfusion.  
 
1.2.5.1 Modulation of OPC proliferation and differentiation 
The ability of OPCs to proliferate and differentiate in response to white matter 
damage plays a critical role in white matter repair following injury. Increased NG2 




48 hours following focal cerebral ischaemia with restoration of numbers of mature 
oligodendrocytes observed following 7 days (McIver et al., 2010). Post-mortem 
study of aged human brains has shown increased numbers of remyelinating 
oligodendrocytes and the presence of OPCs in periventricular white matter (Simpson 
et al., 2007a). In addition, increased numbers of OPCs have been demonstrated in the 
brains of individuals with vascular dementia (Back et al., 2011). Furthermore 
microarray analysis of white matter from mice subject to 3 days of cerebral 
hypoperfusion has revealed significant upregulation of a number of genes involved in 
cell proliferation (Reimer et al., 2011). Taken together these studies indicate that 
OPCs may respond to reductions in cerebral blood flow in an attempt to ameliorate 
white matter damage.  
 
Recent study has identified the G protein-coupled receptor 17 (GPR17) as a key 
modulator of OPC differentiation in response to injury such as ischaemia, spinal cord 
injury and cortical stab wound (Ciana et al., 2006; Lecca et al., 2008; Ceruti et al., 
2009; Boda et al., 2011). Identified ligands of the GPR17 receptor include members 
of the cysteinyl leukotriene family of inflammatory mediators and uracil nucleotides 
which are both released in high concentrations following CNS injury (Ciana et al., 
2006). GPR17 is expressed by a subset of OPCs and pre-myelinating 
oligodendrocytes and increased numbers of GPR17-expressing cells have been 
reported 24 hours following focal cerebral ischaemia (Lecca et al., 2008). 
Importantly, receptor activation has been demonstrated to increase OPC 
differentiation and thus may play an important role in oligodendrogenesis and white 




hypothesised that receptor upregulation may also act as an early sensor of local 
damage and contribute to local white matter remodelling and repair (Lecca et al., 
2008).  
 
A number of other studies have identified additional mechanisms involved in the 
mediation of OPC proliferation and differentiation. For example, early studies 
identified that growth factors such as platelet derived growth factor (Raff et al., 
1988), neurotrophin-3, and brain derived neurotrophic factor (McTigue et al., 1998) 
promote OPC proliferation and differentiation. In addition, it has been reported that 
the neurotransmitters ATP and glutamate inhibit OPC proliferation but stimulate 
differentiation (Yuan et al., 1998; Agresti et al., 2005; Cavaliere et al., 2012). This is 
of particular relevance to cerebral ischaemia as the severe and rapid depletion of 
oxygen and glucose results in decreased energy production and the release of these 
neurotransmitters in high (i.e. excitotoxic) concentrations (reviewed by Lo et al., 
2003). It has recently been demonstrated in slice culture that decreasing glucose 
concentration dose-dependently influenced numbers of oligodendroglial cells and the 
extent of myelination, which were restored by application of lactate (Rinholm et al., 
2011). It has also been reported that OPC proliferation is enhanced by the 
inflammatory mediator TNFα (Arnett et al., 2001). In addition, whilst oxidative 
stress inhibits OPC differentiation, a recent study has demonstrated that treatment 
with the antioxidant compound edaravone can restore the ability of OPCs to 
differentiate following chronic cerebral hypoperfusion in mouse (Miyamoto et al., 




mechanisms which may influence the ability of these cells to respond to chronic 
cerebral hypoperfusion.   
 
1.2.5.2 Modulation of inflammation and oxidative stress 
As indicated in Section 1.2.4.2, reactive oxygen and nitrogen species are generated 
as a consequence of normal cellular metabolism but cells are equipped with 
endogenous antioxidant defence mechanisms to prevent oxidative damage to DNA, 
proteins and lipids. One key mechanism by which cells mediate antioxidant 
responses occurs at the transcriptional level through activation of nuclear factor 
erythroid-derived 2-like 2 (Nrf2 or NFE2L2) transcription factor (Itoh et al., 1997; 
Kensler et al., 2007). This transcription factor is normally present within the 
cytoplasm of cells where it is inactive however in the presence of reactive oxygen 
species it translocates to the nucleus (Itoh et al., 1999) and increases the transcription 
of a battery of antioxidant and anti-inflammatory genes (reviewed by Kensler et al., 
2007). In the CNS, Nrf2 is preferentially expressed by astrocytes (Vargas and 
Johnson, 2009) but has also been demonstrated in neurons (Ramsey et al., 2007; 
Linker et al., 2011; Dang et al., 2012), oligodendrocytes (Linker et al., 2011) and 
microglia (Dang et al., 2012) following injury.  
 
The beneficial effects of Nrf2 activation in the brain have been demonstrated in 
mouse models of MS and focal cerebral ischaemia. It has been reported that 
pharmacological activation of Nrf2 with dimethyl fumarate (DMF) in the 




decreased numbers of macrophages and increased levels of the anti-inflammatory 
cytokine interleukin-10 (Schilling et al., 2006). Activation of Nrf2 has also been 
reported to decrease oxidative stress-mediated cell death, prevent myelin and axonal 
damage and improve clinical score following EAE (Linker et al., 2011). In support of 
this Nrf2 knockout mice display widespread myelin disruption and degeneration in 
addition to pronounced inflammation (Hubbs et al., 2007). Pharmacological 
activation of Nrf2 in mouse following focal cerebral ischaemia has been shown to 
significantly decrease hippocampal neuronal death and infarct size and improve 
neurological score (Son et al., 2010; Zhang et al., 2012). Furthermore, additional 
studies have demonstrated that brief (15 minute) hypoperfusion induced by middle 
cerebral artery occlusion in mouse activates Nrf2 target genes (Bell et al., 2011). 
This experimental paradigm is known to induce neuroprotective ischaemic 
preconditioning whereby a mild non-lethal stimulus can protect against subsequent 
ischaemic events (Stenzel-Poore et al., 2003). Thus a mild episode of reduced CBF 
can induce Nrf2-mediated antioxidant and anti-inflammatory signalling. Taken 
together these studies suggest that Nrf2 is important in the maintenance of white 
matter integrity and modulation of inflammation. Importantly these studies 
demonstrate that Nrf2 is activated in response to reduced CBF and indicate that 
pharmacological activation of Nrf2 may represent a valid therapeutic target for 








The presence of a myelin sheath around an axon together with the defined domain 
structure of myelinated axons is essential for efficient action potential conduction 
within the brain. Diffuse white matter disruption is observed in ageing brains and it is 
thought that chronic cerebral hypoperfusion may underlie these age-related white 
matter alterations and contribute to cognitive impairment. Previous studies using a 
mouse model of chronic cerebral hypoperfusion have demonstrated that 1 month of 
hypoperfusion results in diffuse white matter damage, increased microglial number 
and impaired spatial working memory. The studies described in this thesis sought to 
build upon these findings to further investigate the effects of chronic cerebral 
hypoperfusion on white matter structure and function. Specifically, the impact of 
chronic cerebral hypoperfusion on the domain structure of myelinated axons and on 
oligodendroglial populations was examined. A further aim was to identify potential 
mechanisms which may contribute to white matter disruption with cerebral 
hypoperfusion.  
 
1.4 Thesis hypotheses and aims 
It was hypothesised that that chronic cerebral hypoperfusion would disrupt the 
structural integrity of nodal and paranodal domains of myelinated axons and result in 
decreased numbers of oligodendrocytes and OPCs. It was additionally hypothesised 
that treatment with the anti-inflammatory and antioxidant drug DMF would 
ameliorate structural and functional alterations to white matter following severe 




1. To determine the impact of chronic cerebral hypoperfusion on the structural 
integrity of nodal and paranodal domains of myelinated axons and to identify 
potential underlying mechanisms. To investigate this, the distribution of 
nodal, paranodal and internodal proteins was examined in response to 
differing durations of chronic cerebral hypoperfusion. 
 
2. To determine the effects of chronic cerebral hypoperfusion on 
oligodendroglial populations. This was assessed using markers of mature 
oligodendrocytes and OPCs in addition to markers of cellular proliferation. 
The expression of GPR17 was also assessed to determine whether this 
receptor was activated in response to chronic cerebral hypoperfusion.  
 
3. To investigate whether modulation of inflammation and oxidative stress 
could ameliorate alterations to white matter structure and function following 
chronic cerebral hypoperfusion. To investigate this, the mixed coil model of 
severe cerebral hypoperfusion was employed and mice were administered the 
Nrf2-activating drug DMF. The extent of pathology to myelinated axons and 
oligodendroglial populations was examined to determine whether alleviation 
of inflammation and oxidative stress could prevent damage to white matter 



















Adult male C57Bl/6J mice (25-30g, aged 3-5 months) were purchased from Charles 
River UK. All animals were housed on a 12 hour light/dark cycle and had access to 
food and water ad libitum. All experiments were conducted under a project and 
personal licence issued by the UK Home Office under the Animals (Scientific 
Procedures) Act 1986. 
 
2.2 Surgery 
Animals were anaesthetised with isoflurane (5% in oxygen) and the common carotid 
arteries exposed via a midline cervical incision. Anaesthesia was maintained at 1.5% 
via a face mask. Cerebral hypoperfusion was induced via bilateral common carotid 
artery stenosis (Figure 2.1; Shibata et al., 2004). Wire microcoils (0.18 or 0.16 mm 
internal diameter; Sawane Spring Co, Japan) were twined around the carotid arteries, 
just below the carotid bifurcation. A 30 minute recovery period was allowed between 
the application of the first and second coil. Sham animals underwent identical 
surgical procedures but were not fitted with microcoils. For 0.18 mm microcoil 
studies (Chapters 3 and 4) mice were fed on a soft food diet and monitored closely 
following surgery until termination. Animals fitted with a combination of 0.18 and 




for 7 days following surgery. Any animal showing poor recovery following surgery 
was culled. All surgeries were carried out by Dr Philip R Holland except for animals 






Figure 2.1: Chronic cerebral hypoperfusion is induced by bilateral common 
carotid artery stenosis. (A) Schematic diagram showing microcoil placement 
around the common carotid arteries just below the carotid bifurcation. (B) Schematic 
diagram showing the structural dimensions of microcoils. Figure adapted from 






2.3 Cerebral blood flow measurement 
2.3.1 Principle of laser speckle contrast imaging 
CBF measurements were carried out using laser speckle flowmetry. This technique 
exploits the fact that when an object is illuminated with a laser, it generates a speckle 
image on a connecting camera due to the scattered light travelling in different paths 
(Dunn et al., 2001). When the illuminated object contains moving components, e.g. 
red blood cells within a perfused tissue, the resulting speckle images change over 
time (Dunn et al., 2001). Analysis of the speckle pattern can be analysed to quantify 
motion within the area examined. This approach can therefore be used to accurately 
assess CBF in anaesthetised animals.   
 
2.3.2 Acquisition of speckle sequences 
Animals were anaesthetised with 5% isoflurane in oxygen for 80 seconds in an 
anaesthetic chamber. Animals were then transferred to a stereotaxic frame and their 
heads were fixed into position. Anaesthesia was maintained at 2-2.5% isoflurane via 
a nose cone. Body temperature was monitored and maintained at 37 °C. Where 
necessary, additional heat was provided to the mice via a heated mat. An incision 
was made down the midline of the head to expose the skull, and the skin overlying 
the skull was reflected. The skull was cleaned using warmed saline (37 ºC) and a 
cotton bud. Warmed KY gel (37 °C) was spread evenly over the skull to prevent 
drying out. A moorFLPI2 Speckle Contrast Imager (Moor Instruments, UK) 




acquired using moorFLIP2 Measurement software (v1) at a resolution of 752 x 580 
pixels and a frequency of 25 frames/second. Following stabilisation of CBF readings, 
a 2 minute CBF recording was carried out. Mice were then placed in an incubator at 
28 °C for approximately 5-10 minutes until fully recovered. The mean time under 
anaesthesia per recording was approximately 10-15 minutes. 
 
2.3.3 Analysis of speckle sequences 
Following recording, speckle images were analysed using moorFLPI2 Review 
software (v4.0; Moor Instruments, UK). Regions of interest were placed on each 
hemisphere corresponding to approximately +1.7 mm to -4.36 mm from bregma and 
care was taken to avoid any artefacts on the skull. Mean perfusion measured over the 
2 minute stable recording period was averaged across both hemispheres. Data were 
measured in arbitrary blood perfusion units and are expressed as the percentage 
change relative to baseline. 
 
2.4 Radial arm maze 
Spatial working memory was assessed using an 8-arm radial arm maze (Figure 2.2). 
The maze consists of an octagonal central platform with 8 arms (47 cm in length and 
7 cm in width) leading from the central zone (Stoelting Europe, Ireland). Each arm 
had plexiglass walls (20 cm high) and a single food well was located at the distal end 
of each arm. The entrance to each arm from the central zone was blocked by doors 




Europe, Ireland). A camera was fixed in position directly above the maze to monitor 
the movement of the animals and visual cues were placed around the room to aid 
spatial navigation.  
 
The aim of the radial arm maze task is for the mice to retrieve a single food pellet 
from the end of each arm whilst remembering the arms they have already visited. 
The number of novel entries (i.e. visiting an arm that has not yet been visited) and 
the number of revisiting errors (i.e. re-entering an arm that has already been visited) 
were recorded by a remote operator observing via the PC. 
 
2.4.1 Radial arm maze pre-training 
Animals were food deprived for 7 days prior to radial arm maze testing in order to 
reduce body weight by approximately 10-15%. To maintain this weight reduction, 
animals were weighed daily and kept on a restricted diet until the end of testing.  
 
To habituate the mice to the maze and to the task, two days of pre-training were 
carried out. On the first pre-training day, mice were placed in the central zone for 5 
minutes and allowed to freely explore and consume food pellets that were scattered 
around the maze. On the second pre-training day, mice were placed in the central 
zone and food pellets were placed at the end of each arm. The door to one arm at a 




eaten a food pellet they were placed back in the central zone and the next door was 
opened. This was repeated until the mice had consumed a food pellet in each arm.  
 
2.4.2 Radial arm maze testing 
Radial arm maze testing was carried out for 16 consecutive days, with each animal 
undertaking one trial per day. The arms were baited with a single food pellet and at 
the start of the trial mice were placed in the central platform with all doors opened to 
allow them to make an arm choice. Following entry into the arm, the other 7 doors 
automatically closed. Once the animal left the arm it was held in the central zone for 
5 seconds before all doors were once again opened allowing the animal to make 
another arm choice. The trial was completed when all 8 food pellets had been 
retrieved from each arm or a 25 minute period had elapsed. The number of novel arm 
entries within the first eight visits and the number of revisiting errors were recorded 






Figure 2.2 Assessment of spatial working memory using the radial arm maze. 
(A) Schematic diagram showing a top-down view of the radial arm maze including 
spatial dimensions. (B) Photograph showing the radial arm maze and the extra-maze 





All electrophysiology experiments and data analysis were carried out by Dr Philip R 
Holland.  
 
2.5.1 Tissue preparation and slice cutting 
Mice were terminated by cervical dislocation followed immediately by decapitation. 
Brains were then rapidly dissected, placed in a cell strainer and submerged in ice-
cold oxygenated artificial cerebrospinal fluid (aCSF) (containing in mM: sucrose, 
189; D-glucose, 10; NaHCO3, 26; KCl, 3; MgCl2, 5; CaCl2, 0.1; NaH2PO4, 1.25) for 
2-3 minutes. Brains were then removed from the sucrose-aCSF solution, placed on 
an ice-cold petri dish and the cerebellum removed using a blade. The brain was then 
affixed to a metal vibratome plate and placed in a bath of oxygenated ice-cold 
sucrose-aCSF. A single 400 µm coronal slice approximately -1.2 – -1.7 mm from 
bregma was cut using a vibratome (Zeiss, Germany). Slices were then transferred to 
a warmed incubation chamber (32-35 °C) containing oxygenated aCSF (containing 
in mM: D-Glucose, 10; NaHCO3, 26; KCl, 5; CaCl2, 2; NaCl, 124; NaH2PO4, 1.25; 
MgSO4, 1.3). The incubation chamber was then allowed to return to room 







2.5.2 Slice recording 
Slices were then transferred to the slice chamber and super-perfused with oxygenated 
aCSF (2-3 ml/minute) at room temperature. Recording electrodes were comprised of 
borosilicate glass capillaries filled with aCSF and a resistance of 1-5 MΩ. These 
were connected to Ag/AgCl wires and lowered into the appropriate location within 
the corpus callosum. A stimulating electrode was connected to a stimulus isolation 
unit (NL200 Digitimer) and lowered into the corpus callosum 2.5 mm from the 
recording electrode using a computer controlled micromanipulator (patchstar 
micromanuipulator, Scientifica). Constant current square wave pulses were delivered 
at 0.2 Hz for 8 sweeps and the average response of the final 4 sweeps were used for 
analysis. The data was digitised at 200 kHz, amplified at x100, low-pass filtered at 5 
kHz and recorded using an Axopatch 200B and a PC running Clampex (v10.3) 
software (Molecular Devices LLC, USA). Analysis was conducted offline using 
Clampit v10.3. 
 
2.5.3 Calculation of conduction velocity 
Stimulating and recording electrodes were kept at a distance of 2.5 mm apart. The 
peak latency of the N1 and N2 components of the CAP were measured and 
conduction velocity calculated by dividing the distance (2.5 mm) by the latency of 






2.6 BrdU labelling 
To determine the extent of proliferation following cerebral hypoperfusion mice were 
administered 5-bromo-2'-deoxyuridine (BrdU; Fluka, UK). BrdU was administered 
by intraperitoneal injection (35 mg/kg body weight, in phosphate buffered saline 
(PBS) twice daily for the first 3 days following surgery.  
 
2.7 Administration of dimethyl fumarate 
Dimethyl fumarate (DMF: C6H8O4; Sigma, UK) was administered twice daily (at 8 
am and 5pm) by oral gavage at 100 mg/kg body weight in 0.8% hydroxypropyl 
methylcellulose (hypromellose; Sigma, UK) vehicle as previously described 
(Scannevin et al., 2012). Control animals received vehicle only. Administration of 
DMF or vehicle began 24 hour prior to surgery.  
 
2.8 Perfusion fixation and tissue processing for immunohistochemistry 
2.8.1 Transcardial perfusion fixation 
Animals were deeply anaesthetised using 5% isoflurane in oxygen. A midline 
incision was made and the diaphragm cut to expose the heart. A needle was inserted 
into the left ventricle and held in place using surgical clamp. Mice were perfused at a 




the right atrium to allow blood to flow out. Mice were then perfused with 20 ml of 
4% paraformaldehyde (PFA) in 0.1M phosphate buffer (PB, pH7.4)1. 
 
2.8.2 Tissue processing for vibratome sections 
Following perfusion, the heads were removed and post-fixed in 4% PFA for 2 hours 
at room temperature. The brains were then removed from the skull and post-fixed in 
4% PFA overnight at 4 °C. Brains were then transferred to PB and stored overnight 
at 4 °C. The brains were cut along the longitudinal fissure into hemi-brains and free-
floating 50 µm sagittal sections were cut using a vibrating blade microtome (Zeiss, 
Germany.) Sections were stored in cryoprotective medium (30% glycerol and 30% 
ethylene glycol in PB) at -20 °C until required.  
 
2.8.3 Tissue processing for cryostat sections 
Following perfusion, the heads were removed and post-fixed in 4% PFA for 1 hour at 
room temperature. The brains were then carefully removed from the skull and post-
fixed in 4% PFA for 24 hours at 4 °C. Brains were then transferred to 30% sucrose in 
phosphate buffered saline (PBS) and left for 48-72 hours until the brains sank to the 
                                                 
1 As hypoperfused animals have microcoils around both common carotid arteries, there is a possibility 
that insufficient perfusion fixation may generate artefacts and potentially influence pathology. Studies 
within the group have shown that overnight post-fixation in 4% PFA significantly improves the 
quality of fixation and tissue preservation. It has been demonstrated that this post-fixation step ensures 
adequate fixation even in brains perfused only with saline. Furthermore, assessment of nodal length 
and nodal gap has shown similar differences between sham and hypoperfused mice in brains perfused 
with either saline or PFA followed by overnight post-fixation. Thus the presence of the overnight 
fixation step for all studies described in this thesis should improve fixation and eliminate potential 




bottom of the solution. Brains were then frozen in isopentane for 2 minutes at -42 °C 
and were stored at -20 °C. Brains were cut into 30 µm coronal sections using a 
cryostat (Bright Instruments, UK). Immediately following cutting sections were 
transferred into PB, mounted directly onto slides and air-dried overnight. Slide-








2.9.1 FluoroMyelin staining 
FluoroMyelin staining was used to assess myelin integrity following chronic cerebral 
hypoperfusion. Free-floating vibratome sections were given three 15 minute washes 
in PBS and two 15 minute washes in tris buffer (TB) to remove traces of 
cryoprotective medium. Sections were then mounted onto SuperFrost glass slides and 
left to air dry. Following rehydration in PBS, sections were incubated for one hour in 
FluoroMyelin at 1:200 in PBS. Sections were then given three 15 minute washes in 
PBS before being coverslipped using Vectashield Hardset mounting medium. 
 
2.10 Immunohistochemistry 
This technique is used to visualise proteins of interest and is routinely used to 
investigate tissue structure. It exploits the ability of antibodies to bind strongly to 
foreign proteins allowing their visualisation using microscopy. For all 
immunohistochemistry experiments the concentration of antibody was optimised by 
testing a range of dilutions. Negative controls, in which the addition of primary 
antibody was omitted, were run alongside experimental sections to determine the 





2.10.1 Vibratome sections 
Free-floating vibratome sections were given three 15 minute washes in PBS to 
remove traces of cryoprotective medium. Sections were then washed twice for 15 
minutes in PBS containing 0.1% TritonX100 (PBS-Tx) prior to antigen retrieval (if 
required; see Section 2.10.3) Sections were then incubated for 1 hour at room 
temperature in 10% normal serum (optimised with or without 0.5-1% bovine serum 
albumin; BSA) to block non-specific binding. The blocking solution was then 
removed and sections were incubated in primary antibody (diluted in blocking 
solution) overnight at 4 °C. The following day sections were given three 15 minute 
washes in PBS and incubated in secondary antibody (in PBS) either overnight at 4°C 
or for 1 hour at room temperature. Sections were then given three 15 minute washes 
in PBS followed by two 10 minute washes in TB before being mounted onto slides. 
Sections were coverslipped using Vectashield HardSet mouning medium containing 
the nuclear stain 4',6-diamidino-2-phenylindole (DAPI). Primary and secondary 
antibodies are listed in Tables 2.1 and 2.2 respectively.  
 
2.10.2 Cryostat sections 
Cryostat sections were dehydrated through an increasing alcohol series as follows: 2 
minutes in 70% ethanol, 2 minutes in 90% ethanol, and 5 minutes and 10 minutes in 
100% ethanol. Sections were then immersed in xylene for 10 minutes before being 
rehydrated through a decreasing alcohol series as follows: 10 minutes and 5 minutes 
in 100% ethanol, 2 minutes in 90% ethanol and 2 minutes in 70% ethanol before 




PBS for 5 minutes before antigen retrieval (if required; see Section 2.10.3). Sections 
were then blocked using 20% normal serum (optimised with or without 1% BSA) for 
2 hours at room temperature. Primary antibodies were made up in blocking solution 
and sections were incubated in primary antibody at 4 ºC overnight. The following 
day sections were given two 10 minute washes in PBS before incubation with 
secondary antibody (diluted in PBS) for 2 hours at room temperature. Following 
secondary antibody incubation, sections were given two 15 minute washes in PBS 
followed by a 10 minute wash in TB prior to air drying. Coverslips were mounted 
using Vectashield HardSet mounting medium with or without DAPI. 
 
2.10.3 Antigen retrieval  
Antigen retrieval was required to ensure optimal labelling with a subset of 
antibodies. Antigen retrieval was carried out using 10 mM citric acid (pH6), 2M 
hydrocholoric acid (HCl) or 1 mM tetrasodium ethylenediaminetetraacetic acid 
(EDTA; pH8) as shown in Table 2.3. Free-floating sections were placed in 24-well 
plates containing retrieval solution and placed in a water bath (Grant Instruments, 
UK). Slide-mounted sections were immersed in retrieval solution inside a heatproof 
container and placed inside a pressure cooker (A. Menarini Diagnostics Ltd, UK). 
Following antigen retrieval, sections were rinsed in PBS prior to blocking. Following 









Table 2.1: Primary antibodies used in immunohistochemistry experiments
Antibody Label Species raised in Clone Source Dilution 
Ankyrin G Ankyrin G Rabbit Polyclonal Santa Cruz 1:50 
APP Amyloid precursor protein Mouse 22C11 Millipore 1:200 
BrdU BrdU incorporating cells Rat BU1/75 (1CR1) Abcam 1:200 
Caspr Caspr Mouse K65/35 Neuromab 1:50 
CC1 (APC) Mature oligodendrocytes Mouse Ab-7 Calbiochem 1:20 
GFAP GFAP+ astrocytes Rabbit Polyclonal Dako 1:1000 
GPR17 GPR17 receptor Rabbit Polyclonal Cayman Chemical 1:200 
Iba1 Iba1+ microglia Goat Polyclonal Abcam 1:100 
MAG Myelin associated glycoprotein Goat Polyclonal Santa Cruz 1:100 
MBP Myelin basic protein Rat 12 Millipore 1:100 
Nav1.6 Nav1.6 channels Rabbit Polyclonal Millipore 1:100 
NG2 NG2+ OPCs Rabbit Polyclonal Millipore 1:100 
Olig2 Oligodendrocyte lineage cells Mouse 211F1.1 Abcam 1:100 
Olig2 Oligodendrocyte lineage cells Rabbit Polyclonal Millipore 1:500 
PCNA PCNA+ proliferating cells Mouse PC10 Abcam 1:500 
PDGFRα PDGFRα+ OPCs Rat APA5 BD Pharmingen 1:100 
PDGFRβ PDGFRβ+ pericytes Goat Polyclonal R and D Systems 1:100 
Porin (VDAC) Mitochondrial inner membrane 
voltage-gated anion channels 
















Anti-goat IgG Alexa Fluor 546 Donkey Invitrogen 1:500 
Anti-mouse IgG Alexa Fluor 488 Goat Invitrogen 1:500 
Anti-mouse IgG Alexa Fluor 488 Donkey Jackson ImmunoResearch 1:200 
Anti-mouse IgG1 Alexa Fluor 647 Goat Invitrogen 1:500 
Anti-mouse IgG2b Alexa Fluor 488 Goat Invitrogen 1:500 
Anti-mouse IgG DyLight 488 Donkey Jackson ImmunoResearch 1:200 
Anti-rabbit IgG Cy3 Donkey Jackson ImmunoResearch 1:100 
Anti-rabbit IgG Alexa Fluor 546 Goat Invitrogen 1:500 
Anti-rat IgG Alexa Fluor 647 Donkey Jackson ImmunoResearch 1:200 

























85 °C for 30 
minutes 
Water bath PCNA 
2M HCl Free-floating 
vibratome sections 
37 °C for 30 
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2.11.1 Confocal laser scanning microscopy 
Immunolabelled sections were imaged using confocal laser scanning microscopy 
(Axioskop LSM 510 or LSM710, Zeiss, Germany). Images were acquired using 
either 20x, 40x or 63x objectives at a 1024 x 1024 pixel resolution. For images 
obtained at 20x (numerical aperture 0.75) the field of view represented an area of 460 
x 460 µm. For images acquired at 40x (numerical aperture 1.3) the field of view 
represented 212.5 x 212.5 µm. For images acquired using a 63x objective (numerical 
aperture 1.4), the correct Nyquist settings (3.1x zoom and 0.13 µm z-step) were used 
to allow image deconvolution. The corresponding field of view represented 43.5 x 
43.5 µm. All images were acquired by the author who was blinded to surgical 
condition. 
 
2.11.1.1 Image deconvolution 
Images acquired using a 63x objective underwent image deconvolution using 
Huygens Professional deconvolution software (Scientific Volume Imaging, The 
Netherlands; v3.6).  
 
2.11.2 Fluorescent microscopy 
Images were acquired at 20x magnification using a Zeiss AX10 fluorescent 




images at a resolution of 1388 x 1040 pixels. All images were acquired using 
constant exposure settings by the author who was blinded to surgical condition. 
 
2.11.3 Regions of interest 
Regions of interest for analysis of immunohistochemistry studies are shown in Figure 
2.3.  
 
2.12 Image analysis 
Image analysis was carried out using ImageJ software (National Institutes of Health, 
USA; v1.42q).  
 
2.12.1 Assessment of fluorescent intensity 
For assessment of labelling intensity, all sections were imaged using identical gain 
and offset settings on the confocal microscope which ensured a common threshold 
was set across all images. To assess FluoroMyelin and MBP staining intensity, the 
corpus callosum was manually outlined and mean gray value was measured using 
ImageJ. For GPR17 labelling intensity, individual GPR17+ cells were manually 
outlined and mean gray value was measured. All intensity measurements were 






Figure 2.3: Regions of interest for immunohistochemistry studies. (A) For 
immunohistochemistry experiments described in Chapter 3, sagittal sections were 
used and images taken in the corpus callosum (CC), internal capsule (IC) and optic 
tract (OT). For studies outlined in Chapter 4 the corpus callosum was imaged above 
the lateral ventricle (LV) as indicated. (B) For immunohistochemistry studies 
described in Chapter 5, coronal sections were used and the corpus callosum imaged 





2.12.2 Assessment of density of staining 
To assess the density (i.e. percentage area) of MAG, APP and MBP labelling, images 
were acquired using identical gain and offset settings on the confocal microscope, 
ensuring a common threshold. Images of MBP and MAG were subject to background 
subtraction (mean grey value of background + 3x standard deviation). A common 
threshold was set for images of APP labelling to ensure that APP+ oligodendrocytes, 
microglia and astrocytes were excluded and that only APP+ axonal bulbs were 
detected. For all density measurements, the corpus callosum was manually outlined 
and the percentage area of positive staining measured. All density measurements 
were carried out in duplicate across two days and values averaged. 
 
2.12.3 Nodal domain length and nodal gap measurements 
Nodal domain length and nodal gap were measured in deconvolved images using 
ImageJ. To eliminate sampling bias, the first 40 nodes which appeared whilst 
scrolling through the stack were selected for length measurement. Nodes were 
included on the basis of positive Nav1.6 or Ankyrin G labelling delineated either side 
by positive Caspr staining of paranodal domains. For nodal gap measurements the 
distance between a pair of Caspr+ paranodes was measured. Images were magnified 
3x to ensure accurate measurement and lengths were manually measured using the 






2.12.4 Assessment of porin localisation to nodal and paranodal domains  
To assess porin localisation at nodal and paranodal domains following 6 weeks and 3 
months of cerebral hypoperfusion, the 40 nodes that underwent Nav1.6 length and 
nodal gap measurements were counted based on the presence of porin reactivity 
within nodes and paranodes.  
 
2.12.5 Stereological counting  
Nodes of Ranvier were manually identified on the basis of positive Nav1.6 
immunoreactivity and numbers of nodes were counted using the ImageJ Cell Counter 
plugin in a 43.5 x 43.5 x 5 µm image stack. To prevent over-counting, any nodes 
crossing the left and top boundaries of the image were excluded, whilst those 
crossing the right and lower boundaries of the image were included in the analysis. 
 
For stereological cell counting, cells were identified based on expression of the 
immunolabel(s) of interest co-localised with the nuclear stain DAPI. Cells were 
manually identified and counted using the ImageJ Cell Counter plugin. The corpus 
callosum was manually outlined and cells crossing the left and top sides were 
included, but any cells crossing the right or bottom boundaries were not counted. 
Images from the top of the Z-stack were excluded from analysis whilst counts from 
the bottom image from the stack were included. Cell counts are expressed as the as 





2.13 Perfusion fixation and tissue processing for electron microscopy 
2.13.1 Transcardial perfusion fixation  
Animals were transcardially perfused with 20 ml of 0.9% heparinised saline followed 
by 20 ml of 5% glutaraldehyde and 4% paraformaldehyde in 0.1M PB. Perfusion was 
carried out manually and rapidly without the use of a perfusion pump. Following 
perfusion, the brains and optic nerves were removed and postfixed in the same 
fixative. Following 24 hours of post-fixation, a 1 mm thick section of brain 
(approximately 0 to -1 mm from bregma) was cut using a mouse brain matrix and the 
corpus callosum was manually dissected using a scalpel and a dissecting microscope. 
Corpus callosum and optic nerve samples were stored in fixative until processed.  
 
2.13.2 Tissue processing  
Optic nerve and corpus callosum samples were transferred into 3% glutaraldehyde in 
0.1M sodium cacodylate buffer (pH 7.3) for 2 hours and then washed 3 times in the 
same buffer. Samples were then post-fixed in 1% osmium tetroxide in 0.1M sodium 
cacodylate. Following dehydration, sections were embedded in araldite resin. For 
corpus callosum samples, the corpus callosum was cut along the midline and 60 nm 
ultrathin transverse sections of corpus callosum were cut. Optic nerve sections were 
cut into 60 nm ultrathin longitudinal sections. All sections were cut using a Reichert 
OMU4 ultramicrotome (Leica Microsystems (UK) Ltd, UK) and stained in uranyl 
acetate and lead citrate. Tissue processing and cutting was carried out by Stephen 




2.14 Acquisition and analysis of electron micrographs 
2.14.1 Acquisition of electron micrographs  
Ultrathin sections were viewed using a Philips CM120 transmission electron 
microscope (FEI UK Ltd, UK) and images acquired using a Gatan CCD camera 
(Gatan, UK). Images of cross-sectional myelinated fibres of the corpus callosum 
were used to measure g-ratio and were acquired at 3500x. Longitudinal optic nerve 
sections were used to visualise paranodal domains and were imaged at 28000x. All 
images were acquired by the author who was blind to surgical condition.  
 
2.14.2 G-ratio measurements 
To quantify changes in myelin sheath thickness, a lined grid of 0.95 x 0.95 µm2 was 
overlaid onto each image using Image J software (v1.42q). To eliminate selection 
bias, fibres were selected for analysis if their myelin sheath was intersected by a grid 
line. Using the freehand tool, the perimeters of each fibre and axon were manually 
traced and whole fibre area and axonal area measured. These values were used to 
calculate corresponding fibre and axonal diameters. To calculate g-ratio, axonal 
diameter was divided by whole fibre diameter. The mean number of fibres analysed 
were not significantly different between groups following either 3 days (sham- 355, 
hypoperfused- 300; p = 0.427) or 1 month (sham- 214, hypoperfused- 236 p = 
0.469). Animal numbers for the 3 day cohort were n = 5 sham, 6 hypoperfused. 





2.14.3 Assessment of paranodal disruption 
The presence or absence of paranodal septate-like junctions and the morphology or 
paranodal myelin loops (normal or misfolded) were assessed by the author and Dr 
Michell Reimer who were blinded to surgical condition. Twelve individual 
paranodes were analysed per animal. Animal numbers were n = 3 sham, 3 
hypoperfused.  
 
2.15 Statistical analysis 
Statistical analysis was carried out using GraphPad Prism 5 (GraphPad Software Inc, 
USA) or SPSS (v22, IBM Ltd, USA) software packages. Data are presented as the 
mean ± standard error of the mean. A probability (p) value of < 0.05 was considered 
to be statistically significant. 
 
2.15.1 Cerebral blood flow data 
CBF data in Chapter 4 were analysed using Student’s t-test. CBF data in Chapter 5 
were analysed using using a 2-way ANOVA. Student’s t-test with Bonferroni 





2.15.2 Radial arm maze 
Radial arm maze data were analysed using a 2-way repeated measures ANOVA. 
Student’s t-test with Bonferroni correction for multiple comparisons was used post-
hoc.  
 
2.15.3 Electrophysiology data 
 The peak latency of the action potential was measured for myelinated and 
unmyelinated fibres and calculated per animal. Student’s t-test was used to compare 
groups.  
 
2.15.4 Domain length and nodal gap measurements 
The lengths of Nav1.6, Caspr and Ankyrin G domains and the nodal gap were plotted 
as cumulative frequency (%) and were analysed using a two-sample Kolgomorov-
Smirnov test.  
 
2.15.5 Stereological cell counts, intensity and density of staining 
Analysis of cell counts, intensity of staining and density of staining described in 
Chapters 3 and 4 was carried out using Students t-test or Mann-Whitney U-test 
depending on parametric or non-parametric distribution. Analysis of cell counts and 




followed by Student’s t-test with Bonferroni correction for multiple comparisons. A 
p value of < 0.01 was considered statistically significant. 
 
2.15.6 Survival analysis 
Analysis of survival in Chapter 5 was performed using Kaplan-Meier curves and 










The impact of chronic cerebral hypoperfusion on 









The structural integrity of myelinated axons of the white matter is essential for 
efficient action potential conduction and normal cognitive function. Disruption to 
white matter and cognitive decline are commonly observed with ageing (Breteler et 
al., 1994a; Bartzokis et al., 2004) and it is thought that chronic cerebral 
hypoperfusion may underlie these structural and functional alterations (DeCarli et al., 
1995; O'Sullivan et al., 2002; Holland et al., 2008; Appelman et al., 2010) however 
the underlying mechanisms are unknown.  
 
Myelinated axons are comprised of nodal, paranodal, juxtaparanodal and internodal 
domains which are characterised by unique protein architectures. The high density 
clustering of Nav1.6 channels at nodes of Ranvier is essential for saltatory conduction 
and is mediated by interactions with other nodal proteins and by the neighbouring 
paranodal septate-like junctions which act as physical barriers to prevent diffusion of 
Nav1.6 channels away from the nodes. Disruption to proteins located at nodal or 
paranodal domains may therefore have important consequences for action potential 
conduction along myelinated axons. Importantly, paranodal disruption has been 
demonstrated to occur in ageing mice which show loss of paranodal septate-like 
junctions, ‘piling’ of paranodal myelin loops and diffusion of Caspr away from 
paranodal domains (Shepherd et al., 2012). Similarly, in aged primates, altered 




disruption (Hinman et al., 2006). Furthermore, paranodal disruption and associated 
disruption to the localisation of Nav1.6 channels at nodes of Ranvier has been 
reported in human MS tissue (Coman et al., 2006) and in mice subject to EAE 
(Howell et al., 2010). Taken together these studies indicate that nodal and paranodal 
domains of myelinated axons are vulnerable to injury and ageing, which may have 
important consequences for downstream cognitive function.  
 
The mechanisms underlying nodal and paranodal disruption in ageing and in disease 
are unclear however a strong association between microglial activation and 
paranodal disruption has been reported in human post-mortem cases of MS and 
Parkinson’s disease and in mice subject to EAE (Howell et al., 2010). Additional 
studies using Caspr knockout mice (Einheber et al., 2006; Garcia-Fresco et al., 2006) 
or mice expressing mutant Caspr (Sun et al., 2009) have demonstrated abnormal 
accumulation of mitochondria within swellings along myelinated axons suggesting 
that paranodal disruption results in impaired axonal transport of mitochondria. Given 
the importance of mitochondria in generating energy for myelinated axons, any 
disruption to mitochondrial transport may influence white matter integrity.    
 
Previous studies using the mouse model of hypoperfusion have reported diffuse 
white matter pathology using histological (Shibata et al., 2004), 
immunohistochemical (Coltman et al., 2011) and MRI (Holland et al., 2011) 
approaches however a robust assessment of the effects of cerebral hypoperfusion on 




and paranodal domains are required for action potential conduction along myelinated 
axons, alterations to these regions may contribute to the observed working memory 
deficit in these animals. 
 
3.1.1 Study hypothesis and aims 
It was hypothesised that chronic cerebral hypoperfusion would result in disruption to 
nodal and paranodal domains of myelinated axons. This was tested using 
immunohistochemistry against key proteins found at nodal, paranodal and internodal 
domains of myelinated axons and electron microscopy was used to examine 
paranodal integrity. A further aim was to investigate whether microglial activation 
may contribute to nodal and paranodal disruption and whether mitochondrial 








3.2.1 Animals and surgery 
Male C57Bl/6J mice (aged 3-4 months old, 25-30g) underwent bilateral common 
carotid artery stenosis using 0.18 mm microcoils or sham surgery as previously 
described in Section 2.2. Group sizes for immunohistochemistry studies are listed in 
Table 3.1.  
 
Additional cohorts of animals were used for electron microscopic analysis of 
paranodal integrity (n = 3 sham, 3 hypoperfused), measurement of cerebral blood 
flow (n = 8 sham, 6 hypoperfused) and assessment of spatial working memory (n = 
















1 3 days 12 13 
2a 1 month  9 9 
2b 1 month  10 11 
3 6 weeks 12 11 






3.2.2 Radial arm maze 
Radial arm maze assessment of spatial working memory was carried out as described 
in Section 2.4. Testing lasted for 16 consecutive days and began 3 weeks following 
surgery.  
 
3.2.3 Perfusion/tissue processing for immunohistochemistry 
At 3 days, 1 month, 6 weeks or 3 months post-surgery, mice were deeply 
anaesthetised with 5% isoflurane and transcardially perfused as described in Section 
2.8.1. Following perfusion, the brains were processed and sagittal sections cut using 
a vibratome as described in Section 2.8.2. 
 
3.2.4 FluoroMyelin labelling 
FluoroMyelin labelling was carried out as described in Section 2.9.1 
 
3.2.5 Immunohistochemistry 
Immunohistochemistry was carried out as described in Section 2.10. Anti-MAG 
antibody was used to assess internodal axon-glial integrity and anti-Caspr, Nav1.6, 
Ankyrin G antibodies were used to assess alterations in nodal and paranodal 
domains. Anti-Iba1 and anti-porin antibodies were used to assess numbers of 




3.2.6 Confocal laser scanning microscopy and image analysis 
Immunolabelled 50 µm sections were imaged using confocal laser scanning 
microscopy as described in Section 2.11.1. Images were acquired in the corpus 
callosum, internal capsule and optic tract as shown in Figure 2.3A and were analysed 
as described in Section 2.11.2.   
 
3.2.7 Perfusion/tissue processing for electron microscopy  
Animals were transcardially perfused with 5% glutaraldehyde/4% paraformaldehyde 
1 month after the onset of cerebral hypoperfusion as described in Section 2.13.1. 
Optic nerve samples were processed for electron microscopy as described in Section 
2.13.2. Images were acquired at a magnification of 28000x.  
 
3.2.8 Statistical analysis 
Nav1.6, Caspr, Ankyrin G and nodal gap measurements are plotted as cumulative 
frequency (%) and were analysed using a two-sample Kolgomorov-Smirnov test. 
Radial arm maze data was analysed using a 2-way repeated measures ANOVA. 
Student’s t-test with Bonferroni correction for multiple comparisons was used post-
hoc. All other measures were analysed using student’s t-test or Mann-Whitney U-test 
depending on parametric or non-parametric distribution. A probability p value < 0.05 







3.3.1 Abnormal localisation of Nav1.6 channels at nodes of Ranvier following 
chronic cerebral hypoperfusion 
To test the hypothesis that chronic cerebral hypoperfusion would result in disruption 
to nodes of Ranvier, sections were stained for Nav1.6 and the domain length of 
Nav1.6 channel clusters was measured in the corpus callosum (Figure 3.1A). This 
revealed a significant increase in Nav1.6 domain length following 3 days (D = 
0.1781; p < 0.0001) and 1 month (D = 0.2304, p < 0.0001) of hypoperfusion as 
compared to shams (Figure 3.1B). This increase in Nav1.6 domain length was 
similarly observed in the internal capsule and optic tract (Appendix A1.1). To 
determine the effects of longer term hypoperfusion, Nav1.6 domain length was 
measured following 6 weeks and 3 months of chronic cerebral hypoperfusion (Figure 
3.1C). This revealed that following 6 weeks of cerebral hypoperfusion, Nav1.6 
domain length was not significantly different between sham and hypoperfused 
animals (D = 0.0854; p = 0.066; Figure 3.1D). However, a significant decrease in 
Nav1.6 domain length was observed in hypoperfused mice compared to shams (D = 
0.1446; p = 0.003; Figure 3.1E). Taken together these results demonstrate dynamic 
alterations in Nav1.6 localisation in response to chronic cerebral hypoperfusion. Data 





Figure 3.1: Dynamic changes in Nav1.6 domain length with chronic cerebral 
hypoperfusion. (A) Representative confocal images showing Nav1.6 labelled nodes 
of Ranvier (red) flanked either side by Caspr labelled paranodes (green) following 3 
days, 1 month, 6 weeks and 3 months of chronic cerebral hypoperfusion. Scale bar = 
1 µm. (B) Nav1.6 domain length was significantly increased  following 3 days (p < 
0.0001) and (C) 1 month (p < 0.0001) of chronic cerebral hypoperfusion as 
compared to shams. (D) Nav1.6 domain length was not significantly different 
between sham and hypoperfused mice following 6 weeks of hypoperfusion (p = 
0.0854). (E) Following 3 months of hypoperfusion, Nav1.6 domain length was 
significantly decreased as compared to shams (p = 0.003). Nav1.6 domain length 







3.3.2 Numbers of nodes are unaltered following chronic cerebral hypoperfusion 
To investigate whether chronic cerebral hypoperfusion altered numbers of nodes of 
Ranvier, numbers of Nav1.6
+ nodes were counted in sections from 3 day, 1 month, 6 
weeks and 3 month cohorts (Figure 3.2). This revealed that numbers of Nav1.6
+ 
nodes were unchanged following chronic cerebral hypoperfusion (3 days p = 0.931; 1 
month p = 0.857; 6 weeks p = 0.665; 3 months p = 0.117). Thus chronic cerebral 
hypoperfusion does not impact on numbers of nodes of Ranvier but instead alters the 
localisation of Nav1.6 channels at nodes.  
 
3.3.3 Ankyrin G distribution at nodes of Ranvier is unaltered following 3 days 
or 1 month of chronic cerebral hypoperfusion 
Nav1.6 channels at nodes of Ranvier are associated with Ankyrin G, which tethers 
the channels to the cytoskeleton through an interaction with βIV spectrin. To 
determine whether Nav1.6 channel diffusion following 3 days and 1 month of 
hypoperfusion was accompanied by underlying alterations to Ankyrin G localisation, 
sections were labelled with Ankyrin G and domain lengths measured (Figure 3.3A). 
This revealed that Ankyrin G domain lengths were unchanged in the corpus callosum 
after 3 days (D = 0.046; p = 0.818; Figure 3.3B) and 1 month (D = 0.057; p = 0.486; 
Figure 3.3C) of chronic cerebral hypoperfusion. Therefore the diffusion of Nav1.6 
away from nodes of Ranvier in response to cerebral hypoperfusion occurs 






Figure 3.2: Numbers of nodes of Ranvier are unchanged following chronic 
cerebral hypoperfusion. (A) No significant differences in numbers of Nav1.6
+ 
nodes of Ranvier was observed following 3 days (p = 0.931) or (B) 1 month (p = 
0.857) of hypoperfusion. Similarly, numbers of nodes were unchanged following (C) 









Figure 3.3: Ankyrin G domain length is unaltered following 3 days and 1 month 
of chronic cerebral hypoperfusion. (A) Representative images of Ankyrin G and 
Caspr labelling in the corpus callosum following 3 days and 1 month of 
hypoperfusion. Scale bar = 1 µm. (B) Ankyrin G domain length was unaltered in the 
corpus callosum following 3 days (p = 0.818) and (C) 1 month of hypoperfusion (p = 




3.3.4 Nodal gap is differentially altered in response to short and long term 
chronic cerebral hypoperfusion 
Paranodal septate-like junctions are the main sites of axon-glial connection in the 
CNS and act as a physical barrier to prevent the diffusion of Nav1.6 channels away 
from nodes of Ranvier. To determine whether the observed alterations in Nav1.6 
distribution following cerebral hypoperfusion were accompanied by disruption to 
paranodal domains, the ‘nodal gap’ (the internal space between a pair of adjacent 
paranodes; Figure 3.4A) was measured in the corpus callosum. Alterations in the 
length of the nodal gap have been reported to occur in animals with paranodal 
disruption (Thaxton et al., 2011; Ritter et al., 2013). In the current study, 
measurement of nodal gap length revealed a significant increase in length (D = 
0.136; p = 0.002) after 3 days of hypoperfusion compared to sham-operated controls 
(Figure 3.4B). However, following 1 month of cerebral hypoperfusion, nodal gap 
was significantly decreased as compared to shams (D = 0.1195; p = 0.005; Figure 
3.4C). These findings were confirmed in the internal capsule and optic tract 
(Appendix A1.3) and measurement of Caspr domain length revealed that alterations 
in nodal gap were not due to alterations in Caspr distribution (Appendix A1.4).  
 
To determine the effects of longer term hypoperfusion nodal gap was also measured 
in the corpus callosum following 6 weeks and 3 months of hypoperfusion. This 
revealed a significant decrease in nodal gap following 6 weeks of hypoperfusion as 




hypoperfusion, nodal gap was not significantly different between groups (D = 







Figure 3.4: Nodal gap is differentially altered in response to increasing 
durations of chronic cerebral hypoperfusion. (A) Representative confocal 
images showing the nodal gap delineated by Caspr labelling following 3 days, 1 
month, 6 weeks and 3 months of hypoperfusion. The nodal gap was defined as the 
internal distance between two Caspr+ paranodes and is indicated by the asterisk. 
Scale bar = 1 µm. (B) Nodal gap was significantly increased following 3 days of 
hypoperfusion as compared to shams (p = 0.002). (C) Following 1 month of 
hypoperfusion, a significant decrease in nodal gap was observed (p = 0.005). (D) 
A significant decrease in nodal gap was observed following 6 weeks of 
hypoperfusion as compared to shams (p = 0.003). (E) Following 3 months of 






3.3.5 Paranodal septate-like junctions are disrupted following chronic cerebral 
hypoperfusion 
To further investigate paranodal disruption following chronic cerebral 
hypoperfusion, ultrastructural analysis was undertaken in longitudinal sections of 
optic nerves of mice subjected to 1 month of cerebral hypoperfusion. Paranodal 
domains of myelinated axons were imaged and assessed for the presence or absence 
of paranodal septate-like junctions and whether or not paranodal myelin loops made 
contact with the underlying axon (Figures 3.5A-C). This revealed that intact 
paranodal junctions were observed in approximately 64 ± 7.35 % of shams compared 
to only 15 ± 7.64% in hypoperfused animals (p = 0.009; Figure 3.5D). Abnormal 
folding of paranodal loops was also observed. Observed abnormalities included 
paranodal loops which lacked contact with the axon, eversion of paranodal loops and 
the formation of double paranodal structures. Analysis revealed that abnormal 
paranodal loops were observed in 62.7 ± 13.9% of hypoperfused paranodes 
compared to 27.0 ± 3.1 % of paranodes in sham controls (p = 0.03; Figure 3.5E). 
Together these data show that 1 month of chronic cerebral hypoperfusion results in 
disruption to the paranodal domains of myelinated axons.  
 
3.3.6 Hypoperfusion causes an impairment in internodal axon-glial integrity 
In addition to their role in restricting Nav1.6 channels to nodes of Ranvier, paranodes 
are the primary sites of axon-glial connection in the CNS. To further investigate the 
impact of chronic cerebral hypoperfusion on axon-glial integrity, the distribution of 




maintenance of axon-glial connection at internodal domains and has been shown to 
be preferentially disrupted in hypoxic lesions (Aboul-Enein et al., 2003). To test 
whether MAG was altered following hypoperfusion, sections were stained and the 
percentage area occupied by MAG was measured (Figure 3.6A). This revealed a 
significant decrease in MAG density following 3 days (p = 0.008; Figure 3.6B) and 1 
month (p = 0.027) of chronic cerebral hypoperfusion (Figure 3.6C). Additionally, 
MAG labelling appeared granular and discontinuous in hypoperfused mice as 
compared to shams. These data indicate that chronic cerebral hypoperfusion leads to 
disruption of axon-glial integrity at both paranodal and internodal domains. 
 
3.3.7 No gross myelin changes following 3 days or 1 month of chronic cerebral 
hypoperfusion 
The results of the current study indicate that chronic cerebral hypoperfusion results 
in rapid disruption to nodal and paranodal domains of myelinated axons and an 
impairment in axon-glial integrity. To assess whether hypoperfusion also led to 
disruption of compact myelin, FluoroMyelin staining was carried out and the 
intensity of staining was analysed (Figure 3.7A). This revealed no significant 
differences in staining intensity after 3 days (p = 0.598; Figure 3.7B) or 1 month of 
hypoperfusion (p = 0.063; Figure 3.7C). Thus cerebral hypoperfusion causes a 







Figure 3.5: Chronic cerebral hypoperfusion results in paranodal disruption. (A) 
Schematic diagram showing the paranodal domains of myelinated axons and the 
septate-like junctions between the paranodal myelin loops and underlying axon. (B) 
Electron micrograph showing paranodal myelin loops making contact with the 
underlying axonal membrane. Paranodal septate-like junctions are visible between 
paranodal myelin and the underlying axon in the sham animal (indicated by arrows) 
but are absent in the hypoperfused animal. Scale bar = 0.1 µm. (C) Electron 
micrograph showing paranodal misfolding in the form of a double nodal structure. 
The asterisk indicates a paranodal loop which is not making contact with the 
underlying axon. (D) The percentage of paranodes with intact septate-like junctions 
was significantly decreased after 1 month of cerebral hypoperfusion compared to 
sham controls. (E) A significant increase in the number of misfolded paranodes was 
observed after 1 month of cerebral hypoperfusion relative to sham controls. *p = 






Figure 3.6: Myelin associated glycoprotein labelling is decreased following 3 
days and 1 month of chronic cerebral hypoperfusion. (A) Representative confocal 
images showing MAG labelling in the corpus callosum after 3 days and 1 month of 
cerebral hypoperfusion. Scale bar = 20 µm. (B) The percentage area of MAG 
labelling was significantly decreased after 3 days of hypoperfusion as compared to 
sham controls. (C) Density of MAG labelling was similarly decreased following 1 






Figure 3.7: FluoroMyelin staining is unchanged with cerebral hypoperfusion. 
(A) Representative confocal images showing FluoroMyelin staining in the corpus 
callosum. Scale bar = 20 µm. (B) FluoroMyelin staining intensity was not 
significantly different between groups following either 3 days (p = 0.598) or (C) 1 






3.3.8 Microglial number is increased following 1 month of chronic cerebral 
hypoperfusion 
To determine whether microglial activation may contribute to paranodal disruption 
early in response to chronic cerebral hypoperfusion, sections were stained for the 
microglial marker Iba1 and numbers of Iba1+ microglia counted in the corpus 
callosum following 3 days and 1 month of hypoperfusion (Figure 3.8A). This 
revealed that numbers of microglia were not significantly different between groups 
following 3 days of hypoperfusion (p = 0.425; Figure 3.8B). However following 1 
month, a significant increase in microglial number was observed (p = 0.001; Figure 
3.8C). Thus microglial number does not appear to mediate paranodal disruption 
following 3 days but may contribute to ongoing pathology following 1 month of 
hypoperfusion. 
  
3.3.9 Altered mitochondrial localisation at nodes of Ranvier following chronic 
cerebral hypoperfusion 
Previous studies in peripheral nerves have shown that paranodal disruption is 
associated with accumulation of mitochondria at nodes of Ranvier and paranodes 
(Einheber et al., 2006; Sun et al., 2009), indicating a defect in axonal transport of 
mitochondria. As axonal mitochondria are essential for energy generation within 
myelinated axons, impaired mitochondrial trafficking may influence white matter 
integrity. To investigate whether mitochondrial accumulation at nodes of Ranvier 
was observed following chronic cerebral hypoperfusion and to determine a potential 




hypoperfusion, sections were labelled with anti-Nav1.6 and anti-Caspr antibodies 
together with an antibody against the mitochondrial membrane marker porin. 
Numbers of Nav1.6
+ nodes and Caspr+ paranodes with positive porin reactivity were 
then counted (Figure 3.9A). After 6 weeks of hypoperfusion, the percentage of nodes 
with porin reactivity was decreased in hypoperfused mice compared to sham controls 
(p = 0.03; Figure 3.9B). However following 3 months of cerebral hypoperfusion, no 
significant differences were observed between groups (p = 0.742; Figure 3.9C). No 
significant differences in porin localisation at paranodes were observed after either 6 
weeks (p = 0.07; Figure 3.9D) or 3 months (p = 0.694; Figure 3.9E). Taken together 
these results indicate that paranodal disruption following long term chronic cerebral 
hypoperfusion is not associated with accumulation of mitochondria at nodal or 





Figure 3.8: Numbers of microglia are unchanged following 3 days but are 
significantly increased after 1 month of chronic cerebral hypoperfusion. (A) 
Representative confocal images showing Iba+ microglia in the corpus callosum 
following sham and hypoperfusion surgery. Scale bar = 20 µm. (B) No significant 
difference in number of microglia was observed between groups following 3 days of 
cerebral hypoperfusion (p = 0.425). (C) Following 1 month of hypoperfusion, a 
significant increase in microglial number was observed relative to sham controls. ** 





Figure 3.9: Decreased number of nodes with mitochondria following 6 weeks of 
chronic cerebral hypoperfusion. (A) Confocal image showing porin+ mitochondria 
(green) present at a Nav1.6
+ node of Ranvier (red) and Caspr+ paranodes (blue). Scale 
bar = 1 µm. (B) A significant decrease in the numbers of nodes with porin reactivity 
was observed following 6 weeks of hypoperfusion as compared to shams (p = 0.03). 
(C) However no significant difference in numbers of nodes with porin reactivity was 
observed following 3 months of chronic cerebral hypoperfusion (p = 0.742). (D) No 
significant differences in numbers of paranodes with porin reactivity was observed 
between groups following 6 weeks (p = 0.07) or (E) 3 months (p = 0.694) of cerebral 




3.3.10 Chronic cerebral hypoperfusion impairs spatial working memory 
Previous studies have demonstrated that in addition to diffuse white matter damage, 
chronic cerebral hypoperfusion causes an impairment in spatial working memory 
(Shibata et al., 2007; Coltman et al., 2011). To confirm this, spatial memory was 
assessed in a cohort of 1 month hypoperfused mice using the radial arm maze. 
Analysis of both parameters (number of novel entries and revisiting errors) revealed 
a significant effect of trial block (p < 0.0001) indicating that both groups had 
improved over time and successfully learned the task.  
 
Hypoperfused animals made significantly fewer novel entries as compared to sham 
controls (F(4.9, 147) = 3.192; p = 0.011; Figure 3.10A). In addition, the number of 
revisiting errors was significantly higher in hypoperfused mice (F(1, 21) = 7.274; p = 
0.013; Figure 3.10B). Total trial duration did not differ between groups (Appendix 








Figure 3.10 Spatial working memory is impaired in hypoperfused mice. (A) 
Hypoperfused mice made significantly fewer novel entries than sham control mice (p 
= 0.011). (B) Hypoperfused mice also made significantly more revisiting errors than 
sham controls (p = 0.013). A significant effect of trial block was observed indicating 








 3.4 Discussion 
 
The current study sought to test the hypothesis that chronic cerebral hypoperfusion 
would lead to disruption of nodal and paranodal domains of myelinated axons. The 
results support the hypothesis and demonstrate that chronic cerebral hypoperfusion 
results in alterations to Nav1.6 localisation at nodes of Ranvier, nodal gap length and 
loss of paranodal septate-like junctions. Furthermore this study unexpectedly 
revealed that alterations to Nav1.6 distribution and nodal gap are dynamic and vary 
with increasing duration of chronic cerebral hypoperfusion. Importantly, chronic 
cerebral hypoperfusion also led to disruption of axon-glial integrity at internodal 
domains but no gross myelin pathology was observed following 3 days or 1 month of 
hypoperfusion. The results demonstrate increased numbers of microglia following 1 
month of hypoperfusion and altered mitochondrial localisation following 6 weeks of 
hypoperfusion. Critically an impairment in spatial working memory was observed in 
mice subject to 1 month of chronic cerebral hypoperfusion indicating that alterations 
to nodal and paranodal domains of myelinated axons may have functional 
consequences.  
 
3.4.1 Dynamic changes in the localisation of nodal and paranodal proteins 
In the current study, paranodal disruption was observed following 3 days and 1 
month of cerebral hypoperfusion resulting in diffusion of Nav1.6 channels away from 




domain length were highly dynamic and varied with increasing duration of 
hypoperfusion (summarised in Figure 3.11). Indeed despite increased Nav1.6 domain 
length following 3 days and 1 month of hypoperfusion, no significant difference in 
domain length was observed following 6 weeks of hypoperfusion with a significant 
decrease observed following 3 months as compared to controls. The current study 
also demonstrated that Nav1.6 domain length and nodal gap were differentially 
affected by hypoperfusion. Critically, following 1 month of hypoperfusion nodal gap 
was significantly decreased in hypoperfused animals while Nav1.6 domain length 
was increased. One possible explanation is that this decrease in nodal gap may arise 
from the passive diffusion of Caspr along the axon as a result of the loss of its 
binding partner Nfasc155 as demonstrated by Reimer et al (2011). In support of this, 
a recent study using transgenic mice in which Nfasc155 is specifically ablated has 
shown that loss of Nfasc155 results in loss of paranodal localisation of Caspr (Pillai 
et al., 2009). On the other hand, it is equally possible that the decreased nodal gap at 
1 month is associated with reformation of paranodal domains. Indeed in human MS 
studies, Caspr+ and Nfasc+ paranodes flanking Nav1.6
+ nodes are observed in areas of 
remyelination suggesting that these proteins can re-cluster following injury to form 
nodal and paranodal domains (Coman et al., 2006; Howell et al., 2006). Additionally, 
the decrease in Nav1.6 domain length following longer term hypoperfusion suggests 
that these channels are re-clustered to form nodes of Ranvier. To determine whether 
alterations in nodal gap are associated with reformation of paranodal domains, it 
would be pertinent to study Nfasc155 localisation following 6 weeks and 3 months of 





It should be noted that the alterations in Nav1.6 domain length reported in the current 
study may be associated with alterations in number of Nav1.6 channels. For example, 
it is unknown whether increased Nav1.6 domain length following 3 days and 1 month 
of hypoperfusion is due to diffusion of existing channels along the axon or the result 
of increased numbers of Nav1.6 channels recruited to the axonal membrane. 
Similarly, the decreased Nav1.6 domain length following 3 months of hypoperfusion 
may be due to a loss of Nav1.6 channels. This could be assessed in future studies by 
measuring the fluorescent intensity or volume occupied by Nav1.6 staining. 
 
Given that the highly organised domain structure of myelinated axons is essential for 
efficient action potential conduction, the observed disruption to axon-glial 
connection and alterations in the localisation of Nav1.6 channels at nodes of Ranvier 
are likely to impair saltatory conduction along myelinated axons. In support of this, 
recent studies within the group have demonstrated that the conduction velocity of 
myelinated axons in the corpus callosum is significantly decreased following 6 
weeks and 3 months of chronic cerebral hypoperfusion (Dr Philip R Holland, 
unpublished observations). Additional studies by other groups have also revealed that 
paranodal disruption and subsequent alterations in Nav1.6 localisation and nodal gap 
negatively impact on conduction velocity (Bhat et al., 2001; Nie et al., 2006; Ritter et 
al., 2013). In the current study the observed alterations in Nav1.6 localisation were 
subtle, with no differences in numbers of nodes between groups at any time point 
suggesting that hypoperfusion does not induce a widespread loss of nodes. Despite 
this, a recent mathematical modelling study has revealed that even modest paranodal 




alterations to paranodal resistance to mimic slight retraction of paranodal myelin and 
by increasing the theoretical nodal length from 0.65 µm to 1.95 µm, the authors 
demonstrated that conduction velocity was decreased up to 40% (Babbs and Shi, 
2013). This is in keeping with the current study which showed that the mean Nav1.6 
domain length was 2.08 µm following 1 month of hypoperfusion, and indicates that 
the subtle alterations observed in this study may significantly influence conduction 
velocity. Taken together these studies highlight the importance of intact axon-glial 






Figure 3.11: Dynamic alterations in Nav1.6 localisation and nodal gap following 
chronic cerebral hypoperfusion. (A) In a normal myelinated axon, Nav1.6 channels 
(red) are clustered at nodes of Ranvier which are flanked either side by Caspr+ 
paranodes (green). Nodal and paranodal proteins are spatially segregated such that 
neighbouring domains do not show any overlap. In the current study, Nav1.6 domain 
length (red arrows) and the internal space delineated by two Caspr+ paranodes 
(‘nodal gap’; green arrows) were measured. (B) Following 3 days of cerebral 
hypoperfusion, diffusion of Nav1.6 channels away from nodes of Ranvier was 
observed, corresponding to a significant increase in Nav1.6 domain length in addition 
to an increase in nodal gap. However following 1 month of cerebral hypoperfusion, 
Nav1.6 domain length remained significantly increased but nodal gap was 
significantly decreased as compared to shams. Following 6 weeks of hypoperfusion, 
Nav1.6 domain length was unchanged between groups but a significant decrease in 
nodal gap was observed. Finally, 3 months of chronic cerebral hypoperfusion 






3.4.2 Rapid disruption to internodal axon-glial integrity following chronic 
cerebral hypoperfusion 
This study has demonstrated that the density of MAG labelling was decreased 
following 3 days and 1 month of chronic cerebral hypoperfusion whilst 
FluoroMyelin staining was unchanged. This selective disruption to MAG is 
consistent with previous studies using the mouse model of hypoperfusion (Coltman 
et al., 2011; Reimer et al., 2011). Although MAG accounts for less than 1% of 
myelin protein composition it appears particularly vulnerable to decreased blood 
flow. Post-mortem study of hypoxic ‘type III’ MS lesions and ischaemic white 
matter lesions has shown that MAG is preferentially lost in both types of lesions 
whilst the compact myelin proteins MBP and PLP are unchanged (Aboul-Enein et 
al., 2003). A recent post-mortem investigation of individuals with small vessel 
disease and vascular dementia has shown decreased protein levels of MAG compared 
to controls (Barker et al., 2013). One possible reason for this selective vulnerability 
of MAG corresponds to its periaxonal localisation within the most distal 
oligodendrocyte processes (Aboul-Enein et al., 2003). An earlier study of anoxia in 
optic nerve preparations has demonstrated that terminal oligodendrocyte processes at 
paranodes are the first to be affected and that damage spreads from nodes of Ranvier 
outwards (Waxman et al., 1992). Consistent with this the periaxonal localisation of 
MAG suggests it will be one of the first internodal myelin proteins to be disrupted. It 
is important to note that MAG disruption indicates that the myelin sheath is detached 
or in the process of detaching from the axon however it is possible that despite this 
detachment, compact myelin remains intact hence the lack of apparent changes in 




characterise the axonal binding partners of MAG to determine whether these are also 
altered in response to chronic cerebral hypoperfusion. Furthermore it would also be 
pertinent to study MAG distribution following longer term hypoperfusion to 
determine whether this disruption to internodal axon-glial connection worsens with 
time or if there is any evidence of recovery. 
 
The finding that MAG was preferentially disrupted in the absence of gross myelin 
disruption contrasts with earlier studies by another group using the mouse model of 
chronic cerebral hypoperfusion. These studies have demonstrated extensive myelin 
damage following 1 month of hypoperfusion (Fujita et al., 2010; Washida et al., 
2010; Maki et al., 2011; Seo et al., 2013) which was not observed in the current 
study. These studies were carried out by another group in another institution and 
therefore one possible reason for the discrepancy in results may be due to subtle 
differences in surgical technique. Similarly, although both groups use C57/Bl6J mice 
from a commercial supplier, there may be slight strain differences based on the 
geographical location of the supplier. Given that C57Bl/6J mice are known to have 
an incomplete circle of Willis, any subtle differences in the cerebral architecture 
between commercial suppliers in different countries may have profound effects on 
the extent of pathology induced following chronic cerebral hypoperfusion. The 
different approaches used to visualise myelin may also partially contribute to the 
discrepancy between the current study and previous studies. The initial 
characterisation of the model used a Klüver-Barerra histological stain (also known as 
Luxol fast blue) to quantify myelin pathology which was assessed using a grading 




lipophilic dye FluoroMyelin and the fluorescent intensity of the staining was 
measured. Whilst neither Luxol fast blue nor FluoroMyelin label specific myelin 
lipids, quantifying the intensity of staining is a more accurate way of assessing 
myelin integrity compared to a qualitative grading scale. In support of the current 
study it is important to note that previous studies within the Horsburgh group have 
consistently reported a lack of gross myelin pathology as assessed by MBP labelling 
and western blotting (Reimer et al., 2011; and unpublished observations) therefore 
the results of the current study are in keeping with previous results from the group.  
 
3.4.3 Potential mechanisms involved in nodal and paranodal disruption 
following hypoperfusion 
The exact mechanisms underlying paranodal disruption following cerebral 
hypoperfusion are unknown. Microarray analysis of white matter from mice subject 
to 3 days of chronic cerebral hypoperfusion has demonstrated significant 
upregulation of genes involved in inflammatory responses (Reimer et al., 2011) 
suggesting that inflammatory signalling cascades may be an important mediator of 
white matter disruption following hypoperfusion. In support of this, previous study in 
post-mortem MS tissue and in EAE mice has demonstrated a close association 
between paranodal disruption and microglial activation (Howell et al., 2010). 
Interestingly this study demonstrated that inhibition of microglial activation through 
administration of minocycline preserved paranodal structure (Howell et al., 2010) 
therefore modulation of inflammation may be an important therapeutic strategy to 




significantly different between groups following 3 days of hypoperfusion but were 
significantly increased after 1 month. Given that axon-glial disruption is evident as 
early as 3 days following surgery it is unlikely that increased microglial number 
mediates early paranodal disruption following chronic cerebral hypoperfusion. 
Despite this, the evidence from microarray analysis indicates significant upregulation 
of inflammatory signalling at this time point thus a role for inflammation as a 
mediator of paranodal disruption cannot be excluded. Furthermore, there is growing 
evidence that microglia are highly dynamic cells and that phenotypically distinct pro-
inflammatory (termed M1) and anti-inflammatory (M2) activation states exist within 
the greater microglial pool (Edwards et al., 2006; Mosser and Edwards, 2008). It has 
recently been demonstrated that the M1 or M2 phenotype can directly influence 
white matter damage following traumatic brain injury (Wang et al., 2013) or 
demyelination (Miron et al., 2013). The current study utilised the general microglial 
marker Iba1 to determine numbers of microglia following hypoperfusion but future 
studies should aim to characterise specific microglial phenotypes and to assess levels 
of pro-inflammatory mediators to fully clarify whether increased inflammation 
modulates paranodal disruption following chronic cerebral hypoperfusion. 
 
In addition to inflammation, studies have demonstrated that myelinated axons are 
vulnerable to reductions in oxygen and glucose (Pantoni et al., 1996; Fern et al., 
1998; Wender et al., 2000). Indeed given the extent of blood flow reduction reported 
in the mouse model of hypoperfusion (~30%; Shibata et al., 2004) it is likely that 
there is an energy deficit within the white matter following hypoperfusion. As 




axonal mitochondria which are trafficked along axons. Previous studies in the 
peripheral nervous system (PNS) have demonstrated that mitochondria are 
preferentially localised to nodes of Ranvier and are thought to be recruited to this 
region in an activity-dependent manner (Zhang et al., 2010; Chiu, 2011). A recent 
study has additionally reported that in the CNS mitochondria preferentially localise 
to juxtaparanodal and internodal regions and that neuronal activity decreases 
mitochondrial motility in nodal and paranodal regions (Ohno et al., 2011). Indeed the 
presence of Na+/K+/ATPase pumps within internodal domains suggests that these 
regions have a high energy demand. These pumps require ATP to power the export 
of three Na+ ions in exchange for two K+ ions and thus play a key role in maintaining 
resting membrane potential (Waxman and Ritchie, 1993). Given the pronounced 
paranodal disruption and consequent altered distribution of Nav1.6 at nodes of 
Ranvier observed in the current study it was hypothesised that the distribution of 
mitochondria along myelinated axons may also be disrupted in response to cerebral 
hypoperfusion. In support of this, accumulation of mitochondria within swellings in 
nodal and paranodal domains of peripheral nerves has been reported in Caspr 
knockout mice (Einheber et al., 2006) and in mice expressing mutant Caspr (Sun et 
al., 2009) demonstrating that disruption to paranodes can influence mitochondrial 
localisation. In the current study a significant decrease in the number of nodes 
containing mitochondria was observed after 6 weeks of hypoperfusion with no 
difference observed between groups following 3 months. Although speculative it is 
possible that disruption to Nav1.6 channels following hypoperfusion results in 
increased Na+ influx into the axon therefore increasing the energy demand of the 




Ranvier into internodal domains. Alternatively it is possible that the decrease in 
mitochondrial localisation at nodes of Ranvier following 6 weeks of hypoperfusion is 
due to a loss of mitochondria which is restored by 3 months. One limitation of 
immunohistochemical approaches to study the localisation of mitochondria is that 
mitochondrial movement along axons is a dynamic process, which may not be 
readily detected at the end stage of animal experiments (Chiu, 2011). Transgenic 
mice in which mitochondria are fluorescently labelled have been developed (Misgeld 
et al., 2007) therefore future studies could conduct live imaging in slice preparations 
from such mice to determine whether modest reductions in oxygen and glucose 
influence the distribution of mitochondria along myelinated axons. Indeed these mice 
could also be subject to chronic cerebral hypoperfusion and in vivo mitochondrial 
dynamics studied using two-photon microscopy (Helmchen and Denk, 2005). 
 
Mitochondria are transported along axons via microtubules and actin filaments of the 
cytoskeleton (Chang and Reynolds, 2006). Importantly, most nodal and paranodal 
proteins are also associated with the cytoskeleton either indirectly (in the case of 
Nav1.6) or directly (e.g. βIV spectrin) and thus disruption to the underlying 
cytoskeleton may contribute to nodal and paranodal alterations following 
hypoperfusion. Ultrastructural analysis has revealed that paranodal junctions in CNS 
fibres are directly connected to cytoskeletal microtubules and neurofilaments and to 
axonal organelles through small filamentous connections (Ichimura and Ellisman, 
1991; Nans et al., 2011). This direct association of paranodal junctions with the 
cytoskeleton further highlights the role of the paranodes in maintaining the domain 




demonstrated axonal swellings close to paranodal domains which contain increased 
phosphorylated neurofilaments suggesting underlying deficits in axonal transport 
which may be caused by cytoskeletal disruption (Garcia-Fresco et al., 2006). 
However in the current study, altered localisation of Nav1.6 channels was observed 
in the absence of altered Ankyrin G localisation suggesting an uncoupling of these 
two proteins rather than a generalised cytoskeletal disruption. To fully clarify 
whether disruption to the underlying cytoskeleton may mediate paranodal disruption 
following hypoperfusion it would be important for future study to investigate the 
effects of hypoperfusion on the distribution of cytoskeleton-associated proteins such 
as βIV spectrin. Interestingly, it has been demonstrated that MAG can modulate the 
spacing and phosphorylation of neurofilaments (Yin et al., 1998; Dashiell et al., 
2002) which may alter axonal transport. Additionally MAG knockout mice exhibit 
paranodal disruption resulting in diffusion of juxtaparanodal Kv channels into 
neighbouring paranodes (Marcus et al., 2002). The rapid disruption to MAG 
following chronic cerebral hypoperfusion observed in the current study may 
therefore be directly associated with paranodal disruption. 
 
3.4.4 Chronic cerebral hypoperfusion and impaired spatial working memory 
A strong association between chronic cerebral hypoperfusion, white matter damage 
and cognitive decline has been demonstrated in imaging studies of elderly humans 
(DeCarli et al., 1995; Ruitenberg et al., 2005; Appelman et al., 2010). Age-related 
cognitive alterations in humans include decreases in processing speed and memory 




arm radial arm maze was used to assess spatial working memory following chronic 
cerebral hypoperfusion in mice. The results revealed that hypoperfused animals made 
significantly more revisiting errors and fewer novel entries than sham controls, 
indicative of a deficit in spatial working memory. This finding is consistent with 
earlier studies in the model (Shibata et al., 2004; Coltman et al., 2011). Successful 
completion of the 8-arm radial arm maze task requires the mice to retrieve a food 
pellet from the end of each arm whilst remembering the arms they have previously 
visited. This task therefore requires significant memory flexibility as the animals 
need to constantly update their memory regarding the arms which they have visited 
and those which they have not. It is thought that the circuits involved in working 
memory tasks in rodents involve the hippocampus, prefrontal cortex, striatum and 
thalamus (Hodges, 1996; Floresco et al., 1997; Floresco et al., 1999). The diverse 
anatomical regions involved suggest that white matter pathways play a key role in 
transmission of information during memory encoding and retrieval therefore any 
disruption to white matter may significantly impair performance in the task. Indeed 
combined MRI and cognitive testing in humans has shown that ageing is associated 
with a slowing of memory retrieval and that this is correlated with decreased white 
matter integrity in the genu and splenium of the corpus callosum and frontal white 
matter in addition to other regions (Bucur et al., 2008).  
 
The current study revealed that Nav1.6 localisation to nodes of Ranvier was disrupted 
as early as 3 days following hypoperfusion and was accompanied by paranodal 
disruption and altered MAG labelling. Given the importance of both an intact myelin 




conduction it is likely that these observed alterations may contribute to the spatial 
working memory deficit following cerebral hypoperfusion. Indeed, a recent study 
within the group has demonstrated that the length of Nav1.6
+ nodes of Ranvier is 
significantly decreased in aged mice and is correlated with poorer performance in 
radial arm maze testing (Miss Kanelina Karali, PhD thesis 2014). Critically the 
current study demonstrated that impaired axon-glial integrity and paranodal 
disruption occurred in the absence of widespread damage to compact myelin 
demonstrating that even subtle alterations to the structure of myelinated axons can 
have significant effects on functional capabilities.  
 
3.4.5 Summary and conclusions 
Previous studies have demonstrated that chronic cerebral hypoperfusion in mouse is 
associated with widespread and diffuse white matter damage (Shibata et al., 2004; 
Coltman et al., 2011). Critically the results presented in this chapter demonstrate the 
novel finding that chronic cerebral hypoperfusion results in paranodal disruption and 
diffusion of Nav1.6 channels away from nodes of Ranvier. Furthermore impaired 
internodal axon-glial integrity was observed in the absence of gross myelin 
disruption. Importantly, this study has demonstrated that hypoperfused mice show 
decreased performance in the radial arm maze suggesting that relatively modest 
alterations to the domains of myelinated axons may have downstream cognitive 
consequences. In the next chapter the impact of chronic cerebral hypoperfusion on 
oligodendrocytes and OPCs will be examined to determine whether alterations in 




















The finding that chronic cerebral hypoperfusion resulted in disruption to the domain 
structure of myelin axons and impaired axon-glial integrity raised the question as to 
whether this may be driven by a deficit in myelinating oligodendrocytes. Indeed, 
post-mortem studies of MS cases have shown that injury to oligodendrocytes can 
result in a ‘dying back’ retraction of the most distal oligodendrocyte processes, 
resulting in impaired axon-glial connection and paranodal disruption (Ludwin and 
Johnson, 1981; Lassmann et al., 1997). In addition it has been estimated that a single 
oligodendrocyte can myelinate up to 50 internodal segments (Hildebrand et al., 1993; 
Rivers et al., 2008) therefore injury to individual oligodendrocytes may impact on 
multiple axons. Taken together, these studies suggest that oligodendrocyte health 
and/or number of oligodendrocytes may have important consequences for the 
structure of myelinated axons.  
 
Previous studies have demonstrated that oligodendrocytes are particularly vulnerable 
to reductions in CBF. Loss of oligodendrocytes is observed as early as 24 hours 
following focal cerebral ischaemia in rats and mice (Pantoni et al., 1996; Valeriani et 
al., 2000; McIver et al., 2010) and has additionally been reported following 1 month 
of chronic cerebral hypoperfusion in mouse (Fujita et al., 2010; Washida et al., 2010; 
Maki et al., 2011), highlighting the vulnerability of these cells to even modest 




there is an abundance of evidence demonstrating that oligodendrocytes can be 
replaced through the proliferation and/or differentiation of OPCs (Tanaka et al., 
2001; Tanaka et al., 2003). Restoration of mature oligodendrocyte number has been 
demonstrated as early as 7 days post-reperfusion in a study of focal cerebral 
ischaemia in mouse (McIver et al., 2010). Furthermore, increased numbers of 
remyelinating oligodendrocytes and the presence of OPCs has also been described in 
post-mortem study of aged human in regions of the brain where blood flow has been 
compromised (Simpson et al., 2007a). Additionally, increased numbers of OPCs 
have been demonstrated in post-mortem study of individuals with vascular cognitive 
impairment (Back et al., 2011) suggesting that OPCs may respond to reduced 
cerebral blood flow in an attempt to ameliorate white matter damage. Despite these 
studies demonstrating increased numbers of OPCs in response to severe reductions in 
CBF, the effects of modest reductions in CBF on OPC numbers is unknown.   
 
A growing number of studies have investigated the mechanisms underlying OPC 
proliferation and differentiation in response to CNS injury. Several studies have 
identified the GPR17 receptor as a key modulator of OPC differentiation in response 
to insults such as ischaemia, spinal cord injury and cortical stab wound in mice 
(Ciana et al., 2006; Lecca et al., 2008; Ceruti et al., 2009; Boda et al., 2011) and 
more recently traumatic brain injury in humans (Franke et al., 2013). GPR17 is 
upregulated in response to injury and it is thought that receptor activation acts as a 
sensor of local damage (Lecca et al., 2008). Furthermore, GPR17 has been 
demonstrated to be expressed by subsets of OPCs and premyelinating 




differentiation of OPCs (Boda et al., 2011; Fumagalli et al., 2011). This receptor may 
therefore be an important mediator of white matter repair following injury and may 
represent an important therapeutic target for cerebral hypoperfusion.  
 
4.1.1 Study hypothesis and aims 
It was hypothesised that chronic cerebral hypoperfusion would result in loss of 
oligodendrocytes and OPCs. The specific aim of this study was to investigate 
oligodendrocyte and OPC pools in response to short term (3 days) and long term (1 
month) hypoperfusion. A further aim was to characterise whether GPR17 receptor 







4.2.1 Animals and Surgery 
Adult male C57Bl/6J mice (25-30g, age 3-4 months) underwent chronic cerebral 
hypoperfusion or sham surgery as described in Section 2.2. Group sizes for 3 day 
hypoperfusion studies were (1) n = 13 sham, 11 hypoperfused; and (2) n = 10 sham, 
9 hypoperfused. For 1 month hypoperfusion studies group sizes were (3) n = 10 
sham, 11 hypoperfused; and (4) n = 9 sham, 9 hypoperfused.  
 
4.2.2 Laser speckle contrast imaging 
Cerebral blood flow was measured using laser speckle contrast imaging though the 
intact skull as described in Section 2.3. Baseline readings were acquired 1 day prior 
to surgery with subsequent recordings made at 3 days and 28 days following surgery.  
 
4.2.3 BrdU administration 
Animals from cohort 3 were given intraperitoneal injections of the thymidine 






4.2.4 Perfusion and tissue processing for immunohistochemistry 
At 3 days or 28 days (1 month) post-surgery, mice were deeply anaesthetised with 
5% isoflurane and transcardially perfused as described in Section 2.8.1. Tissue was 




Immunohistochemistry was carried out as described in Section 2.10. Anti-CC1, NG2 
and Olig2 antibodies were used to label oligodendroglia, anti-BrdU and PCNA 
antibodies were used to assess numbers of proliferating cells, and anti-GPR17 
antibody was used to assess GPR17 expression.  
 
4.2.6 Confocal microscopy and image analysis 
Immunolabelled 50 µm sections were imaged using confocal laser scanning 
microscopy as described in Section 2.11.1. Images were acquired in the corpus 
callosum immediately adjacent to the lateral ventricle, as shown in Figure 2.3. Image 






4.2.7 Electron microscopy and g-ratio measurement 
Animals were transcardially perfused and the corpus callosum manually dissected as 
described in Section 2.13.1. Tissue was processed and cut into 60 nm transverse 
sections as described in Section 2.13.2. Images of myelinated fibres were acquired at 
3500x magnification and g-ratio was measured as described in Section 2.14.2.  
 
4.2.8 Statistical analysis 
Data were analysed using a two-tailed student’s t-test or Mann-Whitney U-test 
depending on parametric or non-parametric distribution. A probability (p) value < 








4.3.1 Loss of mature oligodendrocytes and OPCs following 3 days of cerebral 
hypoperfusion 
At the outset of the study it was hypothesised that chronic cerebral hypoperfusion 
would lead to a loss of mature oligodendrocytes. To determine the effect of 3 days of 
hypoperfusion on mature oligodendrocyte populations, immunohistochemistry was 
carried out using an antibody against the adenomatous polyposis coli (CC1 or APC) 
protein and numbers of CC1+ mature oligodendrocytes were counted in the corpus 
callosum (Figure 4.1A). This revealed a significant decrease in numbers of mature 
oligodendrocytes in hypoperfused mice as compared to sham controls (p = 0.02; 
Figure 4.1B). The specificity of CC1 as a marker of mature oligodendrocytes was 
confirmed through double labelling experiments with GFAP and NG2 (Appendix 
A2.1). 
 
The impact of short term cerebral hypoperfusion on OPC populations was also 
assessed using anti-NG2 immunohistochemistry and counting numbers of NG2+ cells 
in the corpus callosum. This revealed two distinct populations of NG2+ OPCs: one 
group had circular bipolar reactivity around the nucleus and few processes (‘early 
OPCs’) whilst the other group of cells were intensely stained and processed (‘late 
OPCs’; Figure 4.1C). A significant decrease in numbers of early NG2+ OPCs was 




unchanged following 3 days of hypoperfusion (p = 0.80; Figure 4.1E). The 
specificity of NG2 as a marker of OPCs was confirmed through double labelling with 
PDGFRα and PDGFβ (Appendix A2.2; Nishiyama et al., 1996). 
 
4.3.2 Increased numbers of mature oligodendrocytes and restoration of early 
OPC populations following 1 month of cerebral hypoperfusion 
The impact of longer term (1 month) of chronic cerebral hypoperfusion on numbers 
of mature oligodendrocytes and OPCs in the corpus callosum was also assessed. This 
revealed that numbers of CC1+ mature oligodendrocytes were significantly increased 
in hypoperfused animals as compared to shams (p = 0.007; Figures 4.2A and 4.2B). 
No significant difference in numbers of NG2+ early OPCs (p = 0.281) or late OPCs 
(p = 0.719) was observed between groups following 1 month of chronic cerebral 







Figure 4.1: Decreased numbers of mature oligodendrocytes and OPCs following 
3 days of cerebral hypoperfusion. (A) Representative confocal images showing 
CC1 labelling of mature oligodendrocyte cell bodies in the corpus callosum. Scale 
bar = 10 µm. (B) A significant decrease in the number of CC1+ mature 
oligodendrocytes was observed after 3 days of cerebral hypoperfusion compared to 
sham controls (p = 0.02). (C) Representative confocal images showing morphology 
of early and late NG2+ OPCs. Scale bar = 10 µm. (D) A significant decrease in the 
number of early NG2+ OPCs was observed in the corpus callosum after 3 days of 
cerebral hypoperfusion (p = 0.007). (E) No significant difference in number of late 
NG2+ OPCs was observed between groups following 3 days of cerebral 





Figure 4.2: Increased numbers of mature oligodendrocytes and restoration of 
the early OPC pool following 1 month of chronic cerebral hypoperfusion. (A) 
Representative confocal images showing CC1 labelling of mature oligodendrocytes 
in the corpus callosum. Scale bar = 10 µm. (B) A significant increase in numbers of 
mature oligodendrocytes was observed in the corpus callosum following 1 month of 
cerebral hypoperfusion (p = 0.007). (C) Numbers of NG2+ early OPCs were 
unchanged following 1 month of chronic cerebral hypoperfusion (p = 0.281). (D) 
Similarly, numbers of NG2+ late OPCs were not different between groups following 





4.3.3 Altered proliferation of OPCs following 3 days and 1 month of chronic 
cerebral hypoperfusion 
The unexpected finding of increased numbers of mature oligodendrocytes together 
with restored numbers of early OPCs following 1 month of hypoperfusion raised the 
question as to whether chronic cerebral hypoperfusion increased OPC proliferation. 
To test this and to determine the extent of proliferation following 3 days and 1 month 
of hypoperfusion, sections were labelled with proliferating cell nuclear antigen 
(PCNA) and numbers of positive cells counted in the corpus callosum (Figure 4.3A). 
This marker is acutely expressed by all cells during the S-phase of the cell cycle thus 
can be used to quantify numbers of proliferating cells. Cell counts revealed that total 
numbers of PCNA+ cells were not significantly different between groups after 3 days 
(p = 0.196) or 1 month (p = 0.564) of hypoperfusion (Figures 4.3B and 4.3C 
respectively).  
  
To specifically assess the extent of OPC proliferation, PCNA was used in 
combination with the oligodendroglial marker Olig2 and numbers of double labelled 
cells counted (Figure 4.3D). PCNA+/NG2+ double labelling could not be carried out 
due to the antibodies being raised in the same species. Whilst Olig2 is expressed 
throughout the oligodendrocyte lineage only OPCs have the ability to proliferate thus 
PCNA+/Olig2+ cells represent proliferating OPCs. Cell counts revealed that numbers 
of PCNA+/Olig2+ cells were significantly decreased after 3 days of hypoperfusion 




cerebral hypoperfusion numbers of PCNA+/Olig2+ cells were not different between 
groups (p = 0.264; Figure 4.3F).  
 
4.3.4 OPC differentiation following 1 month of chronic cerebral hypoperfusion 
As PCNA is acutely expressed during the cell cycle, only cells actively proliferating 
at the time of termination will be labelled. This therefore represents a single 
‘snapshot’ of proliferation. To further investigate the extent of proliferation 
following chronic cerebral hypoperfusion one cohort of animals received injections 
of the thymidine analogue BrdU which is incorporated into the DNA of proliferating 
cells and can be visualised using anti-BrdU immunohistochemistry. Importantly this 
approach allows cumulative labelling of proliferating cells during the period of BrdU 
administration and enables the phenotypic fate of proliferating cells to be 
determined. In the current study, animals received twice daily injections of BrdU for 
the first 3 days following surgery and were terminated following 1 month of 
hypoperfusion at which point numbers of BrdU+ cells were counted. This revealed 
that BrdU+ cells were present in 2 out of 9 of the sham control group and 5 out of 10 
of the hypoperfused group although this difference did not reach statistical 
significance (p = 0.157; Figures 4.4A and 4.4B).  
 
Finally, to assess whether newly generated BrdU+ cells had differentiated into 
oligodendrocytes, BrdU+/CC1+ double labelling was carried out and numbers of 




revealed that BrdU+/CC1+ cells were present in 3 out of 10 (30%) of hypoperfused 
mice but were absent in sham controls, however this difference did not reach 
statistical significance (p = 0.09; Figure 4.4D). Together these results indicate that 
chronic cerebral hypoperfusion does not increase OPC proliferation but demonstrates 
that a subset of cells generated following surgery have differentiated into mature 







Figure 4.3: Low numbers of proliferating cells are observed in response to 
hypoperfusion. (A) Representative confocal images showing PCNA labelling in the 
corpus callosum. (B) No significant differences in numbers of PCNA+ cells were 
observed between groups following 3 days (p = 0.196) or (C) 1 month (p = 0.564) of 
chronic cerebral hypoperfusion. (D) Representative confocal images showing 
Olig2/PCNA labelling of proliferating OPCs in the corpus callosum. (E) A 
significant decrease in numbers of Olig2+/PCNA+ cells was observed following 3 
days of chronic cerebral hypoperfusion (p = 0.048). (F) Numbers of Olig2+/PCNA+ 
cells were not significantly different between groups following 1 month of cerebral 





Figure 4.4: A proportion of newly generated cells differentiate into mature 
oligodendrocytes following 1 month of chronic cerebral hypoperfusion. (A) 
Representative confocal images showing BrdU+ cells in the corpus callosum. (B) 
BrdU+ cells were present in 2 out of 9 sham control animals and in 5 out of 10 
hypoperfused animals but were not significantly different between groups (p = 
0.157). (C) Representative confocal images showing BrdU+/CC1+ cells in the corpus 
callosum. (D) CC1+/BrdU+ double labelled cells were present in 3 out of 10 of the 
hypoperfused cohort but were completely absent from the sham control group. 
However as with numbers of BrdU+ cells, this difference did not reach statistical 




4.3.5 GPR17 expression is decreased in response to 3 days of chronic cerebral 
hypoperfusion 
Recent studies have reported an emerging role for the GPR17 receptor in the 
regulation of OPC differentiation following cerebral ischaemia (Ciana et al., 2006; 
Lecca et al., 2008). To determine whether GPR17 activation was involved in 
differentiation of OPCs following chronic cerebral hypoperfusion, sections were 
stained for GPR17 (Figure 4.5A). GPR17/NG2 double labelling could not be carried 
out due to the antibodies being raised in the same species, therefore GPR17 
expression within the oligodendrocyte lineage was determined using GPR17/Olig2 
double labelling. This revealed that approximately 64% of GPR17+ cells co-
expressed Olig2 (Appendix A2.3) which is consistent with a previous report (Lecca 
et al., 2008).  
 
Cell counts revealed that numbers of GPR17-expressing cells were not different 
between groups following 3 days (p = 0.219) or 1 month (p = 0.172) of chronic 
cerebral hypoperfusion (Figures 4.5B and 4.5C respectively). Despite no differences 
in numbers of GPR17 cells, a significant decrease in GPR17 receptor expression (as 
assessed by fluorescent intensity) was observed after 3 days of cerebral 
hypoperfusion (p = 0.007; Figure 4.5D). However following 1 month, GPR17 







Figure 4.5: Decreased GPR17 staining intensity following 3 days of cerebral 
hypoperfusion. (A) Representative confocal images showing GPR17 labelling in the 
corpus callosum following 3 days and 1 month of chronic cerebral hypoperfusion. 
Scale bar = 10 µm. (B) Numbers of GPR17+ cells were unchanged following 3 days 
(p = 0.219) and (C) 1 month (p = 0.172) of hypoperfusion. (D) The intensity of 
GPR17 staining was significantly decreased following 3 days of chronic cerebral 
hypoperfusion (p = 0.007). (E) Following 1 month of hypoperfusion, GPR17 staining 




4.3.6 No difference in g-ratio of myelinated fibres following 3 days or 1 month of 
cerebral hypoperfusion 
The current study revealed a significant decrease in mature oligodendrocyte number 
following 3 days of cerebral hypoperfusion with a significant increase in numbers of 
mature oligodendrocytes following 1 month. It has been estimated that a single 
oligodendrocyte can myelinate up to 50 individual internodes (Rivers et al., 2008) 
therefore the significant decrease and subsequent increase in oligodendrocyte number 
in response to cerebral hypoperfusion was predicted to influence the extent of 
myelination. Despite this, previous study revealed that chronic cerebral 
hypoperfusion resulted in a specific disruption to axon-glial connection in the 
absence of gross myelin changes (see Chapter 3; Reimer et al, 2011). To confirm 
previous findings and to further examine myelin structure following hypoperfusion, 
electron microscopy was carried out and the g-ratio (axonal diameter divided by fibre 
diameter) of myelinated axons was measured (Figure 4.6A). Analysis revealed no 
significant difference in g-ratio values between groups following 3 days (p = 0.792) 
or 1 month (p = 0.692) of hypoperfusion (Figure 4.6B). This finding is consistent 
with previous studies by the group demonstrating that the integrity of compact 
myelin is not altered following chronic cerebral hypoperfusion (see Chapter 3 and 






4.3.7 Cerebral blood flow is reduced in hypoperfused animals 
Taken together the results from the current study demonstrate that mature 
oligodendrocytes and OPCs are lost early in response to cerebral hypoperfusion but 
that they are replaced over time resulting in increased numbers following 1 month of 
hypoperfusion as compared to shams. In addition compact myelin integrity following 
hypoperfusion is unchanged (Chapter 3; Reimer et al., 2011). These unexpected 
findings contrast with earlier studies using the model which report decreased 
numbers of mature oligodendrocytes together with myelin disruption (Fujita et al., 
2010; Washida et al., 2010; Maki et al., 2011). One possible explanation for this 
discrepancy in findings may relate to the extent of CBF reduction induced following 
surgery, therefore laser speckle contrast imaging was used to assess CBF 24 hours 
prior to surgery (baseline), and at 3 days and 28 days following surgery (Figure 
4.7A). This revealed that following 3 days of cerebral hypoperfusion, CBF was 
reduced to approximately 38% of sham levels (p < 0.0001; Figure 4.7B). After 28 
days, CBF in hypoperfused animals had recovered slightly but was still 







Figure 4.6: G-ratio is unchanged following 3 days and 1 month of chronic 
cerebral hypoperfusion. (A) Representative electron micrographs showing 
myelinated fibres in the corpus callosum following 3 days and 1 month of cerebral 
hypoperfusion. Scale bars = 1 µm. (B) G-ratio values were unchanged between sham 








Figure 4.7: Cerebral blood flow is significantly reduced in hypoperfused 
animals. (A) Representative laser speckle images showing surface CBF through the 
intact skull at baseline, 3 days and 1 month after surgery. Images are the average of 
100 frames acquired at 1 frame/second and are expressed in arbitrary perfusion units. 
(B) Following 3 days of hypoperfusion, CBF values were approximately 38% lower 
than those observed in sham animals (< 0.0001). (C) Following 28 days, there was a 
recovery in CBF such that values in hypoperfused animals were less than 20% of 








At the outset of the study it was hypothesised that decreased numbers of 
oligodendrocyte and OPC pools would be observed following chronic cerebral 
hypoperfusion. However the results unexpectedly revealed that despite an initial loss 
of oligodendrocytes and OPCs early in response to hypoperfusion, these populations 
of cells recover over time resulting in increased numbers of mature oligodendrocytes 
and restoration of the OPC pool 1 month after surgery. Subsequent assessment of 
OPC proliferation demonstrated low numbers of proliferating cells but revealed that 
a subset of newly generated cells differentiated into mature oligodendrocytes 
however no significant difference was observed between sham and hypoperfused 
groups. In light of recent studies demonstrating a role for the GPR17 receptor in 
mediating OPC differentiation in response to cerebral ischaemia, the expression of 
GPR17 was examined. This revealed decreased expression of GPR17 following 3 
days suggesting that this receptor was not involved in mediating the OPC response to 
cerebral hypoperfusion. Importantly the observed alterations to mature 
oligodendrocyte number did not influence the g-ratio of myelinated axons, 
confirming previous findings that chronic cerebral hypoperfusion does not lead to 






4.4.1 OPC proliferation and differentiation in response to hypoperfusion 
The vulnerability of oligodendrocytes to severe reductions in CBF is well 
documented, with in vivo models of cerebral ischaemia demonstrating a loss of 
oligodendrocytes (Pantoni et al., 1996; Tanaka et al., 2003; McIver et al., 2010), 
occurring as early as 3 hours after reperfusion (Pantoni et al., 1996). Additionally, 
decreased numbers of oligodendrocytes have been reported following 1 month of 
chronic cerebral hypoperfusion in mouse (Fujita et al., 2010; Washida et al., 2010; 
Maki et al., 2011) suggesting that these cells are susceptible to even modest 
reductions in CBF. The current study sought to determine whether alterations to 
oligodendrocyte pools may explain previous findings of disruption to the domain 
structure of myelinated axons and impaired axon-glial connection following 3 days 
and 1 month of chronic cerebral hypoperfusion. Interestingly, this revealed increased 
numbers of mature oligodendrocytes and restoration of OPC populations following 1 
month of chronic cerebral hypoperfusion raising the question of the source of these 
newly generated oligodendrocytes. The ability of OPCs to proliferate and 
differentiate in response to CNS injury is well characterised (Nait-Oumesmar et al., 
1999; Levine et al., 2001) therefore it was hypothesised that increased proliferation 
and differentiation of OPCs was the likely mechanism underlying 
oligodendrogenesis in response to cerebral hypoperfusion. In support of this, 
upregulation of genes involved in proliferation has been demonstrated following 3 
days of hypoperfusion (Reimer et al., 2011) and a very recent study has reported 
increased numbers of proliferating OPCs following 14 days of chronic cerebral 





Immunohistochemical assessment of proliferation revealed numbers of PCNA+ cells 
were unchanged between groups whilst numbers of PCNA+/Olig2+ OPCs were 
decreased following 3 days of hypoperfusion. Further assessment using BrdU which 
cumulatively labelled proliferating cells over the first 3 days following surgery 
revealed increased numbers of BrdU+ cells in hypoperfused animals relative to shams 
however this was not statistically significant. Overall these data suggest there is not a 
significant upregulation of proliferation in the three day period following the onset of 
hypoperfusion. One possible explanation for these results is that the extent of 
proliferation has been underestimated in this study due to the methodological 
approaches used. It has been reported that the bioavailability of BrdU following 
systemic injection is 2 hours (Taupin, 2007) therefore in this study the total duration 
of BrdU incorporation per day was only 4 hours. This therefore represents a 
‘snapshot’ of proliferation rather than a robust assessment. However, if mice had 
been given several BrdU injections per day this would be likely to cause considerable 
stress to the animals which itself may influence rates of proliferation (Gould et al., 
1998). Additionally, BrdU is known to be toxic in high concentrations (Taupin, 
2007) thus BrdU administration requires a fine balance between adequately labelling 
cells whilst avoiding toxicity. BrdU is commonly administered at doses of 50-100 
mg/kg body weight without any adverse effects (Taupin, 2007). The dosing regimen 
used in this study (70 mg/kg body weight/day) is within this reported safe range 
therefore there is unlikely to be any BrdU-associated toxicity but it is likely that this 
approach has not been sufficient to label all proliferating cells. More recent studies 
are employing another thymidine analogue, EdU, as a superior alternative to BrdU 




require antigen retrieval and therefore is considered to be a more reliable marker of 
proliferation which may be important for future studies.  
 
Whilst methodological approaches may explain the low numbers of proliferating 
cells observed in this study, it is also possible that the data are truly representative, 
i.e. hypoperfusion does not elicit a proliferative response at the time point studied. 
After 3 days of hypoperfusion, blood flow is reduced to around 62% and thus 
damage may still be evolving and alterations within the cellular microenvironment 
may impair the ability of cells to proliferate. As no intermediate time point was 
studied it is difficult to ascertain when, or if, a peak in proliferation occurs in 
response to cerebral hypoperfusion. A recent study has shown increased numbers of 
OPCs following 14 days of hypoperfusion (Miyamoto et al., 2013c) suggesting that 
proliferation may occur at a later time point than investigated in the current study. 
Indeed, in mice aged 2 months, the cell cycle time of OPCs in the corpus callosum is 
estimated to be approximately 10 days (Young et al., 2013) therefore it is perhaps 
unsurprising that  low numbers of proliferating cells were observed following 3 days 
of hypoperfusion in the current study. An alternative explanation is that 
differentiation of existing OPCs may account for increased numbers of 
oligodendrocytes following 1 month of chronic cerebral hypoperfusion. In support of 
this, a study of focal cerebral ischaemia in rat has demonstrated regeneration of 
oligodendrocytes as early as 1 week post-reperfusion. The authors of this study 
reported low numbers of proliferating cells and concluded that increased 
oligodendrocyte number must be due to increased OPC differentiation rather than 




labelling revealed that only a small number of newly generated cells differentiated 
into mature oligodendrocytes, however as indicated earlier the low numbers of cells 
labelled may be a technical limitation of BrdU labelling. Future studies should 
therefore employ a more robust assessment of OPC proliferation to fully address this.  
 
4.4.2 Heterogeneity of NG2+ OPCs 
An interesting finding of the current study was the identification of two 
morphologically distinct types of cell with NG2 immunoreactivity, thought to 
correspond to early and late stage OPCs. Researchers within the field have 
hypothesised that two distinct populations of OPCs may exist: those which retain the 
ability to proliferate in response to injury and those which remain as post-mitotic 
OPCs (Dawson et al., 2000; Nishiyama et al., 2009). Indeed it is thought that NG2+ 
OPCs with a simple, bipolar appearance are more likely to be true progenitor cells 
than their multi-processed counterparts, based on their morphological similarity to 
OPCs found during development (Horner et al., 2000; Reynolds et al., 2002; 
Watanabe et al., 2002). It has additionally been proposed that bipolar NG2+ OPCs 
are more likely to be able to migrate to sites of injury in the adult CNS than multi-
processed late stage OPCs (Watanabe et al., 2002). The current study revealed that 
numbers of early bipolar OPCs were decreased following 3 days of hypoperfusion 
whilst numbers of late OPCs were unchanged. If early OPCs are indeed the subset of 
cells with the ability to proliferate this may partly explain the low numbers of 




suggest that different subtypes exist within the OPC pool and may be differentially 
affected by cerebral hypoperfusion. 
 
More recent studies have revealed that NG2+ OPCs possess Na+ channels and can 
generate action potentials (Karadottir et al., 2008) however there is disagreement 
within the literature as to whether all (De Biase et al., 2010) or subpopulations of 
NG2 cells (Karadottir et al., 2005) exert these physical properties. It has additionally 
been demonstrated that NG2+ OPCs possess ionotropic NMDA, AMPA and kainate 
receptors (Bergles et al., 2000; Karadottir et al., 2008; De Biase et al., 2010) 
suggesting they may participate in intercellular signalling. NG2+ cells have also been 
demonstrated to contact nodes of Ranvier (Butt et al., 1999), indicating that they may 
be able to respond to or influence neuronal activity (Levine et al., 2001). It has been 
argued that the molecular composition and corresponding functional characteristics 
of NG2+ cells are not consistent with precursor cells again raising the question of 
whether subpopulations of cells exist within the larger NG2+ cell pool. Additionally, 
differential receptor expression within NG2+ populations may contribute to the 
vulnerability of early OPCs to cerebral hypoperfusion but future studies are required 







4.4.3 Potential mechanisms underlying the OPC response to cerebral 
hypoperfusion 
To investigate a potential mechanism underlying differentiation of OPCs following 
hypoperfusion, GPR17 labelling was carried out. GPR17 has recently been 
characterised as a receptor for cysteinyl-leukotrienes and uracil nucleotides which 
are released in high concentrations following ischaemic injury (Ciana et al., 2006; 
Lecca et al., 2008). Studies have shown that in response to ischaemia, GPR17 is 
upregulated and thus may act as a sensor of local damage (Ciana et al., 2006; Lecca 
et al., 2008). Critically, GPR17 is expressed by a subset of OPCs and pre-
myelinating oligodendrocytes suggesting that receptor activation may be involved in 
the differentiation of OPCs in response to injury (Boda et al., 2011; Fumagalli et al., 
2011). There is however conflicting evidence regarding the exact role of GPR17 in 
OPC differentiation. Whilst the majority of in vitro studies have demonstrated that 
activation of GPR17 promotes OPC differentiation, one study using GPR17 
knockout and overexpressing mice has suggested that GPR17 activation inhibits 
OPC differentiation (Chen et al., 2009b) however the use of CNPase as a promoter of 
GPR17 expression in these studies has attracted some criticism. CNPase is expressed 
by mature oligodendrocytes thus it has been proposed that driving GPR17 expression 
in mature oligodendrocytes (rather than OPCs and immature oligodendrocytes which 
normally express GPR17) may have triggered apoptotic signalling cascades resulting 






In the current study, numbers of GPR17+ cells were unchanged following either 3 
days or 1 month of hypoperfusion but the labelling intensity was decreased in 3 day 
hypoperfused mice compared to controls. After 3 days of hypoperfusion, numbers of 
OPCs were decreased as compared to shams therefore was interesting to find that 
numbers of GPR17-expressing cells are unchanged at this time. It has been suggested 
that GPR17 is primarily expressed by immature pre-myelinating oligodendrocytes 
(Fumagalli et al., 2011) and therefore it is possible that cells at this stage of 
maturation are less susceptible to cerebral hypoperfusion that OPCs and mature 
oligodendrocytes. Another possibility is that surviving cells have upregulated GPR17 
to compensate for the loss of other cells. A recent in vitro study using OPC cultures 
has demonstrated that GPR17-expressing cells are more sensitive to ATP-mediated 
cytotoxicity than non-expressing cells (Ceruti et al., 2011) however it remains to be 
determined whether this is also true in vivo. The downregulation of GPR17 
expression following 3 days of hypoperfusion may therefore represent an attempt to 
limit ATP-mediated cell death or simply may be the result of low levels of its 
endogenous ligands. Taken together, the evidence regarding the role of GPR17 in 
OPC differentiation in response to injury is in many ways conflicting and future 
studies are required to fully clarify the function of this receptor.  
 
The lack of evidence for involvement of GPR17 in mediating the OPC response to 
hypoperfusion suggests that other mechanisms may be involved. Previous studies 
have demonstrated that glutamate and ATP may play important roles in the 
regulation of OPC proliferation and differentiation. In vitro studies have 




promotes OPC differentiation via NMDA receptor activation (Cavaliere et al., 2012). 
Similarly it has been demonstrated that ATP and related derivatives also inhibit 
proliferation whilst promoting OPC differentiation (Agresti et al., 2005). Thus 
glutamate and ATP mediated signalling following hypoperfusion may be acting to 
promote differentiation of existing OPCs. 
 
4.4.4 Oligodendrocytes, myelin and axon-glial integrity 
Although the current study revealed increased numbers of mature oligodendrocytes 
following one month of chronic cerebral hypoperfusion, it is not known whether 
these cells are myelinating or indeed capable of myelination. Mature 
oligodendrocytes were labelled using an antibody against the CC1 protein which 
labels oligodendrocyte cell bodies but not processes, and as a result cannot reliably 
distinguish between myelinating and non-myelinating oligodendrocytes. The results 
outlined in Chapter 3 demonstrate that axon-glial integrity is disrupted at this time 
point suggesting that these newly generated oligodendrocytes are not actively 
involved in myelin repair or remodelling. It is possible that these new 
oligodendrocytes are capable of myelinating but have not yet begun this process or 
that these cells are in some way deficient and unable to myelinate. A recent study 
investigating the effects of hyperoxia on developing white matter has demonstrated a 
rapid recovery of mature oligodendrocyte populations in the absence of increased 
levels of MBP and PLP proteins suggesting that these new oligodendrocytes are not 
myelinating (Ritter et al., 2013) however it remains to be determined whether this is 




cerebral hypoperfusion are Nfasc155 (Reimer et al., 2011) and MAG (see Chapter 3 
and Reimer et al., 2011), both of which are present within the most distal 
oligodendrocyte processes (Tait et al., 2000; Aboul-Enein et al., 2003). Future 
studies should investigate the localisation of Nfasc155 and MAG in response to long 
term hypoperfusion to determine whether these two proteins reappear over time, 
which would suggest that oligodendrocytes generated in response to hypoperfusion 
can contribute to white matter remodelling.  
 
4.4.5 Extent of cerebral blood flow reduction following bilateral common 
carotid artery stenosis 
The finding that numbers of mature oligodendrocytes were increased following 1 
month of chronic cerebral hypoperfusion contrast with earlier studies using the 
model which show that numbers of mature oligodendrocytes remain significantly 
lower than shams following 1 month of hypoperfusion (Fujita et al., 2010; Washida 
et al., 2010; Maki et al., 2011; Seo et al., 2013). To test whether this discrepancy may 
be related to the extent of CBF reduction induced following surgery, CBF was 
measured following 3 days and 1 month of hypoperfusion. This revealed that 
following 3 days CBF was reduced by approximately 38% as compared to shams, 
recovering to around 20% by 1 month. These results are in keeping with previous 
studies in the model which show maximal decreases of approximately 25-37%, 
recovering to around 10-15% after 1 month (Shibata et al., 2004; Maki et al., 2011; 
Duan et al., 2012) therefore the differences between the findings presented in this 




Laser speckle contrast imaging is a widely used alternative to laser Doppler imaging. 
As with laser Doppler, a key advantage of laser speckle imaging is that 
measurements can be carried out non-invasively through the intact skull thus 
avoiding complications of possible surgical trauma (Ayata et al., 2004). Additionally 
this technique allows visualisation of the entire exposed cortical surface unlike 
cranial window preparations or laser Doppler which only allow measurement of CBF 
in a defined area. One drawback of laser speckle imaging is the penetration depth of 
approximately 500 µm to 1 mm (Dunn et al., 2001) which only allows measurement 
of CBF in the most superficial cortical vessels and thus does not necessarily reflect 
changes in the white matter. An additional disadvantage of laser speckle imaging is 
that CBF is measured in arbitrary units rather than absolute values therefore values 
need to be expressed relative to baseline and raw values cannot be compared between 
animals (Ayata et al., 2004). In the current study care was taken to prevent drying out 
of the skull however despite these efforts there were occasionally artefacts on the 
skull that prevented accurate measurement of perfusion within the affected area. 
Additionally, increased opacity of the skull was evident in the majority of animals by 
day 28 which is likely to influence CBF measurements. Indeed, CBF values for sham 
animals were reduced by approximately 11% from baseline following 28 days, which 
is most likely artifactual rather than a biological decrease in CBF. However despite 
these drawbacks, laser speckle contrast imaging is a useful tool to non-invasively 
assess longitudinal changes in CBF. 
 
Another factor which may be important in understanding the differences between the 




oligodendrocyte number. Mature oligodendrocytes were identified in the current 
study using an antibody against the CC1 protein, a commonly used marker of mature 
oligodendrocytes (Ness et al., 2005) and double labelling experiments confirmed the 
specificity of this marker (Appendix A2). Assessment of oligodendrocyte numbers in 
other studies has been carried out using glutathione S-transferase π (GSTπ) which is 
also accepted as marker of mature oligodendrocytes however some studies have 
reported that GSTπ antibodies may additionally label astrocytes (Cammer and 
Zhang, 1993) and OPCs (Tamura et al., 2007). In addition, the current study used 
confocal laser scanning microscopy in thick tissue sections whereas other studies 
have used light microscopy in much thinner sections. The use of confocal 
microscopy allows a 3D picture of the staining to be acquired unlike conventional 
light microscopy which only depicts the staining on the surface of the section. 
Therefore stereological cell counts from a confocal z-stack are likely to be more 
representative than cell counts carried out using single plane images acquired at a 
light microscope. Furthermore, as outlined in Section 3.4.2, there may be subtle 
strain related differences in cerebrovascular integrity between C57Bl/6J mice from 
different suppliers in different countries which may affect the resulting pathology 
following chronic cerebral hypoperfusion and may explain the differences in findings 






4.4.6 Summary and conclusions 
The findings presented in this chapter demonstrate that mature oligodendrocytes and 
OPCs are initially lost following chronic cerebral hypoperfusion but that these 
populations of cells recover over time. Importantly the results suggest that 
differentiation of existing OPCs contributed to the increase in mature 
oligodendrocyte number observed following 1 month of hypoperfusion and that this 
is not associated with GPR17 upregulation. In support of previous findings, the g-
ratio of myelinated axons (an index of the thickeness of the compact myelin sheath) 
was unchanged suggesting that although a loss of mature oligodendrocytes was 
observed in response to 3 days of hypoperfusion there was no downstream impact on 
compact myelin integrity. Despite this, the results presented in Chapter 3 
demonstrate that axon-glial integrity remains disrupted following 1 month of 
hypoperfusion suggesting that although an increase in mature oligodendrocyte 
number was observed at this time, these cells may either be not yet myelinating or 
are incapble of myelination. In the next chapter the effects of modulation of 
inflammation and oxidative stress on myelin and axonal integrity and numbers of 
oligodendroglial cells will be examined to determine whether this may represent an 








The effects of dimethyl fumarate treatment on white 
matter structure and function following severe 








The results presented in this thesis demonstrate that chronic cerebral hypoperfusion 
results in disruption to nodal and paranodal domains of myelinated axons and 
alterations to oligodendrocyte pools, however the underlying mechanisms remain to 
be determined. Increased expression of inflammatory signalling cascades have been 
reported following 3 days of hypoperfusion (Reimer et al., 2011) and increased 
numbers of microglia are observed following 1 month (see Chapter 3; Shibata et al., 
2004; Coltman et al., 2011) suggesting that increased inflammation may contribute to 
white matter damage following chronic cerebral hypoperfusion. Furthermore, recent 
studies have demonstrated that oxidative stress may also be an important mediator of 
white matter damage following hypoperfusion. Administration of the free radical 
scavenger edaravone has been shown to reduce myelin damage and restore numbers 
of oligodendrocytes following 1 month of chronic cerebral hypoperfusion in mice 
(Miyamoto et al., 2013b). In addition, an association between white matter 
hyperintensities and biochemical markers of oxidative stress has been reported in a 
human post-mortem study (Back et al., 2011). Taken together these studies indicate 
that increased inflammation and oxidative stress may contribute to white matter 
damage following chronic cerebral hypoperfusion.  
 
A key mechanism by which cells mediate antioxidant and anti-inflammatory 
responses occurs at the transcriptional level through activation of Nrf2. A number of 




can exert powerful protective effects on white matter integrity. Specifically, DMF 
treatment has been demonstrated to decrease neuroinflammation (Schilling et al., 
2006), ameliorate myelin and axonal pathology, protect against oxidative stress-
mediated cell death and improve clinical score in mice subject to EAE (Linker et al., 
2011). This has led to clinical trials involving DMF (BG-12; Fox et al., 2012; Gold et 
al., 2012) which revealed significantly improved disease outcome and 
neuroradiological measures of white matter integrity, resulting in its licencing as an 
MS treatment in the US. Importantly, in models of focal cerebral ischaemia treatment 
with alternative Nrf2-activating compounds has been demonstrated to significantly 
decrease infarct volume and improve neurological outcome following reperfusion 
(Shih et al., 2005; Son et al., 2010; Zhang et al., 2012). Taken together these studies 
suggest that DMF may exert beneficial effects on white matter structure and function 
following chronic cerebral hypoperfusion. This was examined in the current study 
using the mixed coil model of severe chronic cerebral hypoperfusion which was used 
to induce more pronounced white matter pathology (Miki et al., 2009). 
 
5.1.1 Study hypothesis and aims 
It was hypothesised that treatment with DMF would ameliorate structural and 
functional alterations to white matter following chronic cerebral hypoperfusion. The 
specific aims of the study were to characterise the effects of severe cerebral 
hypoperfusion on myelin and axonal integrity and oligodendroglial populations and 




related aim was to use electrophysiology to assess functional alterations of 








5.2.1 Animals and surgery 
Adult male C57Bl/6J mice (~25 g, aged 3-4 months) underwent chronic cerebral 
hypoperfusion or sham surgery as described in Section 2.2. A 0.18 mm internal 
diameter microcoil was fitted to the left common carotid artery and a 0.16 mm 
microcoil fitted to the right common carotid artery (Miki et al., 2009). Mice were 
terminated 7 days following surgery. 
 
Two cohorts of animals were used: cohort 1 to assess CBF and pathological 
alterations and cohort 2 to assess electrophysiological changes following 
hypoperfusion. Initial cohort sizes used in the study are shown in Table 5.1.  
 
5.2.2 Administration of dimethyl fumarate 





Table 5.1: Initial group numbers for DMF study 
 
 Sham Hypoperfusion 
 Vehicle DMF Vehicle DMF 
Cohort 1 7 8 15 11 






5.2.3 Laser speckle contrast imaging and analysis 
CBF was measured using laser speckle flowmetry as described in Section 2.3. 
Baseline recordings were acquired 2 days prior to surgery with subsequent 
recordings carried out at 1 day and 7 days following surgery.  
 
5.2.4 Electrophysiology 
Electrophysiology was carried out as described in Section 2.5.  
 
5.2.5 Transcardial perfusion and tissue processing 
Seven days following surgery animals from cohort 1 were deeply anaesthetised with 
5% isoflurane and transcardially perfused as described in Section 2.8.1. Brains were 
then processed and cut into 30 µm coronal sections using a cryostat as described in 
Section 2.8.3.  
 
5.2.6 Immunohistochemistry 
Immunohistochemistry was carried out as described in Section 2.10.2. Anti-MBP and 
APP antibodies were used to assess myelin and axonal integrity. Anti-CC1 and NG2 





5.2.7 Confocal and fluorescent microscopy 
All images were acquired at 20x magnification in the corpus callosum as shown in 
Figure 2.3B. Confocal microscopy was carried out as described in Section 2.11.1.  
Images of APP labelling were acquired using a Zeiss AX10 fluorescent microscope 
as described in Section 2.11.2. 
 
5.2.8 Image analysis 
Image analysis was carried out as described in Section 2.12. One image from each 
hemisphere was analysed and mean values calculated per animal.  
 
5.2.9 Statistical analysis 
Data were analysed using a 2-way ANOVA followed by Student’s t-test with 
Bonferroni correction for multiple comparisons. Analysis of animal survival 
following surgery was performed using Kaplan-Meier curves and corresponding data 
analysed using a log-rank (Mantel-Cox) test. For electrophysiology data the peak 
latency of the response of myelinated and unmyelinated fibres was measured per 







5.3.1 Decreased MBP intensity following severe cerebral hypoperfusion in 
vehicle- treated mice but not in DMF-treated mice 
Myelin disruption is consistently observed following severe reductions in CBF 
(Pantoni et al., 1996; Dewar et al., 2003). Importantly, DMF administration to mice 
subject to EAE has shown a protective effect of the drug on myelin integrity (Linker 
et al., 2011). Therefore to assess myelin integrity following severe hypoperfusion 
and to determine whether DMF treatment could ameliorate any observed changes, 
MBP labelling was carried out and the intensity of staining was measured (Figure 
5.1A). Statistical analysis revealed that there was no significant effect of DMF 
treatment (F(1, 33)  =  1.414, p = 0.243, 2-way ANOVA) however an overall 
significant effect of surgery (F(1, 33)  =  8.103, p = 0.008, 2-way ANOVA) was 
observed between groups. Post-hoc t-tests showed a significant decrease in MBP 
labelling intensity in vehicle-treated hypoperfused animals as compared to shams (p 
= 0.005) with no difference in MBP labelling intensity between DMF-treated sham 
and hypoperfused groups (p = 0.312; Figure 5.1B). There was no significant 






Figure 5.1: MBP intensity is decreased in vehicle-treated animals but not in 
DMF-treated animals following severe hypoperfusion. (A) Representative 
confocal images showing MBP labelling in the corpus callosum. Scale bar = 25 µm. 
(B) MBP labelling intensity was significantly decreased in vehicle-treated 
hypoperfused animals compared to respective shams (p = 0.005). No significant 
difference in MBP labelling intensity was observed between DMF-treated 
hypoperfused mice as compared to shams (p = 0.312). Despite apparent differences 
in the distribution of intensity values between vehicle-treated and DMF-treated sham 





5.3.2 Increased numbers of oligodendrocytes in DMF-treated sham animals 
Previous study has demonstrated the vulnerability of mature oligodendrocytes to 
reduced CBF, with a significant decrease in mature oligodendrocytes observed 
following 3 days of modest cerebral hypoperfusion (see Chapter 4). To investigate 
the impact of severe cerebral hypoperfusion on mature oligodendrocyte populations 
and to determine whether observed changes in myelin integrity may be a 
consequence of reduced oligodendrocyte numbers, CC1 immunohistochemistry was 
carried out and numbers of CC1+ mature oligodendrocytes in the corpus callosum 
were counted (Figure 5.2A). Analysis revealed an overall significant effect of DMF 
treatment on mature oligodendrocyte number (F(1, 33) = 9.699, p = 0.004, 2-way 
ANOVA) but no effect of surgery (F(1, 33) = 2.488, p = 0.179, 2-way ANOVA). 
Surprisingly, post-hoc t-tests revealed a significant increase in oligodendrocyte 
number in DMF-treated shams as compared to vehicle-treated animals (p = 0.003; 
Figure 5.2B). No significant differences were observed between vehicle-treated sham 
or hypoperfused animals, however numbers of oligodendrocytes were significantly 
increased in DMF-treated shams as compared to respective hypoperfused animals 
(Figure 5.2B). Therefore whilst no differences in mature oligodendrocyte number 
were observed following severe cerebral hypoperfusion, an increase in the number of 








5.3.3 Numbers of oligodendrocyte precursor cells are unchanged following 
severe hypoperfusion 
The vulnerability of OPCs to modest hypoperfusion has also been demonstrated 
previously (see Chapter 4) therefore to characterise the effect of severe 
hypoperfusion on OPC populations, NG2 labelling was carried out and numbers of 
NG2+ OPCs were counted (Figure 5.3A). Unlike previous study (Chapter 4) NG2+ 
cells could not be distinguished by early and late morphology due to the use of 
differently processed tissue. Statistical analysis revealed that numbers of OPCs were 
not altered with surgery (F(1, 33) = 0.071, p = 0.791, 2-way ANOVA) or DMF-
treatment (Figure 5.3B; F(1, 33) = 1.349, p = 0.254). These data demonstrate that 
numbers of NG2+ OPCs were not altered in response to severe hypoperfusion or 
DMF treatment. 
 
5.3.4 Extent of axonal pathology following severe cerebral hypoperfusion is 
similar in vehicle and DMF-treated groups 
The results from the current study revealed that myelin integrity in vehicle-treated 
animals was decreased following severe cerebral hypoperfusion as compared to sham 
controls but importantly this difference was not observed in DMF-treated animals. In 
addition to myelin pathology, axonal pathology has been reported in this model of 
severe cerebral hypoperfusion (Miki et al., 2009) therefore the extent of axonal 
pathology in vehicle and DMF-treated groups was assessed in the current study using 
amyloid precursor protein (APP) labelling (Figure 5.4A) and the density of staining 




axons however following axonal damage, APP accumulation is observed in the form 
of APP+ axonal bulbs (Cochran et al., 1991; Ohgami et al., 1992; Suenaga et al., 
1994). Image analysis revealed that 2 out of 13 vehicle-treated animals and 4 out of 9 
DMF-treated animals exhibited positive APP+ labelling in the corpus callosum 
following severe chronic cerebral hypoperfusion. Statistical analysis revealed no 
significant effect of surgery (F(1, 33) = 4.110, p = 0.051, 2-way ANOVA) or DMF-
treatment (F(1, 33) = 1.751, p = 0.051, 2-way ANOVA) on the extent of axonal 






Figure 5.2: Increased numbers of mature oligodendrocytes in DMF-treated 
sham animals. (A) Representative confocal images showing CC1+ mature 
oligodendrocytes in the corpus callosum. Scale bar = 20 µm. (B) No significant 
difference in mature oligodendrocyte number was observed between groups in 
vehicle-treated mice. However, DMF-treated sham animals had significantly higher 
numbers of mature oligodendrocytes than vehicle-treated shams and DMF-treated 
hypoperfused animals. ** p = 0.003 vs sham and p = 0.009 vs sham in vehicle- 





Figure 5.3: Numbers of OPCs are not altered by hypoperfusion or DMF 
treatment. (A) Representative confocal images showing NG2+ OPCs in the corpus 
callosum. Scale bar = 20 µm. (B) Numbers of NG2+ cells were not altered in 






Figure 5.4 DMF does not influence the extent of axonal pathology following 
severe chronic cerebral hypoperfusion. (A) Representative images showing APP 
staining in the corpus callosum in sham and hypoperfused animals. APP+ axonal 
bulbs were present in a proportion of hypoperfused animals but were not observed in 
sham controls. Scale bar = 20 µm. (B) No significant difference in the percentage of 
APP labelling was observed following hypoperfusion between vehicle and DMF-







5.3.5 Cerebral blood flow is reduced in hypoperfused mice but is not altered by 
DMF treatment 
The finding that myelin integrity was not significantly different between DMF-
treated sham and hypoperfused groups was indicative of a beneficial effect of DMF 
treatment. To exclude the possibility that the apparent beneficial effects of DMF 
treatment were due to DMF-mediated modulation of CBF, laser speckle contrast 
imaging was carried out.   
 
Baseline CBF was measured 2 days prior to surgery and subsequent recordings were 
acquired at 1 day and 7 days after surgery (Figure 5.5A). This demonstrated that 
following 1 day of severe hypoperfusion CBF was reduced to approximately 47.6 ± 
5.60% and 54.0 ± 5.63% of baseline values in vehicle and DMF-treated animals 
respectively. CBF in sham animals was approximately 110.8 ± 8.55% in the vehicle-
treated group and 122.4 ± 5.90% in the DMF-treated group (Figure 5.5B). Statistical 
analysis revealed a significant effect of surgery (F(1, 33) = 222.6, p < 0.0001) but no 
effect of DMF treatment (F(1, 33) = 0.041, p = 0.842). Following 7 days of 
hypoperfusion, CBF values were approximately 44.1 ± 6.30% of baseline in vehicle-
treated mice, whilst values for DMF-treated animals were similar at approximately 
42.6 ± 5.71% of baseline (Figure 5.5C). CBF values for sham animals were 79.3 ± 
5.40% and 89.8 ± 4.07% in vehicle and DMF-treated groups respectively. Statistical 
analysis again revealed a significant effect of surgery (F(1, 33) = 55.01, p < 0.0001) but 
no effect of DMF treatment (F(1, 33) = 0.002, p = 0.969). Individual data for each 




significantly decreased following 1 day and 7 days of chronic cerebral hypoperfusion 
as compared to shams however no differences were observed at any time point 
between vehicle and DMF-treated animals in either sham or hypoperfused groups, 






Figure 5.5: Cerebral blood flow is reduced in hypoperfused mice and is not 
altered by DMF treatment. (A) Representative laser speckle images showing 
cortical blood flow through the intact skull of sham and hypoperfused mice. (B) 
Following 1 day of severe hypoperfusion, CBF values were approximately 47.6 ± 
5.60% and 54.0 ± 5.63% of baseline values in vehicle and DMF-treated animals 
respectively. In sham animals CBF was approximately 110.8 ± 8.55% in the vehicle-
treated group and 122.4 ± 5.90% in the DMF-treated group.  (C) Following 7 days of 
severe hypoperfusion, CBF values had decreased to around 44.1 ± 6.30% of baseline 
in vehicle-treated mice and to 42.6 ± 5.71% of baseline in DMF-treated mice. CBF 
values for sham animals were 79.3 ± 5.40% and 89.8 ± 4.07% in vehicle and DMF-




5.3.6 Conduction velocity of myelinated axons is improved in DMF-treated 
animals 
To investigate whether DMF had a protective effect on the function of myelinated 
axons, electrophysiology in slice preparations was carried out and the conduction 
velocity was measured in the corpus callosum (Figure 5.6A). The peak latency of the 
initial N1 component followed by the slower N2 component of the CAP were 
measured, corresponding to myelinated and unmyelinated axons respectively (Figure 
5.6B; Crawford et al., 2009) and conduction velocity was calculated by dividing the 
distance between electrodes (2.5 mm) by the latency of the response. Previous 
studies by the group have revealed a significant decrease in the conduction velocity 
of myelinated axons following severe hypoperfusion as compared to shams 
(Appendix A3.2). Therefore to determine the effects of DMF treatment 
electrophysiology experiments were restricted to hypoperfused animals only. This 
revealed that conduction velocity was significantly increased in DMF-treated 
compared to vehicle-treated mice (p = 0.04; Figure 5.6C). An increase in the 
conduction velocity of unmyelinated axons was also observed however this failed to 





5.3.7 DMF treatment does not improve survival following severe chronic 
cerebral hypoperfusion 
In light of the findings that DMF exerted beneficial effects on myelin integrity and 
conduction velocity, the survival rate of vehicle and DMF-treated animals was 
examined to determine whether DMF improved survival following severe 
hypoperfusion. Animals were closely monitored following surgery and those 
displaying a poor recovery were culled (Figure 5.7A). Survival rate in vehicle-treated 
hypoperfused mice was 80.6%, in line with previously reported findings (Miki et al., 
2009). The survival rate of DMF-treated animals was approximately 87.5% (Figure 
5.7B) however this difference between groups was not significantly different (p = 







Figure 5.6: Increased conduction velocity in DMF-treated mice. (A) Schematic 
diagram showing the region of the corpus callosum in which conduction velocity was 
measured over a 2.5 mm distance. S = stimulating electrode, R = recording electrode. 
(B) Representative trace showing N1 and N2 components corresponding to 
myelinated and unmyelinated fibres respectively. (C) Conduction velocity of 
myelinated axons was significantly increased in DMF-treated mice as compared to 
vehicle-treated hypoperfused mice (p = 0.04). (D) Conduction velocity of 
unmyelinated axons was not significantly different between vehicle and DMF-treated 
groups following severe hypoperfusion (p = 0.054). Electrophysiological measures 
and analysis was carried out by Dr Philip Holland. Image A taken and adapted from 






Figure 5.7: DMF treatment does not improve survival following surgery in 
DMF treated mice. (A) Animals were closely monitored following surgery and 
those displaying a poor recovery were culled. Final cohort sizes are shown in bold 
with numbers of animals culled in brackets. (B) Kaplan-Meier survival curve 
showing percentage survival in vehicle and DMF-treated mice following severe 
hypoperfusion. Survival in vehicle-treated animals was 80.6% compared to 87.5% in 
DMF-treated mice however this difference was not statistically significant (p = 







It was hypothesised at the outset of the study that DMF treatment would improve the 
structure and function of myelinated axons following severe chronic cerebral 
hypoperfusion. The results indicated that myelin intensity (as assessed by MBP 
labelling) was significantly decreased in vehicle-treated hypoperfused mice as 
compared to shams, but that this difference was not observed between DMF-treated 
sham and hypoperfused groups indicative of a beneficial effect of DMF treatment on 
myelin integrity. In contrast, there was no effect of DMF treatment on axonal 
integrity following severe hypoperfusion. It was also hypothesised that severe 
hypoperfusion would lead to loss of oligodendrocytes and OPCs and that DMF 
treatment would ameliorate this. Surprisingly, no significant differences in numbers 
of mature oligodendrocytes and OPCs were observed following severe cerebral 
hypoperfusion in either vehicle or DMF-treated groups however DMF treatment in 
sham animals resulted in increased numbers of mature oligodendrocytes compared to 
vehicle-treated animals. This suggests that DMF, in the absence of cerebral 
hypoperfusion, may have a beneficial action on white matter. Finally, the conduction 
velocity of myelinated axons was assessed to determine whether the effects of DMF 
treatment on myelin integrity had a functional benefit. This revealed a significant 
increase in the conduction velocity of myelinated axons in DMF-treated mice as 





5.4.1 DMF treatment in severe chronic cerebral hypoperfusion 
Whilst increased inflammation (see Chapter 3; Shibata et al., 2004; Coltman et al., 
2011) is observed following modest cerebral hypoperfusion, gross myelin and axonal 
damage are not observed (Reimer et al., 2011), therefore a modified version of the 
mouse hypoperfusion model (Miki et al., 2009) was used in the current study to 
induce more pronounced white matter pathology. Indeed, the results indicated a 
significant decrease in MBP labelling intensity following 1 week of severe 
hypoperfusion. Critically, MBP labelling was not significantly different between 
DMF-treated hypoperfused animals as compared to shams indicating a protective 
effect of DMF treatment on myelin integrity.  
 
The beneficial effects of DMF have been primarily studied in the EAE model of MS 
which exploits the immune system to create autoimmunity to myelin resulting in a 
more gradual disease onset typically occurring approximately 10-14 days post 
injection (Pachner, 2011), however this can vary depending on the antigen used for 
EAE induction. Furthermore, two recent studies have shown beneficial effects of 
long term DMF administration in mouse models of Huntington’s disease treated for 
90 days (Ellrichmann et al., 2011) and in cuprizone-treated mice treated for up to 6 
weeks (Moharregh-Khiabani et al., 2010). Given the beneficial effects of long-term 
DMF treatment in other disease models it would be important to study the effects of 
DMF in the modest cerebral hypoperfusion model to determine whether similar 
structural and functional effects are observed. Indeed, one study has reported that the 
working memory impairment in these animals persists following 6 months of 




and hippocampus (Nishio et al., 2010). The protective effects of DMF treatment 
could therefore be assessed following long term modest hypoperfusion by assessing 
its effects on both pathology and working memory.  
 
5.4.2 CBF reduction and pathology in the mixed-coil model of hypoperfusion 
In chronic cerebral hypoperfusion studies, C57Bl/6J mice are preferentially used due 
to their strain-related incomplete circle of Willis. Compared to other strains, 
C57Bl/6J mice have an under-developed posterior communicating artery which 
impairs collateral flow within the circle of Willis (Yang et al., 1997; Kitagawa et al., 
1998; Wellons et al., 2000; Kelly et al., 2001) and thus the brain is less able to 
compensate for alterations in CBF. A pilot study by the group (n = 6) revealed that 
50% of C57Bl/6J mice had only one posterior communicating artery whilst the other 
50% had neither posterior communicating arteries (Dr Robin Coltman, PhD thesis 
2011). Whilst this compromised circle of Willis is useful for studying the effects of 
cerebral hypoperfusion, a disadvantage is that the difference in circle of Willis 
integrity between mice is an inherent source of variation. In the current study, the 
mixed-coil model was used to induce a more pronounced reduction in CBF however 
this showed a high degree of variability between animals, consistent with a previous 
report (Miki et al., 2009). Initial reductions in CBF 1 day after surgery varied from 
around 22 – 78% in vehicle treated animals and 18 – 93% in DMF-treated animals 
(see Appendix A3.1). Thus this high degree of variability in CBF is likely to have led 
to significant differences in the extent of pathology observed. Indeed a high degree 




significant variability in numbers of NG2+ OPCs in DMF-treated hypoperfused 
animals which may be masking potential effects of DMF. Future studies should 
therefore aim to assess the extent of pathology across a wider area of the corpus 
callosum or to increase cohort sizes in an attempt to reduce variability within groups.  
 
In line with previous findings as reported by Miki et al (2009), pathological 
alterations were often more pronounced in the right hemisphere supplied by the 0.16 
mm coil as compared to the left hemisphere, confirming that circle of Willis integrity 
is impaired in these animals. One technical limitation of the current study was that 
sections were placed in PB or cryoprotective medium before being mounted onto 
slides, thus making the definitive identification of left and right hemispheres 
impossible. Measurements were therefore carried out in both hemispheres and the 
mean of the values taken however this is likely to have masked any inter-hemispheric 
differences.   
 
An associated limitation of the current study relates to the distribution of pathology 
in the mixed-coil model and the regions in which analysis was carried out. The extent 
of white matter pathology in this model varies depending on the anatomical region 
studied, with the most extensive damage reported to occur primarily in the striatum 
and the corpus callosum directly above it (approximately +1.1 mm from bregma)  
(Figure 5.8; Miki et al., 2009). In the current study, staining was analysed in the 
corpus callosum above the hippocampus (approximately -1.82 mm from bregma) as 
this is the approximate level that electophysiological testing in slice preparations was 




more modest at this level (Figure 5.8). Additionally, due to the severity of blood flow 
reduction in this model, focal areas of tissue damage and cell loss were observed but 
the exact locations of these ‘lesions’ varied between animals. Therefore insufficient 
sampling of the corpus callosum is likely to have been an issue for the current study. 
In addition, white matter damage is reported in other white matter regions including 
the anterior commissure and fimbria as well as white matter bundles of the striatum 
(Figure 5.8; Miki et al., 2009) therefore analysis within other white matter regions 
should be carried out in future studies using this model to fully characterise white 
matter alterations.  
 
Additionally, the myelin and axonal markers used in the current study may not have 
been sensitive to subtle alterations in myelin and axonal integrity. Previous studies 
by the group have demonstrated that staining of MBP (Reimer et al., 2011) and 
FluoroMyelin (Figure 3.7) are unchanged following hypoperfusion but disruption to 
MAG is consistently observed  (Figure 3.6; Coltman et al., 2011; Reimer et al., 2011) 
The current study demonstrated that the intensity and density of MBP labelling was 
reduced in vehicle-treated hypoperfused mice as compared to sham controls but was 
not different between DMF-treated sham and hypoperfused groups. This finding is 
suggestive of a protective effect of DMF on myelin integrity, consistent with the 
observed increase in the conduction velocity of myelinated axons. It would be 
pertinent for future studies to carry out a more robust assessment of myelin integrity 
in other white matter tracts and using additional markers including MAG which is 
known to be disrupted with cerebral hypoperfusion. Similarly, whilst APP is a useful 




alterations. For example, there are a growing number of studies utilising markers of 
non-phosphorylated neurofilaments which can be indicative of underlying axonal 
stress (Trapp et al., 1998; Howell et al., 2010; Ritter et al., 2013). Therefore the use 
of additional axonal and myelin markers may reveal subtle beneficial effects of DMF 







Figure 5.8: Distribution of white and grey matter pathology in the mixed coil 
model of chronic cerebral hypoperfusion. Schematic diagram showing the 
distribution of white and grey matter pathology following cerebral hypoperfusion. 
Severe white matter damage is observed in the corpus callosum above the striatum at 
approximately +1.1 mm from bregma. White matter disruption is less evident in the 
corpus callosum in sections corresponding to approximately -1.82 mm from bregma. 
Additional white matter tracts exhibiting white matter damage include fibre bundles 
of the striatum, the anterior commissure and fimbria. Image taken and adapted from 









5.4.3 Functional benefit of DMF treatment 
To determine the effects of DMF on the function of myelinated axons, 
electrophysiology was carried out and the conduction velocity of myelinated axons in 
the corpus callosum was measured. Importantly this revealed a significant increase in 
conduction velocity in DMF-treated animals as compared to the vehicle-treated 
group, indicative of a beneficial effect of DMF. Indeed pathological assessment 
revealed that myelin integrity was unchanged between DMF-treated sham and 
hypoperfused animals. Given the importance of the myelin sheath in efficient action 
potential conduction along axons it is likely that the increased conduction velocity in 
DMF-treated animals is due to preservation of myelin. Despite this, findings from 
previous studies (see Chapter 3; Reimer et al., 2011) demonstrate disruption to nodes 
of Ranvier and impaired axon-glial integrity as early as 3 days following modest 
chronic cerebral hypoperfusion whilst compact myelin is unaffected. It would 
therefore be important for future studies to determine the effects of severe 
hypoperfusion on axon-glial integrity and whether DMF restores any observed 
deficit.  
 
In the current study the conduction velocity was measured by placing the stimulating 
and recording electrodes 1.25 mm either side of the midline corpus callosum (2.5 
mm apart). This placement of electrodes was chosen due to the high density of 
aligned fibres in this region, ensuring strong CAP readings. Importantly the 
pathological analysis was carried out in the corpus callosum approximately 2 mm 




greater sampling of the corpus callosum should be carried out to accurately assess 
pathological alterations in response to severe hypoperfusion. 
 
 
5.4.4 DMF boosts oligodendrocyte number in healthy animals 
In addition to investigating whether DMF could protect myelinated axons, a further 
aim of this study was to determine whether DMF influenced numbers of 
oligodendrocytes following cerebral hypoperfusion. Previous study in the modest 
hypoperfusion model (see Chapter 4) has shown loss of mature oligodendrocytes and 
OPCs following three days of hypoperfusion but demonstrates that these cells are 
restored within one month. In the current study it was hypothesised that 
oligodendrocyte loss would be observed following severe cerebral hypoperfusion and 
that DMF treatment would ameliorate this loss. Surprisingly, no significant 
differences in oligodendrocyte number were observed between vehicle-treated sham 
and hypoperfused animals. Possible reasons for this unexpected finding may relate to 
the region of the corpus callosum in which cells were counted, as outlined in Section 
5.4.2. A surprising and interesting finding from this study however was that DMF-
treated sham animals had higher numbers of oligodendrocytes than vehicle-treated 
shams indicating that in the absence of hypoperfusion, DMF may act to boost 
oligodendrocyte number. One possible explanation for this increased 
oligodendrocyte number in DMF-treated animals may be the result of increased 
differentiation of OPCs. A recent in vitro study using the Nrf2-activating compound 
CDDO has shown increased maturation of OPCs as compared to non-treated cultures 




DMF treatment has been demonstrated suggesting that DMF may act directly on 
these cells (Scannevin et al., 2012). In the current study, numbers of OPCs were 
counted to determine whether increased OPC differentiation may have resulted in 
increased mature oligodendrocytes in DMF-treated shams. No significant differences 
in numbers of NG2+ OPCs were observed between groups however this may be 
related to the time point studied. The cell cycle duration of OPCs in healthy adult 
mice aged 2 months is estimated to be approximately 10 days (Young et al., 2013). If 
cell cycle time is comparable in mice aged 4-5 months, and DMF treatment in vivo 
can enhance OPC differentiation as reported in vitro (Pareek et al., 2011), this may 
account for the increased numbers of mature oligodendrocytes following 1 month. 
However future studies would be required to clarify whether an OPC response is 
observed in this model and the temporal progression of any changes. Additionally, it 
is possible that increased numbers of oligodendrocytes may be due to differentiation 
of immature oligodendrocytes rather than OPCs however this again would need 
further clarification.   
 
5.4.5 Biological properties of DMF 
Despite being licenced for the treatment of MS, there is very little information 
regarding the pharmacokinetics and biological properties of DMF. DMF is also used 
in combination with monoethyl fumarate as an oral treatment for psoriasis (Rostami-
Yazdi et al., 2010; Kees, 2013) and one study using this anti-psoriatic formulation in 
healthy individuals reported that DMF was not detectable in serum however a 




indicating that DMF is rapidly metabolised to MMF (Litjens et al., 2004). Another 
study in individuals with psoriasis similarly reported undetectable levels of DMF in 
blood however the authors of this study hypothesised that a proportion of DMF may 
be rapidly metabolised to MMF in the intestine but that some may enter the blood 
where it is also converted to MMF (Rostami-Yazdi et al., 2010). Regardless of the 
exact mechanisms of absorption and metabolism, both studies in humans reported 
that the elimination half-life of MMF was approximately 40 minutes suggesting that 
this drug is rapidly cleared from the body (Litjens et al., 2004; Rostami-Yazdi et al., 
2010). In the current study, DMF was suspended in a methocel (hypromellose) 
vehicle and administered twice daily by oral gavage. Methocel was used to control 
the rate of drug release and prevent rapid enzymatic degradation in the stomach (Li 
et al., 2005). However one clear limitation of the current study is that circulating 
levels of DMF and MMF were not assessed so the rate of release and half-life are 
unknown.  
 
Importantly even if circulating levels of DMF and MMF had been assessed in the 
current study, this would not necessarily indicate whether DMF was transported to 
the brain. The efficacy of DMF has been tested in the cuprizone model of MS 
(Moharregh-Khiabani et al., 2010) and in mouse models of Huntington’s disease 
(Ellrichmann et al., 2011), however as yet no study has examined DMF or MMF 
levels in brain tissue. It is unknown how effectively DMF or MMF can cross the 
blood brain barrier thus it is possible that very little of the administered dose reaches 
the brain. This could be easily assessed in an acute administration study using mass 




5.4.6 Mechanism of action of DMF  
In the current study DMF significantly improved the conduction velocity of 
myelinated axons following hypoperfusion in addition to boosting oligodendrocyte 
numbers in sham animals. Whilst it has been reported in previous studies that DMF 
exerts its protective effects via antioxidant and anti-inflammatory effects of Nrf2 
activation (Ellrichmann et al., 2011; Linker et al., 2011; Scannevin et al., 2012), this 
was not confirmed in the current study. Quantitative assessment of Nrf2 target genes 
would be required to show whether administration of DMF was activating Nrf2 in 
the current study. Upregulation of the haem oxygenase 1 (HO-1) gene, an Nrf2 target 
gene, has been demonstrated following focal cerebral ischaemia (Zhang et al., 2012) 
and following 3 days of modest hypoperfusion (Dr Jill Fowler, unpublished 
observations). HO-1 is induced in response to increased oxidative stress and its 
upregulation is thought to confer cytoprotection both in vitro (Dwyer et al., 1995) 
and in vivo (Panahian et al., 1999). Therefore hypoperfusion alone may modulate 
Nrf2 target genes but future studies should clarify whether DMF can further 
modulate this gene expression. An additional Nrf2 target gene is NAD(P)H quinone 
oxidoreductase 1 (NQO1) which has been shown to be upregulated in response to 
oxygen-glucose deprivation in vitro (Soane et al., 2010) and thus may be important 
following hypoperfusion. Additionally, many other Nrf2-activating compounds are 
available which may exert more powerful effects than DMF however the safety 
profiles of these compounds are not as well characterised.   
 
An increase in microglial number has been consistently reported in mouse studies of 




whilst an increase in both microglial and astrocyte populations has been reported in 
the mixed-coil model (Miki et al., 2009). Given the anti-inflammatory role of DMF it 
would be critical for future studies to determine whether DMF can decrease the 
extent of inflammation following severe hypoperfusion. This could be achieved by 
assessing the levels of circulating inflammatory mediators in plasma from vehicle 
and DMF-treated animals in addition to immunohistochemistry to assess numbers of 
microglia and astrocytes. Indeed previous study has demonstrated that DMF 
decreases levels of circulating inflammatory mediators following EAE (Schilling et 
al., 2006) which may influence inflammation within the brain (Arvin et al., 1996).  
 
The current study sought to determine the beneficial effects of DMF on myelinated 
axons and oligodendrocyte populations within the white matter, however DMF may 
exert additional protective effects in grey matter. Several studies using mouse models 
of Parkinson’s disease (Chen et al., 2009a), motor neuron disease (Vargas et al., 
2008), Huntington’s disease (Ellrichmann et al., 2011), and MS (Linker et al., 2011) 
have shown that activation of Nrf2 is neuroprotective. Nrf2-mediated 
neuroprotection has also been described in models of focal ischaemia (Shih et al., 
2005; Son et al., 2010; Zhang et al., 2012)  suggesting that a similar protective effect 
may be observed following severe hypoperfusion. It is thought that the protective 
effect of Nrf2 activation is mediated indirectly through astrocytes rather than a direct 
effect on neurons (Calkins et al., 2009; Vargas and Johnson, 2009). Astrocyte-
specific Nrf2 expression has been demonstrated to protect against neuronal death in 
vitro (Kraft et al., 2004) and more recently astrocyte-targeted overexpression of Nrf2 




2008). Interestingly, recent studies have demonstrated Nrf2 activation in 
oligodendrocytes (Linker et al., 2011) and OPCs (Pareek et al., 2011) suggesting that 
Nrf2 may act on other glial cells. The exact role of Nrf2 activation in astrocytes and 
oligodendroglial cells should be investigated in future studies as these may be 
important for both grey and white matter protection.  
 
5.4.7 Summary and conclusions 
This study sought to determine whether treatment with the anti-inflammatory and 
antioxidant compound DMF could protect the structure and function of myelinated 
axons following severe chronic cerebral hypoperfusion. The results demonstrated 
that myelin integrity was not different between vehicle and DMF-treated 
hypoperfused mice. A significant decrease in myelin integrity was oberved between 
vehicle-treated hypoperfused mice as compared to shams, however there was no 
differnce between DMF-treated groups. Numbers of mature oligodendrocytes were 
not different between vehicle and DMF-treated hypoperfused mice however DMF 
treatment led to increased numbers of mature oligodendrocytes in sham animals as 
compared to vehicle-treated shams. In addition, increased conduction velocity was 
observed in hypoperfused DMF-treated animals as compared to vehicle-treated 
animals. Taken together the results of this study indicate that DMF may exert 
beneficial effects on white matter structure and function in response to reduced CBF 



















The findings presented in this thesis demonstrate the vulnerability of the white matter 
to chronic cerebral hypoperfusion. Specifically, cerebral hypoperfusion disrupts 
axon-glial integrity and the domain structure of myelinated axons which is likely to 
contribute to observed deficits in working memory. Additionally, cerebral 
hypoperfusion leads to a rapid loss of oligodendroglial cells which recover over time. 
Finally, treatment with DMF improved functional outcome following severe cerebral 
hypoperfusion suggesting that modulation of inflammation and oxidative stress may 
be important for the treatment of chronic cerebral hypoperfusion.  
 
6.2 Alternative approaches to study the effects of cerebral hypoperfusion on 
white matter structure 
The current study used wild-type C57Bl/6J mice and conventional 
immunohistochemistry and imaging techniques to investigate alterations in white 
matter structure following chronic cerebral hypoperfusion. However, a growing 
number of transgenic animals are available which may be advantageous to study 
myelinated axons and oligodendrocyte populations. For example, a recent study has 
described a novel transgenic mouse line in which existing myelin and newly 




This is achieved by using mice which express membrane targeted tomato fluorescent 
protein however following Cre-mediated recombination switches to express 
membrane bound green fluorescent protein (GFP). By injecting a retroviral vector 
expressing Cre recombinase driven by the NG2 promoter the authors were able to 
identify existing myelin and myelin generated as a result of OPC proliferation and 
differentiation based on expression of tomato or green fluorescent proteins 
respectively. This work has demonstrated that following spinal cord injury, GFP is 
first detected in NG2+ OPCs but following differentiation of these cells GFP+ mature 
oligodendrocytes and myelin sheaths are evident (Powers et al., 2013). Thus a similar 
approach could be employed to investigate differentiation of OPCs following chronic 
cerebral hypoperfusion and whether newly generated oligodendrocytes are 
functionally able to myelinate. Additionally, an MBP-GFP line has also been 
described which allows visualisation of mature oligodendrocytes and their processes 
(Chong et al., 2012) which could also be used in combination with a proliferation 
marker such as EdU to assess the extent of myelination by newly generated 
oligodendrocytes following hypoperfusion.  
 
An alternative approach to transgenic modification is the labelling of 
oligodendrocytes using lentiviral injection of a fluorescent reporter. Lentiviral 
injection of MBP-GFP into the corpus callosum of mice has been described (McIver 
et al., 2005) and more recently utilised to study oligodendrocyte numbers and 
morphology following focal cerebral ischaemia (McIver et al., 2010). However 
disadvantages of this approach include the limited diffusion of the vector, resulting in 




brain, and the transduction efficiency of the virus (McIver et al., 2005). Additionally, 
a growing number of studies are utilising recombination technology to track the 
phenotypic fate of OPCs during development and following injury. This involves 
using Cre-lox technology to drive the conditional expression of a fluorescent reporter 
driven by PDGFRα or NG2 promoters which label OPCs and their progeny (Rivers 
et al., 2008; Zhu et al., 2011; Young et al., 2013). A similar approach could be used 
to track the fate of OPCs following chronic cerebral hypoperfusion to fully 
characterise the OPC response.  
 
One common limitation of the studies described in this thesis is the limited sampling 
of white matter which may not be representative of the brain as a whole. Additionally 
assessment of pathology in a small number of brain sections may not reveal 
pathological differences at different anatomical levels. However robust 
characterisation of pathology within different white matter tracts and at several 
anatomical levels would be expensive, labour intensive and slow. A novel approach 
to studying whole brain structure has recently been described which transforms 
mouse brains into optically transparent structures which do not require sectioning 
and thus whole brains can be labelled and imaged using conventional techniques 
(Chung et al., 2013). This technique therefore provides the opportunity to study 
regional differences within the brain which may be important in chronic cerebral 
hypoperfusion. Additionally, myelinated fibres could be labelled and followed along 
their entire length allowing a rigorous characterisation of the extent of paranodal 




6.3 Alternative approaches to study the mechanisms underlying white matter 
disruption following chronic cerebral hypoperfusion 
The studies described in this thesis attempted to characterise potential mechanisms 
involved in mediating axon-glial disruption and alterations to oligodendrocyte pools 
following chronic cerebral hypoperfusion. To build upon the findings of these 
studies, transgenic mouse lines could be used in future studies. For example, 
transgenic mice overexpressing MAG or Nfasc155 could be subject to chronic 
cerebral hypoperfusion to assess whether stabilising paranodal or internodal axon-
glial connection could prevent white matter disruption and impaired cognition 
following hypoperfusion. A similar approach could be applied to GPR17 to 
determine the exact role, if any, of this receptor in mediating the OPC response to 
hypoperfusion.  
 
The final study described in this thesis investigated the protective effects of Nrf2 
activation on white matter structure following severe hypoperfusion. Previous studies 
in the EAE model of MS have demonstrated a poorer outcome in Nrf2 knockout 
mice subject to EAE than wild type counterparts (Schilling et al., 2006; Johnson et 
al., 2010). Chronic cerebral hypoperfusion could therefore be induced in Nrf2 
knockouts to determine white matter damage and functional outcome were 
attenuated compared to shams. Additional studies have demonstrated that astrocyte-
specific Nrf2 overexpression can increase neuronal survival in mouse models of 
Parkinson’s disease (Gan et al., 2012) and motor neuron disease (Vargas et al., 




could be employed in the mouse model of hypoperfusion to investigate the role of 
astrocytes in the modulation of white matter damage. Alternatively, an 
oligodendrocyte-specific Nrf2 overexpressing mouse could be generated to 
determine whether protection of oligodendrocytes from inflammation and oxidative 
stress could prevent against oligodendrocyte loss and impaired axon-glial integrity 
following hypoperfusion.  
 
6.4 Clinical relevance and potential therapeutic strategies 
The mouse model of modest chronic cerebral hypoperfusion was designed to model 
age-related decreases in CBF and to determine the resulting effects on white matter 
integrity and cognition. Indeed CBF was shown to be approximately 38% lower than 
sham controls following 3 days of hypoperfusion recovering to around 19% by 28 
days. In humans CBF is estimated to decrease by approximately 0.5% per year from 
age 20 to age 80 (Leenders et al., 1990; Scheel et al., 2000) therefore CBF values 
reported in mouse are within the predicted range of blood flow reduction over the 
course of an adult lifetime. The pathological findings in the current study are also 
consistent with studies of aged brains which show paranodal disruption (Hinman et 
al., 2006; Shepherd et al., 2012), increased numbers of oligodendrocytes (Simpson et 
al., 2007a; Lasiene et al., 2009) and increased inflammation (Conde and Streit, 2006; 
Simpson et al., 2007b). One limitation of the mouse model of cerebral hypoperfusion 
is that, although modest, the initial reduction in CBF is approximately 30-38% 
(Shibata et al., 2004; Washida et al., 2010; Maki et al., 2011; Duan et al., 2012) 




an adult lifetime. A novel approach to studying cerebral hypoperfusion has been 
recently described in rat whereby stenosis of the carotid arteries is induced gradually 
using an ameroid constrictor device (Kitamura et al., 2012). This small device is 
placed around each common carotid artery and slowly absorbs water over 
approximately 3 days leading to swelling and subsequent constriction of the artery it 
surrounds. A similar approach could be applied to mice to more accurately mimic the 
onset of hypoperfusion. Despite this, the bilateral carotid artery stenosis model of 
hypoperfusion remains a clinically relevant and useful tool to study the effects of 
hypoperfusion on white matter and cognition.  
 
Importantly, the studies described in this thesis investigated the effects of cerebral 
hypoperfusion in young animals (aged 3-5 months) which may not reflect the 
response in the ageing brain. A recent study has demonstrated that the extent of white 
matter disruption and working memory impairment induced by hypoperfusion is 
more severe in aged animals as compared to young, and importantly the endogenous 
OPC response to hypoperfusion is attenuated (Miyamoto et al., 2013c). These 
findings are supported by additional studies demonstrating increased white matter 
damage and inflammation following focal cerebral ischaemia in aged mice as 
compared to young mice (Rosenzweig and Carmichael, 2013) and a significant 
decrease in the cell cycle duration of OPCs in aged mice (Psachoulia et al., 2009; 
Young et al., 2013) which may impact on white matter repair. It would therefore be 
pertinent for future studies to distinguish the effects of cerebral hypoperfusion on 
myelinated axons and oligodendrocyte populations in aged animals as the underlying 




regarding the cause of white matter disruption and cognitive decline with ageing 
relates to OPC and oligodendrocyte population dynamics in the aged brain. It has 
been proposed that in the adult brain OPCs and oligodendrocytes may have a finite 
lifetime and that disruption to white matter with increasing age is the result of an 
inability of white matter repair mechanisms to match the rate of oligodendrogenesis 
with myelin loss (Richardson et al., 2011). This could be assessed by comparing the 
extent of white matter pathology in addition to CBF measurement in young and aged 
mice to determine whether there is evidence of white matter pathology between 
groups in the absence of significant decreases in CBF.  
 
Although chronic cerebral hypoperfusion and subsequent age-related cognitive 
decline are features of the ‘normal’ ageing process, decreased cerebral blood flow is 
also observed in mild cognitive impairment (Hirao et al., 2005), vascular dementia 
(Kawamura et al., 1991) and Alzheimer’s disease (AD; de la Torre, 1994). This 
raises the question of whether early pharmaceutical intervention may prevent the 
transition from subtle age-related changes in cognitive ability to end-stage AD. There 
is a growing body of research showing that the presence of vascular risk factors 
during mid-life can predispose to Alzheimer’s disease in later life (Kivipelto et al., 
2001) therefore this may represent a key time for pharmacological intervention. 
Indeed increased inflammation (Akiyama et al., 2000) and oxidative stress 
(Markesbery, 1997) are both features of AD and thus may represent key therapeutic 
targets for the treatment of cerebral hypoperfusion and subsequent cognitive decline 




The beneficial effects of the anti-inflammatory and antioxidant Nrf2 activator DMF 
were examined in this thesis which demonstrated improved functional outcome 
following hypoperfusion as assessed by electrophysiology. Importantly this 
functional benefit was observed following severe hypoperfusion implying that even 
greater protective effects may be observed following mild cerebral hypoperfusion. 
Additional studies have demonstrated that long term dosing of DMF for 6 weeks to 3 
months can improve disease progression in mouse models of MS (Moharregh-
Khiabani et al., 2010) and Huntington’s disease (Ellrichmann et al., 2011) 
respectively. This raises the question of whether long term DMF administration prior 
to and following hypoperfusion may exert greater protective effects on white matter 
than observed in this thesis. Additionally the current study revealed that 7 days of 
DMF treatment significantly increased numbers of mature oligodendrocytes in sham 
animals such that despite a decrease in oligodendrocyte number following 
hypoperfusion, values of DMF-treated hypoperfused animals were comparable to 
those of non-treated controls. This DMF-mediated increase in oligodendrocyte 
number over an extended period of time may help protect against white matter from 
the effects of cerebral hypoperfusion however future studies would be required to 
clarify this.  
 
Although Nrf2 activation using DMF is a valid therapeutic approach for modulating 
inflammation and oxidative stress following cerebral hypoperfusion, alternative 
compounds exist which may be equally or more effective. For example, studies using 
the antibiotic drug minocycline have demonstrated improved white matter integrity 




al., 2006). Additionally, administration of minocycline has been demonstrated to 
decrease inflammation and protect against paranodal disruption in EAE (Howell et 
al., 2010). Similarly, treatment with the antioxidant drug edaravone has shown 
improved spatial memory and white matter integrity following chronic 
hypoperfusion in rat (Ueno et al., 2009) and treatment with idebenone has been 
shown to improve functional outcome and enhance cerebral metabolism following 
global ischaemia (Nagaoka et al., 1989). Indeed a growing number of studies have 
shown that cerebral metabolism can be boosted at the mitochondrial level through 
activation of proliferator-activated receptor-γ co-activator 1α (PGC-1α) which may 
improve antioxidant capacity and energy metabolism within the ageing brain (Austin 
and St-Pierre, 2012). Thus whilst a single drug approach is always preferable, a 
combination of different drugs may be required for the effective treatment of chronic 
cerebral hypoperfusion.  
 
6.5 Conclusion 
The results outlined in this thesis build on previous studies demonstrating the 
detrimental effects of chronic cerebral hypoperfusion on white matter integrity and 
working memory. Additionally, these findings reveal that treatment with DMF 
results in improved functional outcome following hypoperfusion suggesting that this 
may represent an important pharmacological target. Future studies should aim to 
fully characterise the mechanisms underlying white matter disruption following 
chronic cerebral hypoperfusion and whether intervention can prevent or halt these 




growing need for therapeutic strategies aimed at improving cognitive function in 
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Appendix 1: Additional domain length and behavioural data for experiments 
described in Chapter 3 
 
 
Figure A1.1 Nav1.6 domain length is increased in the internal capsule and optic 
tract following 3 days and 1 month of chronic cerebral hypoperfusion. (A) 
Following 3 days of chronic cerebral hypoperfusion, Nav1.6 domain length was 
significantly increased in the internal capsule (D = 0.1125; p = 0.032). (B) Nav1.6 
domain length was not altered in the optic tract following 3 days of chronic cerebral 
hypoperfusion (D = 0.0987; p = 0.103). (C) Following 1 month of hypoperfusion, 
Nav1.6 domain length was significantly decreased in the internal capsule (D = 






Figure A1.2: Nav1.6 domain length measurements plotted as relative frequency. 
Relative frequency graphs showing the relative frequency of Nav1.6 domain length 
measurements in response to (A) 3 days, (B) 1 month, (C) 6 weeks and (D) 3 months 





Figure A1.3 Nodal gap length in the internal capsule and optic tract is 
differentially altered with increasing duration of hypoperfusion. (A) Following 3 
days of hypoperfusion, nodal gap length was significantly increased in the internal 
capsule (D = 0.1122; p = 0.026) and (B) the optic tract (D = 0.2017; p < 0.0001). (C) 
However following 1 month of hypoperfusion nodal gap length was significantly 
decreased as compared to shams in the internal capsule D = 0.3275, p 0.001) and (D) 






Figure A1.4 Caspr domain length is unchanged following 3 days and 1 month of 
chronic cerebral hypoperfusion. (A) Caspr domain length was not significantly 
different between groups in the corpus callosum following 3 days (D = 0.0797; p = 
0.172) or (B) 1 month (D = 0.0898; p = 0.064) of hypoperfusion. (C) Caspr domain 
lengths in the internal capsule were also unchanged following 3 days (D = 0.0858; p 
= 0.157) or (D) 1 month (D = 0.0591; p = 0.446) of chronic cerebral hypoperfusion 
following 3 days of chronic cerebral hypoperfusion. (E) A significant decrease in 
Caspr length was observed in the optic tract following 3 days of hypoperfusion (D = 
0.1104; p = 0.03) however (F) no significant difference was observed between 






Figure A1.5: Trial duration in the radial arm maze was not different between 
groups. Analysis revealed a significant effect of trial block (p < 0.0001) indicating 
that trial duration for both groups decreased with increasing time, i.e. mice were 
performing the task faster each day. Trial duration was not significantly different 




Appendix 2: Confirmation of antibody specificity for oligodendroglial markers 
described in Chapter 4 
 
Figure A2.1: CC1 is a specific marker of mature oligodendrocytes. (A) 
Representative confocal images showing CC1 and GFAP and (B) CC1 and NG2 
double labelling in the corpus callosum. Scale bars = 20 µm. (C) Cell counts of 
double labelled cells revealed only 0.83% of CC1+ cells were also labelled with 
GFAP. Similarly only 2.06% of CC1+ cells were CC1+/NG2+. This small proportion 
of cells expressing both markers likely represents cells in the transition between 






Figure A2.2: NG2 is a specific marker of OPCs. To confirm the specificity of NG2 
as a marker of OPCs double labelling with another OPC marker, PDGFRα, was 
carried out (A). This revealed colocalisation of both OPC markers. (B) NG2 has also 
been descried as a marker of pericytes therefore to determine whether NG2 was 
labelling pericytes in addition to OPCs, double labelling with the pericyte marker 
PDGFRβ was carried out. This showed that both markers did not colocalise in either 







Figure A2.3: GPR17 is expressed by oligodendroglia and a small percentage of 
microglia. (A) Representative confocal images showing Olig2 and GPR17 and (B) 
Iba1 and GPR17 double labelling in the corpus callosum. Scale bars = 20 µm. (C) 
Cell counting revealed GPR17 was expressed by approximately 64% of Olig2+ cells, 





Appendix 3: Additional blood flow and conduction velocity data for animals 
subject to severe cerebral hypoperfusion using the mixed-coil model 
 
  
Figure A3.1: Variable response to severe cerebral hypoperfusion. Alterations in 
CBF are plotted individually for each animal. All values are expressed as a 
percentage relative to baseline values. (A) CBF values for vehicle-treated 
hypoperfused animals showed significant variability between animals. (B) CBF was 







Figure A3.2: Conduction velocity of myelinated axons is significantly decreased 
following 1 week of hypoperfusion in the mixed coil model. Statistical analysis 
revealed a significant decrease in conduction velocity of hypoperfused animals as 
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Abstract
Chronic cerebral hypoperfusion, a sustained modest reduction in cerebral blood flow, is associated with damage to
myelinated axons and cognitive decline with ageing. Oligodendrocytes (the myelin producing cells) and their precursor cells
(OPCs) may be vulnerable to the effects of hypoperfusion and in some forms of injury OPCs have the potential to respond
and repair damage by increased proliferation and differentiation. Using a mouse model of cerebral hypoperfusion we have
characterised the acute and long term responses of oligodendrocytes and OPCs to hypoperfusion in the corpus callosum.
Following 3 days of hypoperfusion, numbers of OPCs and mature oligodendrocytes were significantly decreased compared
to controls. However following 1 month of hypoperfusion, the OPC pool was restored and increased numbers of
oligodendrocytes were observed. Assessment of proliferation using PCNA showed no significant differences between
groups at either time point but showed reduced numbers of proliferating oligodendroglia at 3 days consistent with the loss
of OPCs. Cumulative BrdU labelling experiments revealed higher numbers of proliferating cells in hypoperfused animals
compared to controls and showed a proportion of these newly generated cells had differentiated into oligodendrocytes in a
subset of animals. Expression of GPR17, a receptor important for the regulation of OPC differentiation following injury, was
decreased following short term hypoperfusion. Despite changes to oligodendrocyte numbers there were no changes to the
myelin sheath as revealed by ultrastructural assessment and fluoromyelin however axon-glial integrity was disrupted after
both 3 days and 1 month hypoperfusion. Taken together, our results demonstrate the initial vulnerability of
oligodendroglial pools to modest reductions in blood flow and highlight the regenerative capacity of these cells.
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Introduction
Oligodendrocytes are the myelin producing cells of the CNS
and are critical for maintaining and regulating the myelination of
axons. Oligodendrocyte survival and the integrity of myelinated
axons is essential for maintaining saltatory conduction, neuronal
communication and normal cognitive function (for review see [1]).
A single oligodendrocyte can myelinate up to 50 axonal segments
[2] and thus damage to individual oligodendrocytes could have a
major effect on myelination of axons and efficiency of the relay of
information.
Oligodendroglia appear to be particularly vulnerable to blood
flow reductions and in animal models of cerebral ischemia and
severe hypoperfusion a marked loss of oligodendrocytes occurs
rapidly in response to severe reductions in blood flow [3–6].
Additionally, in vitro models of hypoxia and oxygen-glucose
deprivation, common pathways in cerebral ischaemia, have
demonstrated the susceptibility of oligodendrocytes to these
conditions [7,8] and it is now thought that damage to oligoden-
drocytes is mediated by oxidative stress, inflammation and
excitotoxicity (for review see [9]). Indeed, damage to myelinated
axons and oligodendrocytes is prominent in various conditions in
which cerebral blood flow is compromised such as the ageing brain
[10,11], Alzheimer’s disease [12,13] and stroke [4,14] and may
contribute to a functional impairment.
Despite the initial degeneration of oligodendrocytes following
injury there is now evidence to indicate that oligodendrocyte
precursor cells (OPCs) can proliferate and differentiate and as a
result may serve to replenish the loss of damaged oligodendrocytes
and potentially repair functional deficits. In neonatal models of
hypoxic-ischaemic injury, cell proliferation is increased and new
oligodendrocytes are generated up to several weeks after the initial
injury [15]. In the adult brain there also appears to be an
endogenous capacity to generate new oligodendrocytes in response
to cerebral ischaemia. In models of focal cerebral ischaemia when
either blood flow is restored with reperfusion or in the peri-infarct
region where there is sufficient collateral flow, increased numbers
of OPCs are detectable [6,16,17]. Interestingly, in aged human
brain, increased numbers of oligodendrocytes and OPCs occur in
areas adjacent to white matter disruption where blood flow is
compromised [18] and increased numbers of oligodendrocytes
have been demonstrated in cases of vascular cognitive impairment
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[19]. Together these studies suggest that OPCs may respond to
reduced cerebral blood flow in an attempt to ameliorate white
matter damage.
There are a number of mechanisms that may regulate OPC
proliferation and differentiation. Relevant to blood flow alterations
both glutamate and ATP, the extracellular levels of which may be
increased with reduced blood flow, have been shown to be
important in regulating OPC proliferation and differentiation
[20,21]. In addition, recent studies have identified a role for a G-
coupled protein receptor, GPR17, as an important mediator of
OPC differentiation and white matter repair [22,23]. GPR17 has
been shown to be expressed by a subset of OPCs [23,24] and it is
thought that these cells may operate as an early sensor of brain
damage whereby they are activated by uracil nucleotides and
cysteinyl leukotrienes which are increased in response to cerebral
ischemia. In support of this, GPR17 positive cells are upregulated
in response to cerebral ischemia and associated with oligodendro-
cyte differentiation [23].
The present study sought to determine whether the pools of
oligodendrocytes and OPCs would be influenced by modest
reductions in blood flow more akin to those occurring in the
ageing brain. We utilised a mouse model of cerebral hypoperfu-
sion induced by permanent bilateral carotid stenosis which we
have previously shown to result in diffuse white matter pathology
[12,25,26]. Importantly, these mice also exhibit impaired spatial
working memory [12,27], providing a link between white matter
disruption and cognitive decline. More recently, microarray
analysis in mice subject to cerebral hypoperfusion has revealed
increased expression of several genes involved in cell proliferation
[25] which may underlie a potential white matter repair
mechanism. We therefore also investigated the extent of OPC
proliferation and differentiation and whether this was mediated by
GPR17. In addition, ultrastructural analysis and myelin labelling
were carried out to determine whether alterations to oligodendro-
cyte pools influenced myelin sheath thickness.
Materials and Methods
Ethics statement
All procedures were authorised under the Home Office
approved Project Licenses, ‘Pathophysiology of Alzheimer’s
disease: link to cerebrovascular disease’ (licence number 60/
3722) and ‘Pathophysiology of vascular cognitive impairment and
Alzheimer’s disease’ (licence number 60/4350) held by Prof. K.
Horsburgh. The licences were approved by the University of
Edinburgh’s Ethical Review Committee and the Home Office,
and adhered to regulations specified in the Animals (Scientific
Procedures) Act (1986).
Animals and surgery
Adult male C57Bl/6J mice (aged 3–5 months old, 25–30 g)
were obtained from Charles River Laboratories Inc, UK. Animals
were subject to chronic cerebral hypoperfusion as previously
described [25–28]. In brief, wire microcoils (0.18 mm internal
diameter, Sawane Spring Co., Japan) were applied to both
common carotid arteries under isoflurane anaesthesia (induced at
5%, and maintained at 1.2–1.6%). A 30 minute interval was left
between left and right coil application. Sham-operated animals
underwent identical procedures with the exception that coils were
not placed around the arteries. Housing of animals and all
procedures were carried out in pathogen-free animal units.
BrdU labelling
Animals from the 1 month cohort were given intraperitoneal
injections (35 mg/kg body weight) of 59-bromo-29-deoxyuridine
(BrdU; Fluka, UK) twice daily for the first 3 days following surgery
to label proliferating cells during this period by an individual
blinded to surgical group.
Laser speckle contrast imaging
An additional cohort of animals underwent measurement of
cerebral blood flow using laser speckle flowmetry. Animals were
anaesthetised with 5% isoflurane in oxygen for 1.5 minutes in an
anaesthetic chamber. Animals were then transferred to a
stereotaxic frame and their heads were fixed into position.
Anaesthesia was maintained at 2–2.5% isoflurane via a nose cone
and body temperature was monitored and regulated. An incision
was made to expose the skull and the skin overlying the skull was
reflected. The skull was moistened using saline and a small amount
of water-based gel (37uC) was spread evenly onto the skull. A
moorFLPI2 Speckle Contrast Imager (Moor Instruments, UK)
was positioned 20 cm above the head. Image sequences were
acquired at a resolution of 7526580 pixels and a frequency of 1
frames/second (20 ms/frame). Following stabilisation of perfusion
readings, a 2 minute perfusion recording was carried out.
Raw speckle contrast sequences were analysed using
moorFLPI2 Review software (v4.0). Regions of interest were
consistent between each mouse and made 1 mm to 22 mm from
Bregma with care taken to avoid any artefacts on the skull surface.
Data were measured in blood perfusion units (PU) and calculated
for each mouse as the percentage change relative to baseline
(Figure S1).
Tissue preparation and immunohistochemistry
At 3 days or 28 days post-surgery, mice were deeply
anaesthetised with 5% isoflurane and transcardially perfused with
20 ml 0.9% heparinised saline followed by 20 ml 4% paraformal-
dehyde (PFA) in 0.1% phosphate buffer (PB, pH 7.4). Following
perfusion, the brains were removed and post-fixed in 4% PFA
overnight. Brains were then transferred to PB and stored overnight
at 4uC. The brains were cut along the midline and free-floating
50 mm sagittal sections were cut using a vibrating blade microtome
(Hydrax V50, Zeiss, Germany). Sections were stored in cryopro-
tective medium (30% glycerol/30% ethylene glycol in PB) at
220uC until required. Different cohorts of animals were used due
to the sensitivity of some antibodies to tissue fixation (n = 13 sham,
12 hypoperfused and n = 9 sham, 10 hypoperfused for 3 day
studies; n = 10 sham, 11 hypoperfused and n = 9 sham, 9
hypoperfused for 1 month studies). Occasionally animals were
excluded from analysis if there was an absence of cellular staining
or the quality was deemed too poor to perform accurate analysis.
The following primary antibodies were used in this study: anti-
BrdU (1:200, AB6326, Abcam, UK), anti-CC1 (APC 1:20, OP80,
Calbiochem, USA), anti-GFAP (1:1000, Z0334, Dako UK), anti-
GPR17 (1:200, 10136, Cayman Chemical, USA) anti-Iba1 (1:100,
ab5076, Abcam UK), anti-MAG (1:100, sc-9543, Santa Cruz,
USA) anti-NG2 (1:100, AB5320, Millipore, UK), anti-Olig2
(1:500, Ab9610, and 1:100, MABN50, both Millipore, UK),
anti-PCNA (1:500 ab29, Abcam UK), anti-PDGFRa (1:100,
558774, BD Pharmingen UK), and anti-PDGFRb (1:100,
AF1042, R and D Systems, UK). Cy2, Cy3, DyLight 488 and
Alexa Fluor 488 and 647 (all 1:200) conjugated secondary
antibodies were purchased from Jackson ImmunoResearch
Laboratories Inc (USA). Alexa Fluor 488 and 546 conjugated
secondary antibodies (1:500) were purchased from Life Technol-
ogies Ltd (UK). Double labelling experiments were carried out to
Oligodendrocyte Pools after Cerebral Hypoperfusion
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confirm the cellular specificity of antibodies used for OPC and
oligodendrocyte labelling. Non-specific labelling was blocked using
3% normal serum and sections were incubated in primary and
secondary antibodies overnight at 4uC. Sections were mounted
onto SuperFrost slides and mounted using Vectashield hard set
mounting medium containing the nuclear stain 49,6-diamidino-2-
phenylindole (DAPI) (H-1500, Vector Laboratories, USA).
For BrdU labelling experiments, an additional antigen retrieval
step was required. Following 3 washes in PBS, sections were
incubated for 30 minutes in 2M HCl at 37uC to allow
denaturation of DNA. Following this, sections were given three
5 minute washes in 0.1 M sodium borate buffer (Na2B4O7,
pH 8.5). For PCNA labelling, sections were retrieved in 10 mM
citrate buffer for 30 minutes at 85uC and blocked using 10%
normal serum and 0.5% bovine serum albumin.
Fluoromyelin staining was used to assess myelin integrity
following hypoperfusion. Free-floating sections were washed in
PBS and mounted onto slides. Following rehydration in PBS,
sections were incubated in Fluoromyelin Green (1:200, Invitrogen)
for 1 hour at room temperature. At the outset the conditions were
optimised as recommended by the manufacturer. This protocol
was determined to be optimal for studying myelin alterations in
thick vibratome sections and is a slight modification of that
suggested by the manufacturer for thin paraffin sections.
Confocal laser scanning microscopy and image analysis
Immunolabelled 50 mm sections were imaged using confocal
laser scanning microscopy (Zeiss Axioskop LSM 510 or Zeiss
LSM710, Zeiss, Germany). All images were acquired using a 206
objective (numerical aperture 0.75) representing an area of
4606460 mm. Images were obtained at a resolution of
102461024 pixels. Z-stacks of a minimum of 7 mm were acquired
with a step size of 1 mm. The region of the corpus callosum, in
sagittal sections, was imaged above the lateral ventricle at the
stereotactic co-ordinates, lateral 2.4060.1 mm, Bregma
21.560.1 mm.
Stereological cell counting was performed using ImageJ
software (version 1.42q) (National Institutes of Health, USA).
Cells were identified based on expression of the immunolabel(s) of
interest co-localised with the nuclear stain (DAPI). Cells were
manually identified and counted using the ImageJ Cell Counter
plugin. To prevent over-counting, cells crossing the left and top
sides of the region of interest were included, but any cells crossing
the right or bottom boundaries were not counted. Images from the
top of the Z-stack were excluded from analysis whilst counts from
the bottom image from the stack were included. Cell counts are
expressed as the percentage of sham controls or as the number of
cells/0.01 mm3.
To assess the intensity of GPR17 and fluoromyelin staining,
sections were imaged using identical gain and offset settings on the
confocal microscope which ensured a common threshold was set
in the acquisition of all images. For GPR17 staining, individual
GPR17+ cells within the corpus callosum were manually outlined
and the mean gray value measured and expressed as the average
per animal. To assess the intensity of fluoromyelin staining, the
corpus callosum was manually outlined and mean gray value
measured. All intensity measurements were carried out in
triplicate and values averaged. For analysis of MAG immuno-
staining, images were acquired using identical confocal settings
and background subtraction was applied before calculating the
percentage area of positive staining. All experiments and
subsequent analysis were carried out blind to surgical condition.
Western blot analysis
In a separate cohort of mice after one month of hypoperfusion
(n = 8) or a sham (n = 5) procedure, after decapitation, the brain
was rapidly removed, the cerebellum discarded and the remaining
brain frozen in liquid nitrogen. Myelin-enriched fractions were
prepared by sucrose density centrifugation [29] and the total
protein concentration was determined using Pierce BCA Protein
Assay Kit (Thermo Fisher Scientific, UK). Proteins were separated
by Bis-Tris 4–12% SDS-PAGE (NuPageH NovexH, Life Technol-
ogies) and transferred onto PVDF membrane (Immobilon-FL,
Millipore). Immunobloting was performed using the Odyssey
Infrared Imaging System (LiCor Biosciences, Lincoln, NE, USA).
Membranes were blocked 1 hour at room temperature in Odyssey
blocking buffer (diluted 1:1 with phosphate-buffered saline),
washed in phosphate-buffered saline–Tween (phosphate-buffered
saline with 0.1% Tween) and incubated over-night at 4uC with
MBP (1:10.000, Millipore). After gentle washing, membranes were
then incubated 1 hour at room temperature with GAPDH
(1:14.000, Sigma) which was used as a loading control.
Membranes were then incubated for 45 minutes with the
appropriate fluorescent secondaries (1:3000, LiCor Biosciences).
The western blots were analysed using the LiCOR Bioscience
Odyssey system and software. The four MBP isoforms were
analysed together and normalized to GAPDH.
Electron microscopy
To determine whether 3 days or 1 month of chronic cerebral
hypoperfusion led to alterations in myelin sheath thickness in the
corpus callosum, transmission electron microscopy was carried
out.
Animals were transcardially perfused with 5% glutaraldehyde/
4% paraformaldehyde, 3 days (n = 5 sham, 6 hypoperfused) or 28
days (n = 7 sham, 7 hypoperfused) after the onset of cerebral
hypoperfusion. The brains were then cut into 1 mm thick sections
and the corpus callosum manually dissected out. Corpus callosum
samples were fixed in 3% glutaraldehyde in 0.1M sodium
cacodylate buffer (pH 7.3) for 2 hours and then washed 3 times
in the same buffer. Samples were then post-fixed in 1% osmium
tetroxide in 0.1M sodium cacodylate. Following dehydration,
sections were embedded in araldite resin. Samples were then cut
from the midline into the corpus callosum and 60 nm ultrathin
transverse sections were cut using a Reichert OMU4 ultramicro-
tome (Leica Microsystems (UK) Ltd, Milton Keynes) and stained
in uranyl acetate and lead citrate. Sections were viewed using a
Philips CM120 transmission electron microscope (FEI UK Ltd.,
Cambridge, England) and images taken at a magnification of
35006using a Gatan CCD camera (Gatan UK, Oxon, England).
To quantify changes in myelin sheath thickness, a lined grid of
0.9560.95 mm2 was overlaid onto each image using Image J
software (v1.42q) and fibres were selected for analysis if their
myelin sheath was intersected by a grid line. Using the freehand
tool, the perimeters of each fibre and axon were manually traced
and whole fibre area and axonal area were measured. These
values were used to calculate corresponding fibre and axonal
diameters. To calculate g-ratio, axonal diameter was divided by
whole fibre diameter. For each animal a minimum of 137 fibres
were analysed with the observer blind to surgical condition.
Statistical analysis
Data were analysed using Student’s unpaired t-test or the
Mann-Whitney U-test depending on parametric or non-paramet-
ric distribution. Statistical analysis was performed using GraphPad
Prism 5 software (GraphPad Software, San Diego, USA). A
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probability (p) value #0.05 was considered to be statistically
significant.
Results
Decreased numbers of OPCs and mature
oligodendrocytes during the early response to cerebral
hypoperfusion
To assess the acute response of OPCs to chronic cerebral
hypoperfusion, NG2 labelling was carried out and numbers of
NG2+ OPCs were counted. We determined that NG2 specifically
labelled OPCs in the corpus callosum through colocalisation with
the OPC marker PDGFRa (Figure S2A). In addition, NG2+ cells
lacked PDGFRb expression, a marker of pericytes (Figure S2B).
Two distinct populations of NG2+ cells were identified: one
population showed circular immunoreactivity around the nucleus
and few processes, corresponding to ‘early’ stage OPCs, whilst the
other were more intensely stained and displayed more extensive
cellular processes, corresponding to ‘late’ stage OPCs (Figure 1A).
Cell counting of both NG2+ populations revealed that during the
acute response to hypoperfusion, numbers of early NG2+ cells
were significantly decreased compared to sham controls
(p = 0.015) (Figures 1B, S3A). Numbers of NG2+ cells displaying
late OPC morphology were unchanged after 3 days (p = 0.532)
(Figure 1C).
The early effects of cerebral hypoperfusion on mature
oligodendrocyte populations were then examined using CC1
immunolabelling (Figure 1D, Figure S3B). This revealed a
significant decrease in oligodendrocyte number in the hypoper-
fused group compared to sham controls (p = 0.027) (Figure 1E). It
has been reported that astrocytes may express the CC1 antigen
[30], but in this study CC1+/GFAP+ double labelling determined
that only 0.8% of CC1+ cells were GFAP+ in the corpus callosum
(Figure S4A). Furthermore the numbers of astrocytes were
unchanged after 1 month of cerebral hypoperfusion (Figures
S4B-C). Together these results show that rapid alterations in OPC
and oligodendrocyte populations occur in response to modest
reductions in cerebral blood flow.
Restoration of the precursor pool and increased numbers
of oligodendrocytes after long term cerebral
hypoperfusion
The longer term responses of the oligodendrocyte pools to
cerebral hypoperfusion were next investigated. NG2+ labelled cells
were counted and showed no differences in numbers of early
(p = 0.245) or late (p = 0.860) NG2+ cells between sham and
hypoperfused groups (Figure 2A and 2B respectively). In contrast
to the loss of mature oligodendrocytes observed after 3 days of
hypoperfusion, CC1+ labelling (Figures 2C, S3B) revealed a
significant increase (19%) in the number of mature oligodendro-
cytes in the hypoperfused animals compared to sham operated
animals (p = 0.007) (Figure 2D). Together these results indicate
that in response to longer term cerebral hypoperfusion a
replacement mechanism is acting to restore OPCs and in the
case of mature oligodendrocytes, increase numbers of cells.
Proliferation and differentiation of OPCs in response to
cerebral hypoperfusion
To characterise levels of proliferation in response to hypoper-
fusion, PCNA labelling was carried out to determine numbers of
proliferating cells at 3 days and 1 month of hypoperfusion
(Figure 3A). This showed that overall numbers of proliferating cells
were not different between groups at either 3 days (p = 0.20)
(Figure 3B) or 1 month (p = 0.564) (Figure 3C). We next sought to
determine the extent of OPC proliferation and whether this
contributed to the restoration of oligodendroglial pools following
hypoperfusion. For technical reasons PCNA/NG2 double label-
ling could not be carried out therefore PCNA/Olig2 labelling
experiments were carried out in 3 day and 1 month cohorts
(Figure 3D). Whilst Olig2 is expressed throughout the oligoden-
drocyte lineage, only OPCs can proliferate and thus express
PCNA. The number of PCNA+/Olig2+ cells were significantly
decreased in 3 day hypoperfused animals compared to sham
controls (p = 0.02) (Figure 3E) while no differences in proliferating
OPCs were observed after 1 month of hypoperfusion (p = 0.323)
(Figure 3F). Together these results show that whilst overall levels of
proliferation were unchanged after 3 days of hypoperfusion,
numbers of proliferating OPCs were decreased in hypoperfused
animals compared to controls.
To further investigate the early proliferative responses to
cerebral hypoperfusion, animals from the 1 month cohort received
injections of BrdU for the first three days following surgery to label
all proliferating cells within this period (Figure 3G). BrdU+ cells
were present in 2 of the 9 (22%) of the sham control group and in
5 out of 10 (50%) of the hypoperfused group (Figure 3H) although
the difference between groups was not statistically significant
(p = 0.157). BrdU and NG2 double labelling failed to demonstrate
any proliferating OPCs (data not shown).
We next sought to determine whether BrdU+ cells generated
early in response to hypoperfusion had differentiated into mature
oligodendrocytes and carried out BrdU+/CC1+ labelling
(Figure 3I). This showed that BrdU+/CC1+ cells were present in
3 of the 10 (30%) 1 month hypoperfused mice but were completely
absent in sham-operated controls (Figure 3J). Although the
difference was not statistically significant (p = 0.095), the presence
of these double labelled cells in a proportion of hypoperfused
animals indicates that OPC differentiation has occurred in a subset
of animals in response to reduced cerebral blood flow. CBF
responses in individual mice may vary which may account for
differences in the proliferative/differentiation responses. An
indication of the individual CBF responses was investigated in
different cohorts of mice to those used to assess pathology at 3 days
and 1 month hypoperfusion (see Figure S1).
Decreased expression of GPR17 in response to cerebral
hypoperfusion
To elucidate a possible mechanism involved in OPC differen-
tiation in response to cerebral hypoperfusion, we analysed the
expression of the G protein-coupled receptor GPR17 (Figures 4A,
S3D). Previous studies have shown that in the intact brain GPR17
is expressed by premyelinating oligodendrocytes and a subset of
OPCs, and receptor activation has been demonstrated to play a
permissive role in OPC differentiation [22,23]. GPR17/NG2
double labelling could not be performed due to the antibodies
being raised in the same species therefore we confirmed GPR17
expression by oligodendrocyte lineage cells using Olig2. This
showed approximately 64% of GPR17+ cells co-expressed Olig2
(Figure S5), which is in agreement with a previous report [23].
Numbers of GPR17+ cells were not significantly different between
groups at either time point examined (Figures 4B and 4C). We
next assessed expression of the receptor, as indicated by the
intensity of staining. This revealed a decrease in the GPR17
labelling intensity after 3 days in hypoperfused as compared to
shams (p = 0.007) (Figure 4D). However, after 1 month of
hypoperfusion there was no difference between groups
(p = 0.363) (Figure 4E).
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Impairment of axon-glial integrity, increased microglia
and absence of gross myelin alterations in response to
cerebral hypoperfusion
To determine whether alterations in oligodendrocyte numbers
may be paralleled by alterations in myelin density following
cerebral hypoperfusion, myelin status was assessed using the
fluorescent lipophilic dye fluoromyelin (Figure 5A). However,
there were no significant differences in staining intensity following
either 3 days of cerebral hypoperfusion (p = 0.598) or after 1
month of cerebral hypoperfusion (p = 0.063) (Figure 5B & C).
Investigation of myelin-enriched extracts using Western blot
analysis additionally indicated that there was no significant
difference in MBP levels between sham and one month
hypoperfused mice (Figure S6).
To further investigate the myelin integrity, electron microscopy
was carried out and measurements of myelin sheath thickness
relative to fibre diameter, i.e. g-ratio, were conducted in separate
cohorts of 3 day and 1 month hypoperfused animals (Figure 5D).
This revealed no significant difference in g-ratio values following
both short and long term hypoperfusion compared to respective
sham-operated controls (Figure 5E). As a note since the 3 days and
1 month cohorts underwent surgery and tissue processing at
different times no statistical comparisons can be made between
sham cohorts or the hypoperfused cohorts.
Despite an absence of gross myelin alterations, in our group we
have consistently determined that cerebral hypoperfusion results in
a disruption of axon-glial integrity [12,25,26] and thus sought to
verify whether similar alterations occur in the white matter in this
study. Axon-glial integrity was assessed by myelin associated
glycoprotein (MAG), a key myelin protein involved in the
maintenance of axon-glial integrity (Figure 6A). There was a
reduction in the density of MAG staining in the corpus callosum
after 3 days (p = 0.008) and 1 month (p = 0.027) of chronic
cerebral hypoperfusion (Figures 6B and 6C).
Figure 1. Reduced numbers of OPCs and mature oligodendrocytes after 3 days of chronic cerebral hypoperfusion. (A) Representative
confocal images showing morphology of early and late NG2+ OPCs in the corpus callosum. (B) A significant decrease in numbers of early NG2+ OPCs
was found in the corpus callosum after 3 days of chronic cerebral hypoperfusion. (C) No significant differences in numbers of late NG2+ cells were
observed after 3 days. (D) Representative confocal images of CC1+ labelling of oligodendrocyte cell bodies in the corpus callosum. (E) A significant
decrease in CC1+ oligodendrocytes was found after 3 days of hypoperfusion. n = 13 sham, 12 hypoperfused for NG2 labelling experiments; n = 9
sham, 10 hypoperfused for CC1 labelling. Scale bars = 10 mm * p,0.05.
doi:10.1371/journal.pone.0087227.g001
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A pronounced microglial response as determined by Iba1
immunoreactivity has also been a robust finding in our model of
hypoperfusion (Figure 6D). In support of this after 1 month of
hypoperfusion, numbers of microglia were significantly increased
compared to sham controls (p = 0.0011) (Figure 6E), whilst
numbers of microglia were unchanged after 3 days of cerebral
hypoperfusion (p = 0.425) (Figure 6F), consistent with earlier
studies using this mouse model [12,28].
Taken together these data indicate that whilst gross myelin
morphology remains intact and increased numbers of oligoden-
drocytes are observed following hypoperfusion, axon-glial integrity
is impaired supporting our previous observations [25].
Discussion
Previous studies have demonstrated the susceptibility of
oligodendrocytes to severe reductions in cerebral blood flow
(.70% to that of baseline levels) with profound oligodendrocyte
loss occurring early in response to the insult [6,17]. The present
study additionally highlights the vulnerability of these oligoden-
droglial cells to more modest reductions in blood flow comparable
to those observed in the ageing brain.
In the present study we investigated the pools of OPCs and
mature oligodendrocytes. We observed two different populations
of NG2+ cells identified by differences in morphology. One
population of NG2+ cells showed circular reactivity around the
nucleus and few processes, corresponding to ‘early’ stage OPCs,
whilst the other population of cells was more intensely stained and
more processed, corresponding to ‘late’ stage OPCs. Interestingly
only the ‘early’ stage OPCs were affected by hypoperfusion. It is
possible that these early OPCs have responded rapidly to
hypoperfusion by extending more processes and have thus been
classified as late OPCs. Mature oligodendrocytes were also
reduced in response to hypoperfusion, highlighting the vulnera-
bility of these glial cells to even modest reductions in cerebral
blood flow. Although the mechanisms underlying this early
oligodendroglial loss with hypoperfusion remain to be determined,
these may involve damage to the oligodendrocytes and OPCs as a
result of oxidative stress [31,32] or inflammation [33,34], both of
which are known inducers of oligodendroglial damage and/or
death (for review see [9,35]). In the present study, consistent with
our previous work, we demonstrated a marked microglial response
with hypoperfusion. Previously we have also shown alterations in
indices of hypoxia [25] in white matter after hypoperfusion.
Localised alterations in glutamate levels as a result of compromised
blood flow could also contribute to the loss of oligodendrocytes
and OPCs via NMDA receptor activation leading to intracellular
Ca2+-dependent injury to oligodendroglia [36,37]. However it
should be noted that whilst we propose that the loss of CC1+ and
NG2+ labelling of cells is an indicator of cell loss, a loss of cellular
antigenicity could also account for the reduction in cellular
staining.
With sustained hypoperfusion, marked alterations in oligoden-
droglial pools were observed. The OPC pool was restored and
Figure 2. Restoration of the NG2+ precursor pool and increased numbers of mature oligodendrocytes after 1 month of chronic
cerebral hypoperfusion. (A) No significant differences in numbers of early or (B) late NG2+ cells were observed after 1 month of cerebral
hypoperfusion. (C) Representative confocal images of CC1+ labelling of oligodendrocyte cell bodies in the corpus callosum. Scale bar = 10 mm. (D) A
significant increase in CC1+ oligodendrocytes in the corpus callosum was observed following 1 month of chronic cerebral hypoperfusion. n = 10
sham, 11 hypoperfused for NG2 and CC1 labelling. ** p,0.01.
doi:10.1371/journal.pone.0087227.g002
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numbers of mature oligodendrocytes were increased when
examined after 1 month hypoperfusion. This suggests that there
is sufficient capacity with the adult brain to overcome the initial
loss of oligodendrocyte pools. Similarly, in models of focal cerebral
ischaemia when either blood flow is restored with reperfusion or in
the peri-infarct region where there is sufficient collateral flow,
increased numbers of OPCs are detectable [16]. In contrast, other
studies of mouse cerebral hypoperfusion have shown that
oligodendrocyte numbers remain reduced at one month of
hypoperfusion [38,39]. There are notable differences between
the model of cerebral hypoperfusion in our group compared to
others [28,38,39]. Importantly we do not detect demyelination but
instead a robust disruption of axon-glial integrity and a
pronounced microglial response in white matter [12,25,26]. There
may also be differences in the time course of progression of
oligodendrocyte changes between our studies and others. The level
of reduction in cerebral blood flow may be a critical factor which
influences the extent of pathology and proliferation/differentiation
response. We used laser speckle imaging and demonstrated that in
our hands the reduction in CBF was approximately 36% that of
baseline at 3 days and then restored to 22% that of shams at 1
month. These are slightly greater than the levels reported
previously by Shibata et al. 2004 [28] where the maximal levels
of CBF reduction as assessed by laser Doppler flowmetry were
30% although are consistent with more recent studies such as that
by Duan et al. [40] who have reported reductions of 37% from
that of baseline using Laser Speckle imaging. However, there are a
number of other factors that may influence the outcome and
differences in pathology in models between different laboratories
including the anaesthetic used; the background strain of mice
(influences differences in cerebrovasculature) and environment
(pathogen status, temperature). Notably however, in these studies
that report sustained reductions in oligodendrocyte numbers
[38,39,41,42] the pools can be restored by either pharmacological
intervention [39,41,42] or bone marrow cell treatment [38]
indicating that there is restorative capacity of oligodendrocytes in
the model. In a previous study we detected a marked increase in
genes associated with cell proliferation in white matter in response
to hypoperfusion [25] and as a consequence expected to observe
marked increases in cell proliferation. However, assessment using
the acute proliferation marker PCNA showed that overall levels of
proliferation were unchanged with hypoperfusion but revealed
that proliferation of Olig2+ cells was decreased in 3 day
hypoperfused animals compared to controls. It is important to
note that whilst proliferation of OPCs was reduced after 3 days,
there may be a proliferative response of other cells within the white
matter although characterisation of this was beyond the scope of
the current study.
Figure 3. Low numbers of proliferating cells are observed in response to cerebral hypoperfusion however a proportion of newly
generated cells differentiate into mature oligodendrocytes within 1 month of cerebral hypoperfusion. (A) Representative confocal
images showing PCNA labelling of proliferating cells in the corpus callosum. (B) No significant differences in numbers of PCNA+ cells were observed
after 3 days or (C) 1 month of cerebral hypoperfusion. (D) Confocal images showing Olig2+/PCNA+ labelling of proliferating oligodendroglia in the
corpus callosum. (E) Decreased numbers of Olig2+/PCNA+ cells were observed after 3 days of cerebral hypoperfusion. (F) No significant differences in
numbers of Olig2+/PCNA+ cells were found after 1 month of hypoperfusion. (G) Representative confocal images showing BrdU labelled cells in the
corpus callosum. (H) BrdU+ cells were present in 2 out of 9 (22%) sham control animals but were observed in 5 out of 10 (50%) hypoperfused animals.
(I) Representative confocal images showing BrdU+/CC1+ cells in the corpus callosum. (J) CC1+/BrdU+ double labelled cells were present in 3 out of 10
(30%) of the hypoperfused cohort but were completely absent from the sham control group. n = 13 sham, 11 hypoperfused for PCNA and Olig2
labelling at 3 days. One animal was excluded from analysis on the basis of poor cellular staining; n = 9 sham, 9 hypoperfused for PCNA/Olig2 and CC1/
BrdU labelling at 1 month. Scale bars = 10 mm. * p,0.05.
doi:10.1371/journal.pone.0087227.g003
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To further characterise the early proliferative responses to
cerebral hypoperfusion, BrdU incorporation was used to assess the
total number of proliferating cells during the first 3 days after the
onset of hypoperfusion. This revealed that proliferating cells were
detectable in 50% of the hypoperfused cohort compared to 22% of
sham operated animals suggesting a modest proliferative response
early in response to hypoperfusion. However, this low level of
proliferation would be insufficient to account for the restoration of
the oligodendroglial pool. It is possible that the BrdU labelling
protocol used in this study has not adequately labelled all
proliferating cells and thus has underestimated the extent of
proliferation. Although it has been reported that BrdU at 200 mg/
kg body weight is a saturating dose and does not result in
cytotoxicity [43], the dosage used in this study (70 mg/kg body
weight/day) is within the standard range of 50–100 mg/kg
reported in many studies. However, the use of only two injections
per day coupled with the short bioavailability of BrdU may have
been insufficient to label all proliferating cells within the injection
period. In addition, a comprehensive characterisation of cell
proliferation would require continuous administration of BrdU (for
example in drinking water) and assessment of BrdU+ cells at
various time points.
The lack of convincing evidence of proliferation in response to
cerebral hypoperfusion raises the question as to whether differen-
Figure 4. Chronic cerebral hypoperfusion does not alter numbers of GPR17-expressing cells. (A) Representative confocal images
showing GPR17 labelling in the corpus callosum following 3 days and 1 month of hypoperfusion. Scale bar = 10 mm. (B) Numbers of GPR17+ cells in
the corpus callosum were unchanged after 3 days and (C) 1 month of cerebral hypoperfusion. (D) Intensity of GPR17 labelling was significantly
decreased after 3 days of cerebral hypoperfusion. (E) No difference in GPR17 labelling intensity was observed after 1 month of cerebral
hypoperfusion. n = 13 sham and 11 hypoperfused for 3 day analysis; n = 9 sham and 9 hypoperfused for 1 month analysis. ** p,0.01.
doi:10.1371/journal.pone.0087227.g004
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tiation of pre-existing OPCs may contribute to the restoration of
oligodendrocyte pools. Consistent with the hypothesis that
glutamate and ATP may be involved in white matter disruption
following cerebral hypoperfusion, there is growing evidence
implicating these two neurotransmitters in the regulation of
OPC proliferation and differentiation. In vitro studies have
demonstrated that glutamate inhibits OPC proliferation [21] but
promotes OPC differentiation via NMDA receptor activation [44].
Similarly it has been demonstrated that ATP and related
derivatives also inhibit proliferation whilst promoting OPC
differentiation [20]. Therefore it is possible that the low numbers
of proliferating cells in this study may be due to extracellular ATP
and glutamate acting to limit OPC proliferation whilst promoting
differentiation. In the current study we have demonstrated that a
small proportion of newly generated cells had differentiated into
mature oligodendrocytes however this is unlikely to exclusively
account for the significant increase in oligodendrocyte numbers
observed after 1 month. It is possible that differentiation of pre-
existing OPCs has also occurred to boost oligodendrocyte
numbers in response to cerebral hypoperfusion. Interestingly, this
is consistent with a study in a model of cerebral ischaemia which
similarly showed repopulation of the oligodendrocyte pool in the
absence of significant OPC proliferation [6].
To investigate a potential mechanism involved in differentiation
of OPCs in response to hypoperfusion we examined the expression
of GPR17, a novel dual uracil nucleotide and cysteinyl-leukotriene
G protein-coupled receptor which has been implicated in
mediating OPC responses to injury such as ischaemia [22]. It
has previously been demonstrated that expression of GPR17 is
upregulated in response to ischaemia and it has been suggested
that receptor activation may act as a sensor of local damage [22–
24]. In the current study, we have shown that numbers of GPR17-
expressing cells were unchanged but expression of the receptor was
decreased during the acute response to cerebral hypoperfusion.
There is however conflicting evidence regarding the effects of
receptor activation on OPC differentiation. Studies using trans-
genic mice have shown that receptor over-expression results in
decreased myelination whereas knockout leads to increased
myelination suggesting that GPR17 is a negative regulator of
OPC differentiation [45]. In contrast, it has been shown in vitro
that receptor agonism results in increased numbers of mature
oligodendrocytes, implying that receptor activation promotes
differentiation, whilst antagonism increases the proportion of
OPCs [24]. Additionally it has also been demonstrated that when
cultured OPCs are transferred to medium which promotes
differentiation, GPR17 expression is increased [46]. Despite this
apparently permissive role of GPR17 in OPC differentiation, it has
also been reported that receptor expression may also increase the
susceptibility of a cell to ATP-induced death [46]. Thus although
GPR17 activation does not appear to mediate OPC responses to
cerebral hypoperfusion at the time points examined, its downreg-
ulation after 3 days may represent an attempt to limit cell damage
and/or death induced by hypoperfusion.
Figure 5. Alterations to numbers of oligodendrocytes as a result of chronic cerebral hypoperfusion does not impact on myelination
of axons within the corpus callosum. (A) Representative confocal images showing fluoromyelin labelling in the corpus callosum after 3 days and
1 month of cerebral hypoperfusion. Scale bar = 20 mm (B) No significant difference in fluoromyelin intensity was observed after 3 days of chronic
cerebral hypoperfusion. (C) Fluoromyelin intensity was not significantly different between groups after 1 month of cerebral hypoperfusion. n = 13
sham, 12 hypoperfused for 3 day analysis and n = 9 sham, 10 hypoperfused for 1 month analysis. (D) Representative electron micrographs showing
myelinated fibres in the corpus callosum after 3 days and 1 month of cerebral hypoperfusion. Scale bars = 1 mm. (E) G-ratio values were unchanged
following 3 days and 1 month of hypoperfusion compared to respective sham controls. n = 5 sham and 6 hypoperfused for 3 day analysis; n = 7 sham
and 7 hypoperfused for 1 month analysis.
doi:10.1371/journal.pone.0087227.g005
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Myelinated axons in the corpus callosum were examined at the
ultrastructural level to determine whether alterations to oligoden-
drocyte numbers had an impact on myelin sheaths. We observed
no significant differences in g-ratio, an index of myelin sheath
thickness, between sham and 3 day hypoperfused mice despite
hypoperfusion inducing around a 15% reduction in mature
oligodendrocytes at this time point. Furthermore there were no
differences in myelin levels as assessed by fluoromyelin-labelling of
myelin in the corpus callosum or MBP levels measured in myelin-
enriched extracts. Limitations of these approaches may have
precluded detection of myelin alterations after hypoperfusion. In
the present study, fluoromyelin staining was conducted in thick
sections using a slightly modified protocol to that of previously
published work which did detect alterations in myelin in the
hypoperfusion model [38,41]. Thus, differences in fluoromyelin
staining methods might explain the different outcomes. Addition-
ally, the present study assessed MBP alterations in myelin-enriched
fractions [29] prepared from both white matter and grey matter.
Arguably there may have been a dilutional effect of the grey
matter on the measurement of MBP levels since this model has
been shown to exhibit predominantly a white matter pathology
without robust grey matter pathology within 1 month after the
surgery [12,27,28]. However, this finding (loss of oligodendrocytes
and absence of myelin changes), is consistent with a recent study
which used diphtheria toxin to specifically ablate oligodendrocyte
numbers by approximately 26% and reported that myelin was
Figure 6. Axon-glial integrity is disrupted and increased numbers of microglia after cerebral hypoperfusion. (A) Representative
confocal images showing MAG labelling in the corpus callosum following 3 days and 1 month of chronic cerebral hypoperfusion. Scale bar = 20 mm.
(B) A significant decrease in the density of MAG labelling was observed following 3 days of cerebral hypoperfusion compared to sham controls. (C)
Similarly, decreased density of MAG was also observed following 1 month of hypoperfusion. n = 12 sham, 12 hypoperfused for 3 day analysis. One
animal was excluded due to a lack of positive MAG labelling; n = 9 sham, 8 hypoperfused for 1 month analysis. (D) Representative confocal images
showing 1ba1 labelling 3 days and 1 month after the onset of cerebral hypoperfusion. Scale bar = 10 mm. (E) Numbers of microglia were unchanged
following 3 days of cerebral hypoperfusion. (F) Following 1 month of cerebral hypoperfusion, a significant increase in microglial number was
observed compared to sham controls. n = 13 sham, 12 hypoperfused for 3 day analysis; n = 9 sham, 10 hypoperfused for 1 month analysis.
doi:10.1371/journal.pone.0087227.g006
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preserved despite this extensive oligodendrocyte loss [47]. This
lack of effect on myelination despite profound alterations in
oligodendrocyte pools is also consistent with previous studies by
our group which have determined that there are no gross
alterations to the protein levels of myelin basic protein as assessed
by immunohistochemistry [25]. Instead, in this model, hypoper-
fusion results in disruption of MAG and breakdown of axon-glial
integrity associated with disruption of the paranodal septate
junctions [25]. The current study used an antibody against the
CC1 protein which labels oligodendrocyte cell bodies but not
processes, and as a result cannot reliably distinguish between
myelinating and non-myelinating oligodendrocytes. One possible
explanation for our findings is that in response to cerebral
hypoperfusion, a non-myelinating population of CC1+ oligoden-
drocytes are lost and thus no disruption to myelin has been
observed. Another possibility is that neighbouring oligodendro-
cytes may compensate for oligodendrocyte loss by extending
processes and ‘filling in’ non-myelinated areas [48]. We also
observed that g-ratio was similarly unchanged following 1 month
of hypoperfusion and so it remains to be determined whether
increased numbers of oligodendrocytes observed at this time point
are surplus to requirements. Overall these findings suggest that
even in the presence of cerebral hypoperfusion, the CNS can
tolerate significant alterations to mature oligodendrocyte pools
without any apparent detriment to myelin thickness or density.
Thus in conclusion this study provides further support that
oligodendrocytes are vulnerable to modest blood flow reductions
and evidence supporting their regenerative capacity. This turnover
of the pool of oligodendrocytes appears to occur in the absence of
changes in myelination but it would be interesting to investigate in
future studies whether there are any functional consequences of
these changes within the white matter.
Supporting Information
Figure S1 Reduced cerebral blood flow in hypoperfused
animals. Cerebral blood flow was measured using laser speckle
flowmetry prior to surgery (baseline) and at 3 days and 1 month
following surgery to assess the extent of hypoperfusion at the times
white matter alterations were investigated. (A) Representative
images showing speckle images at baseline, 3 days and 1 month for
a sham and hypoperfused mouse. Images show the average of 100
frames. Baseline CBF was not significantly different (p,0.05)
between groups (1130636 perfusion units in shams vs 1072624
perfusion units in hypoperfused group). (B&C) After 3 days and 1
month, CBF was significantly decreased in hypoperfused com-
pared to sham animals to (p,0.001 and p,0.005 respectively).
Data are calculated for each mouse as the percentage change
relative to baseline. (B) Cerebral blood flow was decreased by
approximately 36% to that of shams following 3 days of cerebral
hypoperfusion. (C) Following 1 month of hypoperfusion, CBF
values had recovered to approximately 22% of sham levels. Data is
shown for each mouse, n = 8 sham, 6 hypoperfused.
(TIF)
Figure S2 NG2 is a specific marker of OPCs. NG2 and
PDGFRa labelling confirmed the specificity of NG2 as an OPC
marker in the corpus callosum. (A) NG2 and PDGFRa co-labelled
OPCs in the corpus callosum. Scale bar = 10 mm. (B) Confocal
images showing representative NG2 and PDGFRb labelling. No
PDGFRb+ labelling of pericytes was observed in the corpus
callosum and only occasional PDGFRb+ labelling was observed in
the cortex. No NG2+/PDGFRb+ cells were observed in either
region. Scale bar = 20 mm.
(TIF)
Figure S3 Low magnification images of NG2, CC1,
Olig2 and GPR17 labelling. (A) Low magnification confocal
images showing NG2+ labelling of OPCs in the corpus callosum
(CC). (B) Confocal images showing CC1+ labelling of mature
oligodendrocytes in the corpus callosum. (C) Confocal images
showing Olig2+ labelling of oligodendroglia in the corpus
callosum. (D) Confocal images showing GPR17+ labelling in the
corpus callosum. Scale bars = 50 mm. CTx = Cortex, CC = corpus
callosum, CPu = caudate putamen.
(TIF)
Figure S4 Astrocytes are not labelled with CC1 and
numbers are unchanged following 1 month of cerebral
hypoperfusion. It has been reported that a subpopulation of
astrocytes can express the CC1 (APC) antigen, therefore CC1 and
GFAP double labelling was carried out to determine numbers of
CC1+ astrocytes. (A) Representative confocal images showing
CC1+/GFAP+ double labelling in the corpus callosum (CC). Scale
bar = 50 mm, inset scale bar = 10 mm. Cell counts of numbers of
double labelled cells revealed approximately 0.8% of CC1+ cells
expressed GFAP thus confirming the high specificity of CC1 as a
marker of mature oligodendrocytes. (B) Representative confocal
images showing GFAP+ labelling of astrocytes in the corpus
callosum (CC). Scale bar = 50 mm. (C) Numbers of GFAP+
astrocytes are unchanged following 1 month of chronic cerebral
hypoperfusion. CTx = Cortex, CC = corpus callosum, CPu = cau-
date putamen.
(TIF)
Figure S5 GPR17 is expressed by oligodendroglia and a
small number of microglia. (A) Representative confocal
images showing GPR17+/Olig2+ double labelling in the corpus
callosum. Arrows indicate double labelled cells. (B) Representative
confocal images showing GPR17+/Iba1+ labelling in the corpus
callosum. (C) Cell counting revealed approximately 64.463.33%
of GPR17+ cells express Olig2 in the corpus callosum. Only
8.2960.75% of GPR17+ cells co-expressed Iba1. Scale
bars = 50 mm, inset scale bars = 10 mm. CTx = Cortex,
CC = corpus callosum, CPu = caudate putamen.
(TIF)
Figure S6 MBP levels are unchanged following 1 month
of cerebral hypoperfusion. (A) Representative Western blot
from myelin enriched extracts showing the different MBP isoforms
(25–16 kDa) and GAPDH, the later used as a loading control. (B)
Analysis of fluorescent intensity relative to GAPDH showed no
significant changes in MBP levels after 1 month of cerebral
hypoperfusion. n = 5 sham, n = 8 hypoperfused.
(TIF)
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Rapid Disruption of Axon–Glial Integrity in Response to
Mild Cerebral Hypoperfusion
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Myelinated axons have a distinct protein architecture essential for action potential propagation, neuronal communication, and main-
taining cognitive function. Damage to myelinated axons, associated with cerebral hypoperfusion, contributes to age-related cognitive
decline. We sought to determine early alterations in the protein architecture of myelinated axons and potential mechanisms after
hypoperfusion. Using a mouse model of hypoperfusion, we assessed changes in proteins critical to the maintenance of paranodes, nodes
of Ranvier, axon– glial integrity, axons, and myelin by confocal laser scanning microscopy. As early as 3 d after hypoperfusion, the
paranodal septate-like junctions were damaged. This was marked by a progressive reduction of paranodal Neurofascin signal and a loss
of septate-like junctions. Concurrent with paranodal disruption, there was a significant increase in nodal length, identified by Nav1.6
staining, with hypoperfusion. Disruption of axon– glial integrity was also determined after hypoperfusion by changes in the spatial
distribution of myelin-associated glycoprotein staining. These nodal/paranodal changes were more pronounced after 1 month of hypo-
perfusion. In contrast, the nodal anchoring proteins AnkyrinG and Neurofascin 186 were unchanged and there were no overt changes in
axonal and myelin integrity with hypoperfusion. A microarray analysis of white matter samples indicated that there were significant
alterations in 129 genes. Subsequent analysis indicated alterations in biological pathways, including inflammatory responses, cytokine-
cytokine receptor interactions, blood vessel development, and cell proliferation processes. Our results demonstrate that hypoperfusion
leads to a rapid disruption of key proteins critical to the stability of the axon– glial connection that is mediated by a diversity of molecular
events.
Introduction
The integrity of the brain’s white matter, comprised mainly of
myelinated axons, is critical in regulating efficient neuronal com-
munication and maintaining cognitive function (Nave, 2010).
Myelination of axons, by oligodendrocytes, determines the local-
ization of key proteins along the axon and segregates the axonal
membrane into defined regions: the node of Ranvier, paranode,
juxtaparanode, and internode (Rios et al., 2003; Susuki and Ras-
band, 2008). In the adult brain, the nodes of Ranvier located at
defined points along the axolemma are critical for action poten-
tial propagation. They are comprised of voltage-gated sodium
channels that are clustered at a high density within a diffusion
barrier of septate-like junctions. These paranodal septate-like
junctions, consisting of glial Neurofascin (Nfasc)155, axonal
contactin, and contactin-associated protein (Caspr), are critical
to the maintenance of axon– glial junctions at the paranodes. A
dynamic relationship exists between axons and glia, in addition
to highly coordinated signaling with vascular components (en-
dothelial cells, pericytes) that comprise the oligovascular niche
(Arai and Lo, 2009), which, if disrupted, could impede neuronal
communication and cognitive abilities.
With advancing age, there is a general decline in white matter
integrity associated with cognitive decline (Bartzokis et al., 2004;
Bastin et al., 2009). Although there is evidence that the protein
architecture of myelinated axons may be altered at nodal regions
in the aging brain (Lasiene et al., 2009), as yet the underlying
molecular changes that occur early are not known. Cerebral hy-
poperfusion is suggested to contribute to the development of
white matter changes in the aging brain (Fernando et al., 2006).
In response to severe hypoperfusion as a result of stroke, axon–
glial integrity is impaired, as demonstrated by a loss of myelin-
associated glycoprotein (MAG) (Waxman, 2006), a protein
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important in the maintenance of the axon– glial connection
(Quarles, 2007; Schnaar and Lopez, 2009). Glutamate excitotox-
icity has also been shown to cause paranodal myelin splitting and
retraction (Fu et al., 2009). Disruption of the protein architecture
of myelinated axons is often associated with demyelinating dis-
eases. In multiple sclerosis, paranodal disruption of Nfasc155 and
Caspr leads to dispersion of Nav1.6 and Nfasc186 proteins along
the axon (Howell et al., 2006; Waxman, 2006) and impaired
nerve function (Quarles, 2007).
Using a mouse model of chronic cerebral hypoperfusion (Shi-
bata et al., 2004), which mimics the modest, sustained reductions
in blood flow of the aging brain, we previously demonstrated that
hypoperfusion results in damage to white matter at the cellular
level (Coltman et al., 2011) and in vivo (Holland et al., 2011). We
hypothesized that hypoperfusion would cause alterations in
axon– glial integrity associated with a disruption in key proteins
responsible for anchoring nodal proteins and paranodal junc-
tions. To test this, we undertook a systematic analysis of the in-
tegrity of key proteins at the paranodal and nodal regions in
response to hypoperfusion. To define the complex alterations
in gene expression and biological pathways that may contribute
to axon– glial damage, microarray analysis was conducted in
white matter-enriched tissue. Our results indicate that diverse
molecular pathways are altered with hypoperfusion.
Materials and Methods
Animals. Male C57BL/6J mice (25–30 g, 3– 4 months old) were ob-
tained from Charles River. All procedures were authorized under the
Home Office approved project license number 60/3722 title “Pathophys-
iology of Alzheimer’s disease: link to cerebrovascular disease” held by Dr.
K. Horsburgh. This license was approved by the University of Edin-
burgh’s Ethical Review Committee on 4 June 2007 and the Home Office
on 30 July 2007, is valid until 30 July 2012, and adhered to regulations
specified in the Animals (Scientific Procedures) Act (1986).
Chronic cerebral hypoperfusion. Chronic cerebral hypoperfusion was
induced by applying microcoils (0.18 mm internal diameter; Sawane
Spring Co.) to both common carotid arteries as previously described
(Shibata et al., 2004; Coltman et al., 2011) under isoflurane anesthesia.
There was a period of 30 min between the insertion of each coil. Sham-
operated animals underwent an identical surgical approach except that
microcoils were not applied to the common carotid arteries. The tem-
perature of the mice was maintained between 36.5°C and 37.5°C. The
recovery of the mice was monitored closely, and the weight of the mice,
whether they were eating and drinking, and any signs of overt neurolog-
ical dysfunction (e.g., circling, rolling, hunching) were recorded.
Tissue preparation and immunohistochemistry. At either 3 d or 1 month
after surgery, mice were deeply anesthetized with 5% isoflurane and
transcardially perfused with 20 ml of 0.9% heparinized PBS and then 20
ml of 4% paraformaldehyde in 0.1% phosphate buffer. After perfusion,
brains were removed and postfixed either in 4% PFA overnight (for
nodal and internodal structures) or for 30 min (for Nfasc186 immuno-
labeling or with subsequent Bouins fixation for Nfasc155 immunolabel-
ing). Brains were cut along the midline and floating sagittal sections (50
m thickness) were produced with a vibrating blade microtome (Hydrax
V50; Zeiss). Sections were collected and stored in cryoprotective medium
(30% glycerol/30% ethylene glycol in phosphate buffer) and stored at
20°C until use. Adjacent sections were stained with hematoxylin and
eosin (H&E) stain to determine the presence of ischemic neuronal per-
ikaryal damage. Any animals exhibiting ischemic damage were excluded
from the study.
The antibodies used in this study were as follows: Nav1.6 (1:200,
AB5580; Millipore), MAG (1:100, L20, sc-9543; Santa Cruz Biotechnol-
ogy), myelin basic protein (MBP; 1:100, MAB386; Millipore), SMI312R
(1:100; Covance), Caspr (1:100, clone K65/35; UC Davies NIH Neuro-
Mab), Nfasc155 (NFF3, 1:1000) (Tait et al., 2000), Nfasc186 (MNF2,
1:200) (Tait et al., 2000), Neurofascin common epitope (1:1000,
AB15188; Millipore), AnkyrinG (H-215, sc-28561; Santa Cruz Biotech-
nology), human/mouse active caspase-3 (1:100, AF835; R & D Systems).
Secondary Cy2, 3, and 5 antibodies were purchased from Jackson Immu-
noResearch Laboratories. All antibodies were incubated overnight at 4°C
in PBS, pH 7.4, with 0.1% Triton X-100.
Analysis of immunohistochemistry. Immunolabeled 50 m vibratome
sections were analyzed using a laser scanning confocal microscope (Zeiss
Axioskope LSM 510). All images were acquired with a 63 oil-
immersion objective (numerical aperture, 1.4), a pinhole of 1 Airy unit,
and a 1024  1024 pixel resolution. The corresponding Nyquist settings,
3.1 zoom and 0.13 m z-steps, were used to allow image deconvolution
(Huygens Professional Deconvolution Software; SVI) for nodal counts,
length measurements, and colocalization assessment. All length mea-
surements and counts were performed in an image stack spanning 10 m
using ImageJ MBI 1.43 s. The observer was always blinded to the surgical
procedure.
Sodium channel cluster (Nav1.6) length was assessed after 3 d hypo-
perfusion (n  9 sham; n  8 hypoperfusion) and 1 month hypoperfu-
sion (n  10 sham; n  6 hypoperfusion). The first 40 nodes in the
acquired 10 m confocal stack that were not directly in contact with the
border of the stack were analyzed to exclude only partially imaged nodes
of Ranvier. The regions of the corpus callosum, internal capsule, and
optic tract in sagittal sections were imaged at the stereotactic co-
ordinates, lateral 2.40  0.1 mm, according to Franklin and Paxinos
(1997). The identity of nodes of Ranvier was confirmed by Caspr double-
labeling. AnkyrinG and Nfasc186 cluster length was analyzed accord-
ingly. AnkyrinG was assessed after 3 d (n  9 sham; n  8 hypoperfusion)
and 1 month (n  9 sham; n  10 hypoperfusion) in the corpus callo-
sum. Neurofascin186 was assessed after 3 d (n  6 sham; n  6 hypoper-
fusion) and 1 month (n  6 sham; n  4 hypoperfusion) in the corpus
callosum. Different cohorts needed to be used due to differences in fixa-
tion methods. All animals with ischemic neuronal perikaryal damage or
infarcts confirmed by H&E staining were excluded from analysis (12%).
Colocalization of paranodal proteins was assessed using Caspr and
Neurofascin/Nfasc155 double-immunolabeling. The tissue was post-
fixed using Bouins fixative for Nfasc155 (Sigma Aldrich). The corpus
callosum of animals after 3 d of hypoperfusion (n  5 sham; n  5
hypoperfusion) and 1 month hypoperfusion (n  6 sham; n  4 hypo-
perfusion) was imaged. To identify paranodal pairs, paired Caspr-
positive rectangular clusters (paranodes), separated by a small void of
labeling (indicating the node of Ranvier), were analyzed regarding their
Nfasc155 colabeling. If both labels (Caspr and Nfasc155) were com-
pletely overlapping in a paranodal pair, the node was defined as intact. If
Nfasc155 labeling was absent on one or more sides of a Caspr-positive
paranodal pair, the paranode was defined as disrupted. Overall, after 3 d
of hypoperfusion, 129 paranodal pairs in the sham group and 138 in the
hypoperfused group and after 1 month 185 paranodal pairs in the sham
group and 129 in the hypoperfused group were analyzed. For Caspr and
Neurofascin, common epitope labeling colocalization analysis was per-
formed (Rickman et al., 2007) using ImageJ 1.43 (NIH) and Manders’
coefficients determined.
Fluorescent intensity of MAG, MBP, and SMI312R immunohisto-
chemistry was measured on single optical confocal sections, spanning
47  47 m, of the corpus callosum, internal capsule, and optic tract
after 3 d of hypoperfusion (n  10 sham; n  8 hypoperfusion) and 1
month of hypoperfusion (n  10 sham; n  7 hypoperfusion) using
ImageJ 1.43 (NIH). Activated caspase-3 immunolabeling was assessed
using a Leica DMR fluorescence microscope. All activated caspase-3-
positive cells in a 50 m thick sagittal section in the entire corpus callo-
sum, optic tract, and internal capsule were counted.
Number of nodes of Ranvier. The number of the nodes of Ranvier was
determined on the same sections as the voltage-gated sodium channel
cluster measurements. A 47  47  5 m 3 confocal stack per region was
analyzed. All nodes included in the first optical section and/or contacting
the left or upper edge of the stack were excluded; all nodes contacting the
last and/or right and lower edge of the stack were included.
TEM of optic nerves. Animals were transcardially perfused with 5%
glutaraldehyde/4% paraformaldehyde after 1 month hypoperfusion. Op-
tic nerves were removed, samples were fixed in 3% glutaraldehyde in 0.1
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M sodium cacodylate buffer, pH 7.3, for 2 h, then washed in three 10 min
changes of 0.1 M sodium cacodylate. Specimens were then postfixed in
1% osmium tetroxide in 0.1 M sodium cacodylate. After dehydration,
samples were embedded in Araldite resin. Ultrathin sections (60 nm
thick) were cut on a Reichert OMU4 ultramicrotome (Leica Microsys-
tems), stained in uranyl acetate and lead citrate, then viewed in a Philips
CM120 transmission electron microscope (FEI). Images were taken with
an Orius CCD camera (Gatan). Paranodes in longitudinal sections of
optic nerves were analyzed. The presence or absence of paranodal
septate-like junctions were assessed in 37 paranodes of sham and 35
paranodes of hypoperfused animals (n  3 sham; n  3 hypoperfusion).
The micrographs were assessed by two observers who were blinded to the
surgical procedure. The optic nerve was studied for the ease of identifi-
cation of sufficient numbers of nodal and paranodal structures, which is
precluded in other regions, such as the corpus callosum and internal
capsule, and is known to be damaged in response to hypoperfusion
(Coltman et al., 2011).
White matter micropunch. Seventy-two hours after hypoperfusion or
sham surgery, mice (n  12/group) were deeply anesthetized with iso-
flurane and perfused with 0.9% PBS. Brains were excised and placed in
ice-cold PBS. Brains were subsequently sectioned with a vibratome to
obtain two 1 mm coronal sections containing the genu and body of the
corpus callosum. Sections were placed on glass slides and flash frozen on
dry ice. White matter microsamples were collected via micropunch from
subthawed sections using a 0.5 mm blunt-end needle attached to an
air-filled syringe under a dissecting microscope. Micropunches of the
corpus callosum were collected and aspirated into microcentrifuge tubes
and stored at 80°C until RNA extraction.
RNA extraction. RNA was extracted from white matter micropunches
using an RNeasy Lipid Tissue Mini Kit (Qiagen) according to the man-
ufacturer’s instructions. RNA concentrations were determined using a
Nanodrop (Thermo Scientific).
Microarray analysis. Microarray RNA was pooled from 12 animals per
cohort in groups of three, resulting in four pooled samples per cohort. RNA
quality was confirmed using an RNA BioAnalyzer 2100 (Agilent). cDNA
preparation, the microarray assay, and primary analysis was performed in
the Sir Henry Wellcome Functional Genomics Facility at the University of
Glasgow using standard Affymetrix protocols. Briefly, samples were hybrid-
ized to GeneChip Mouse Exon 1.0 ST arrays (Affymetrix) representing
44,000 genes using the fluidic station 400. Raw data were obtained and
quality control was assessed using the GeneChip Command Console Soft-
ware and the Expression console (Affymetrix).
Raw data were then normalized using GC-content by the Robust
Multichip Average method within Genomics Suite (Partek) using a
selection of probes corresponding to the core annotation level, result-
ing in 23,332 transcripts. Transcripts lacking gene symbol annotation
were filtered out and only transcripts with full annotations (16,711)
were statistically analyzed.
The log2 transformation of normalized signal intensities of anno-
tated transcripts were analyzed with Student’s t test. To control for
false positives, a p value cutoff of 0.001 corresponding to a false
discovery rate 0.11 (Benjamini and Hochberg, 1995) was used. Sig-
nificantly altered genes were uploaded to the WebGestalt Gene Set
Analysis Toolkit version 2 (http://bioinfo.vanderbilt.edu/webgestalt,
Vanderbilt University) for enrichment analysis.
Results
Paranodal breakdown with hypoperfusion
To test whether chronic cerebral hypoperfusion would cause al-
terations in proteins essential for the integrity of the paranodal
junctions, we analyzed two key proteins (Caspr and Nfasc155)
that are contained within the paranodal septate-like junctions.
Caspr is located at the axonal paranode, and Nfasc155 is con-
tained at the opposing paranodal loops of the myelin sheath.
These proteins function as a diffusion barrier for the nodal
Nav1.6 sodium channels and are essential for the integrity of
nodes of Ranvier. Sections were double-immunolabeled with the
axonal Caspr and the glial Nfasc155 proteins and the number of
disrupted paranodes was assessed in the corpus callosum (Fig.
1A). In response to hypoperfusion, there was a significant reduc-
tion in the number of paranodes labeled with both Nfasc155 and
Caspr, due to a marked reduction of Nfasc155 immunolabeling.
After 3 d of hypoperfusion, 21% of the paranodal pairs were
affected compared with 9% in the sham group; after 1 month,
55% displayed a loss of the glial Nfasc155 protein compared with
7% in the sham group (Fig. 1D). To confirm that there was a loss
of colocalization of Caspr and NFasc155, sections were double-
immunolabeled with the axonal Caspr and panNeurofascin (la-
beling glial Nfasc155 and axonal Nfasc186), and colocalization
was determined within the paranodes (Fig. 1B). A significant
reduction in colocalization of Caspr and panNfasc within the
paranodes was determined at both 3 d and 1 month after hypo-
perfusion (Fig. 1E). These data suggest a progressive breakdown
of the paranodal composition with hypoperfusion.
To further determine whether the loss of Caspr/Nfasc double-
immunolabeling indicates paranodal disruption, we performed
ultrastructural analysis by EM on longitudinal optic nerve sec-
tions (Fig. 1C). EM images of paranodes showed a significant loss
of septate-like junctions of paranodal loops in hypoperfused
samples compared with sham controls (Fig. 1F).
Increased voltage-gated sodium channel cluster length
with hypoperfusion
Breakdown of paranodal septate-like junctions could lead to
changes in the structural organization of the nodes of Ranvier,
which depend on a complex interplay between axons and glia. To
determine this, we delineated nodal regions by double-labeling
sections with antibodies to voltage-gated sodium channel
(Nav1.6) and Caspr, an integral component of paranodal junc-
tions. Voltage-gated sodium channel (Nav1.6) clusters are nor-
mally bounded by the paranodal protein Caspr and this was
observed in the sham group (Fig. 2A). However, in response to
hypoperfusion, after 3 d and 1 month, the distribution of the
Nav1.6 channels was markedly altered compared with shams. In
sham-controls, Nav1.6 staining is confined to the nodes of Ran-
vier and does not exceed beyond the localization of the paranodal
barrier, as outlined by the protein Caspr. In contrast, in response
to hypoperfusion, overlap between the Nav1.6 and Caspr staining
was observed (Fig. 2A). To quantify the extent and progression of
these changes, we measured the length of the Nav1.6 clusters in
three white matter tracts (corpus callosum, internal capsule, and
optic tract) after 3 d and 1 month of hypoperfusion (Fig. 2B). We
found that there was a significant increase in the length of the
Nav1.6 domain after 3 d hypoperfusion in the corpus callosum
and internal capsule, which was exacerbated with a longer dura-
tion of hypoperfusion at 1 month. At this later time, the length of
the Nav1.6 channels was also significantly increased in the optic
tract after hypoperfusion (Fig. 2B).
Number of nodes does not change after hypoperfusion
We next determined whether the number of nodes of Ranvier is
changed in response to hypoperfusion. Analysis of a 47  47  5
m 3 confocal stack of the corpus callosum (Fig. 2C), internal
capsule, and optic tract by stereologically counting the number of
nodes of Ranvier for both time points revealed that their number
was not altered in response to hypoperfusion (Fig. 2D). This
indicates that chronic cerebral hypoperfusion does not lead to a
loss in the number of nodes of Ranvier but a disruption of the
distribution of Nav1.6 normally contained within the nodal
region.
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Nodal anchoring proteins remain unaltered
after hypoperfusion
At the node of Ranvier, the scaffolding protein AnkyrinG inter-
acts with Nfasc186 and Nav1.6 channels. This interaction is pro-
posed to be involved in maintenance of the nodal Nav1.6 complex
(Susuki and Rasband, 2008). Nfasc186 connects the complex to
the extracellular matrix and AnkyrinG via IV-spectrin to the
underlying cytoskeleton. Therefore, we assessed changes in the
nodal distribution of these proteins. Surprisingly, in response to
hypoperfusion, at either 3 d or 1 month, AnkyrinG and Nfasc186
show no change in localization (Fig. 3A,B). Furthermore, the
length of the AnkyrinG and Nfasc186 domains after 3 d or 1
month of hypoperfusion were not significantly different to
shams, i.e., there was no lateral spreading of these protein do-
mains along the axon (Fig. 3C).
Internodal axon– glial alterations after hypoperfusion
The axon– glial connection at the internode between nodes of
Ranvier consists of the glial cell membrane glycoprotein MAG
and its axonal binding partners. As the paranodal axon– glial in-
tegrity appeared to be compromised due to hypoperfusion, we
investigated whether the internodal axon– glial connection is
similarly affected. We analyzed the spatial distribution of the glial
MAG protein in response to hypoperfusion and found it to be
markedly changed compared with the sham group. A discontin-
uous granular accumulation of the MAG labeling in the hypoper-
Figure 1. Paranodal disruption occurs early in response to hypoperfusion in the corpus callosum. A, B, Colocalization of axonal Caspr and glial Neurofascin protein indicates intact septate-like
junctions at the paranodes in the sham group. In response to hypoperfusion, at both 3 d and 1 month, there is a selective loss of Neurofascin colocalization with Caspr, which is indicative of a
disruption of the paranodes. Scale bar, 1 m. C, Electron micrographs show paranodal disruption in response to hypoperfusion in the optic nerve. Arrows indicate axonal membrane at the paranodal
region; asterisks indicate paranodal loop. Disruption of septate-like junctions is indicated by loss of transverse bands. Scale bars, 0.1 m. D, There is a nonsignificant increase in the number of
paranodes disrupted at 3 d hypoperfusion (n  5) compared with shams (n  5), which is significant at 1 month after hypoperfusion (n  4) compared with shams (n  6). Analysis was conducted
in the corpus callosum. *p  0.05 (unpaired t test, two-tailed). E, The overlap coefficient after Manders, which is insensitive to differences in signal intensities between the two channels, shows
significant loss in colocalization after 3 d and after 1 month of hypoperfusion (3 d sham: n  13, hypoperfusion: n  12; 1 month sham: n  9, hypoperfusion: n  9). Analysis was conducted in
the corpus callosum. *p  0.05, **p  0.005 (unpaired t test, two-tailed). F, A significant increase in paranodes without septate-like junctions was observed after 1 month of hypoperfusion. *p 
0.05 (unpaired t test, two-tailed).
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fused group was observed (Fig. 4A). To quantify these changes,
we determined the fluorescent intensity of single optical confocal
sections in the same white matter regions that displayed a break-
down in paranodal integrity, and found a significant reduction in
the intensity of MAG staining at both 3 d and at 1 month of
hypoperfusion compared with shams (Fig. 4B). These results
build on and extend our previous findings in which MAG was
shown to be disrupted in response to 1 month of hypoperfusion
(Coltman et al., 2011). Together, these findings suggest that the
internodal axon– glial connection is compromised due to chronic
cerebral hypoperfusion.
Similarly, we assessed the spatial distribution and measured
the intensity of the MBP, which is located in the compact myelin
sheath, in single optical confocal sections. However, we found
Figure 2. Voltage-gated sodium channel distribution is rapidly disrupted by hypoperfusion. A, Nav1.6 sodium channels, which outline the node of Ranvier, are normally bounded by the paranodal
protein Caspr, as shown in the sham. In response to hypoperfusion, after 3 d and 1 month, the distribution of the Nav1.6 sodium channels is markedly altered and laterally spreads along the axon
(corpus callosum). Scale bar, 1 m. B, There is a significant increase in the length of the Nav1.6 clusters after 3 d of hypoperfusion in the corpus callosum and, after 1 month, in the internal capsule
and optic tract. Forty nodes per animal were analyzed and these 240 – 400 nodes are plotted as cumulative frequency distribution, tabulated as relative frequencies as percentage (two-sample
Kolmogorov–Smirnov test). Number of nodes of Ranvier remains unchanged after 3 d or 1 month of hypoperfusion. C, Confocal stack of nodes of Ranvier in the corpus callosum, double-labeled with
Nav1.6 and Caspr. Left, Sham; right, 1 month of hypoperfusion. Scale bar, 1 m. D, Numbers of nodes of Ranvier are not altered in response to hypoperfusion. After 3 d and after 1 month, the number
of Nav1.6 immunopositive nodes was not changed between the sham and hypoperfused groups. Analysis was conducted by confocal laser microscopy in the corpus callosum, internal capsule, and
optic tract in a 47  47  5 m 3 confocal stack (Mann–Whitney, two-tailed).
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that neither the spatial distribution nor
the fluorescent intensity of MBP was
changed in response to hypoperfusion af-
ter 3 d or 1 month compared with shams
(Fig. 4A,B).
In addition, we assessed whether the
underlying axons, which would contain
the binding partners for the MAG protein,
show obvious morphological changes
with hypoperfusion. The axons were la-
beled using the panaxonal neurofilament
marker SMI312R and measured in the
same way as the myelin on single optical
confocal sections. There was no evidence
that there were either structural changes
or differences in the fluorescent intensity
in response to hypoperfusion compared
with shams (Fig. 4).
No evidence of increased apoptosis
with hypoperfusion
To analyze the extent of apoptosis in our
model, we counted activated caspase-3-
positive cells in white matter regions after
3 d and 1 month of hypoperfusion (Fig.
5). No significant increase in numbers of
apoptotic cells were determined in any of
the regions studied or at any time point.
Multiple molecular events in white
matter associated with hypoperfusion
To investigate potential molecular events
in response to hypoperfusion that may
contribute to the axon– glial damage, we
undertook a microarray study in white
matter-enriched tissue at 3 d posthy-
poperfusion, a time when we detected
early changes. Of the 16,711 fully annotated
genes, 129 were found to be regulated differ-
ently within the white matter-enriched
samples in response to hypoperfusion at
p  0.001. Hypoperfusion is associated
with alterations in multiple biological
processes. Enrichment analysis of the 129 regulated genes pre-
sented in Table 1 demonstrates the multiple processes regu-
lated in response to hypoperfusion. In particular, genes
associated with inflammatory responses (Table 1), such as
those represented by the annotations Jak–STAT signaling
pathway (seven genes) and cytokine– cytokine receptor inter-
action (eight genes), which included Stat3, Il2rg, Osmr, and
Tnfrsf1a, were found to be regulated. Cardiovascular develop-
ment, represented by the functional annotations angiogenesis
(nine genes) and blood vessel development (10 genes) and
including the genes Angpt2, Vegfa, Serpine1, and Dll4, were
also altered. Cell proliferation processes were altered as repre-
sented by regulation of cell proliferation (15 genes) and in-
cluded Cdh5, Adm, Igfb3, and Cdkn1a. Other highlighted
processes were anatomical structure formation/morphogene-
sis and cell adhesion.
Hypoperfusion is a complex and multifactorial process, as
demonstrated by the number of biological processes listed in
Table 1. These affect genes involved in cell death and plasticity
across multiple cell types even within white matter-enriched
samples. The exact mechanism leading to the nodal changes ob-
served remains to be established, but the complexity of action of
the molecules involved would indicate that no single molecular
event is responsible.
Discussion
Our results demonstrate that within days of cerebral hypoperfu-
sion, there is a rapid and selective disruption of key proteins
within the paranodal axon– glial junctions, which are critical to
the stability and function of myelinated axons. Furthermore, in
the early response to hypoperfusion, there are several biological
pathways altered (notably inflammatory, vascular development,
and cell adhesion) that could contribute to the axon– glial
damage.
These results are relevant to age-related changes in white
matter to which cerebral hypoperfusion is suggested to con-
tribute. Although there is some evidence that the protein ar-
chitecture may be altered at nodal regions in the aging brain
(Lasiene et al., 2009), specific protein changes have yet to be
identified. The present study identifies key changes in paran-
odal and nodal proteins in response to cerebral hypoperfu-
Figure 3. AnkyrinG and Neurofascin186 distribution remains unchanged with hypoperfusion. A, Axonal AnkyrinG re-
mains within the node of Ranvier in response to hypoperfusion. B, The spatial distribution of Neurofascin186, which
connects nodal proteins to the extracellular matrix, does not change. Scale bar, 1 m. C, There is no significant increase in
the length of the AnkyrinG or Neurofascin186 domains after 3 d or 1 month of hypoperfusion in the corpus callosum. Forty
nodes per animal were analyzed and these 160 – 400 nodes are plotted as cumulative frequency (two-sample Kolmogo-
rov–Smirnov test).
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sion. Normally, Nfasc155 is located at the paranodal loops and
is known to form the paranodal septate-like junctions with the
axonal protein Caspr and contactin. The stability of these pro-
teins is critical to maintain nodal structure. We determined a
disruption of the paranodes occurs in response to hypoperfu-
sion, with a loss of the glial protein Nfasc155 at the paranode
concomitant with a loss of septate-like junctions. This selec-
tive damage to paranodal integrity was also associated with a
compromised nodal structure, as demonstrated by an increase
in Nav1.6 channel cluster length. This increase in nodal length
was dependent on the white matter tract examined. The cor-
pus callosum and internal capsule appeared particularly sus-
ceptible early in response to hypoperfusion, with a significant
increase in nodal length, detectable
within 3 d, while the optic tract re-
mained unaffected. After 1 month of hy-
poperfusion, the effect appeared to be
progressive and alterations within the
optic tract were subsequently deter-
mined. One explanation for this obser-
vation is regional differences of blood
supply due to the cerebrovascular archi-
tecture and increased energy demand of
myelinated fibers during even modest
hypoxia (Dorr et al., 2007; Trapp and
Stys, 2009). In addition to vascular al-
terations, dynamic distribution of blood
and turnover of oligodendrocytes might
result in the differences of progression
between the analyzed white matter
tracts.
Consistent with changes at the paran-
odes, there was a marked and rapid dis-
ruption of the axon– glial connection at
the internodal region of myelinated axons
in response to hypoperfusion. MAG plays
an important role in signaling and main-
tenance of the axon– glial connection and
the myelin sheath (for review, see Quarles,
2007; Schnaar and Lopez, 2009). The cel-
lular distribution of glial MAG protein
was disrupted in response to hypoperfu-
sion and determined to accumulate in
discontinuous granular staining. Interest-
ingly, the protein level of MAG was not
altered after 1 month of chronic cerebral
hypoperfusion. This suggests that the ob-
served changes could be a result of protein
misdistribution rather than a loss of
protein. A preferential loss of MAG in
hypoxia-like white matter damage after
stroke, multiple sclerosis, and other
inflammatory brain diseases has been pre-
viously described (Aboul-Enein et al.,
2003). A link between myelin-associated
glycoprotein disruption and paranodal
integrity has been shown in mice deficient
in both MAG and myelin galactolipids,
which display impaired maintenance of
nodes of Ranvier (Marcus et al., 2002).
At the node of Ranvier, the scaffolding
protein AnkyrinG interacts with Nfasc186
and Nav1.6 channels, and this interac-
tion is proposed to be involved in maintenance of the nodal
Nav1.6 complex (Susuki and Rasband, 2008). Nfasc186 con-
nects the complex to the extracellular matrix and AnkyrinG
via IV-spectrin to the underlying cytoskeleton. Thus, it was
surprising to determine in the present study that alterations in
Nav1.6 were not accompanied by alterations in Nfasc186 and
the anchoring protein AnkyrinG. The lack of changes in Anky-
rinG and Nfasc186 despite alterations in Nav1.6 channels
might indicate a dissociation of Nav1.6 channels from the Anky-
rinG/Nfasc186 complex. There are a number of mechanisms by
which voltage-gated sodium channels could dissociate from
its AnkyrinG scaffolding. Previously, it has been demonstrated
that phosphorylation of the Ankyrin-binding motif of Nav1.2
Figure 4. Axon– glial integrity is disrupted, whereas myelin and axonal integrity remains intact. A, Disruption of axon– glial
integrity was defined as reduced and discontinuous granular accumulation of the MAG staining in response to hypoperfusion
compared with shams. In contrast, the integrity of the myelin sheath (assessed by MBP) and integrity of axons (assessed by
SMI312R) remains intact at 3 d and at 1 month. Scale bar, 10 m. B, Measurement of the fluorescent intensity of MAG, MBP, and
SMI312R staining was conducted by confocal laser microscopy in the corpus callosum, internal capsule, and optic tract in sham and
hypoperfused groups at 3 d (sham, n  9; hypoperfused, n  8) and 1 month (sham, n  10; hypoperfused, n  7). There was
a significant reduction in the intensity of MAG staining at both 3 d and at 1 month hypoperfusion compared with shams. There were
no alterations in MBP and SMI312R immunostaining in response to hypoperfusion at any time studied. *p  0.05 (Mann–
Whitney, two-tailed).
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channels via protein kinase CK2 regulates the sodium channel
interaction with Ankyrins (Bréchet et al., 2008). Alternatively,
calpain-mediated proteolysis of the voltage-gated sodium
channel -subunit has been described for Nav1.2 (von Reyn et
al., 2009). Similar events to Nav1.6 at the nodes of Ranvier
could explain the dissociation of sodium channels from nodal
AnkyrinG.
Additionally, we did not detect axonal damage nor demyeli-
nation in response to hypoperfusion, which is in agreement with
our previous studies using cellular pathology and MRI ap-
proaches (Holland et al., 2011).The observation that AnkyrinG
and Neurofascin186 are unaltered after hypoperfusion supports
the absence of detectable alteration of the underlying axonal cy-
toskeleton. This is in contrast to more severe models of cerebral
ischemia where myelin/axonal pathology is evident, [such as fo-
cal cerebral ischemia (Yam et al., 2000) and global cerebral isch-
emia (Jiwa et al., 2010)] in which blood flow is severely reduced
(70%), and axonal and neuronal perikaryal damage occur within
hours to days of the initial blood flow reduction. In the present
study, hypoperfusion induced by carotid stenosis is associated
with modest reductions in blood flow (30%) within the first
24 h, and recovers gradually over weeks and is reduced by 10 –
20% compared with baseline (Shibata et al., 2004). This is more
akin to changes that occur in the normal aging brain, where blood
flow reductions are modest (20%) and sustained over years. The
myelin sheath and underlying axon do not appear to be changed in
our model of hypoperfusion but instead there is rapid axon–glial
disruption. Western blot analysis revealed that there was no change
in the levels of the proteins studied (MBP, SMI312, MAG, Nfasc155,
and Nav1.6; our unpublished observations), providing further sup-
port that the hypoperfusion causes disruption of the cellular distri-
bution and coupling of axon–glial proteins. Several mechanisms of
damage, including excitotoxicity and caspase activation, have been
suggested (Craner et al., 2004; Fu et al., 2009) to lead to axonal
degeneration in models of severe ischemia. Since we found no evi-
dence of axonal injury or caspase-3-labeled oligodendrocytes at the
times studied (Fig. 5) in our model, alternative mechanisms may
contribute to the axon–glial disruption.
Vascular brain injury has been shown to cause white matter
deterioration and response of the oligodendrocyte lineage in a
Figure 5. Increased apoptosis does not occur after 3 d or 1 month of chronic cerebral hypoperfusion. The number of active caspase-3-positive cells in the corpus callosum, internal capsule, and
optic tract is not increased in response to hypoperfusion. Colocalization of active caspase-3 with DAPI is shown. *p  0.05 (Mann–Whitney, two-tailed).
Table 1. Microarray analysis of enriched white matter from the corpus callosum
indicates multiple pathways involved in the response to hypoperfusion
Database Biological process Observed Expected p value
GO Regulation of cell proliferation 15 3.66 0.001
GO Angiogenesis 9 1.23 0.001
KEGG Jak–STAT signaling pathway 7 1.06 0.0027
KEGG Complement and coagulation cascades 5 0.54 0.0029
GO Organ development 28 12.89 0.0037
GO Blood vessel morphogenesis 9 1.7 0.0037
GO Blood vessel development 10 2.07 0.0037
GO Vasculature development 10 2.11 0.0037
GO Anatomical structure formation/
morphogenesis
12 2.88 0.0037
KEGG Cytokine– cytokine receptor interaction 8 1.79 0.0039
GO Cell adhesion 14 4.34 0.0048
GO Cell proliferation 15 4.99 0.0048
GO Anatomical structure development 32 16.39 0.0048
KEGG Acute myeloid leukemia 4 0.42 0.0058
Genes (n  129) altered ( p  0.001) were uploaded to WebGestalt enrichment analysis based on Gene
Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways. Biological processes ad-
justed p  0.01 (Benjamini and Hochberg, 1995)	 from both Gene Ontology and Kyoto Encyclopedia of Genes
and Genomes databases, along with the observed and expected number of molecules represented for each
category, are listed.
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human cohort (Back et al., 2011). This highlights the link
between vascular disturbances and changes in white matter
integrity. Furthermore, dynamic communication between en-
dothelial cells and oligodendrocytes is suggested to maintain
their homeostasis and the integrity of white matter (Arai and
Lo, 2009). This current view of an oligovascular niche suggests
a highly coordinated exchange mediated by a diversity of sig-
naling molecules between cerebral blood vessels and oligoden-
drocytes (Arai and Lo, 2009). Thus, it is likely that not one
molecular event can explain the axon– glial damage in re-
sponse to hypoperfusion. Indeed, within our microarray anal-
ysis of white matter-enriched tissue from the corpus callosum,
we determined significant alterations in a number of genes
and biological processes in response to hypoperfusion, includ-
ing inflammatory, vascular, and cell-adhesion pathways. Each
of these may contribute to the degenerative processes. The
extent of their participation in axon– glial disruption requires
intensive future studies.
It is well recognized that axon– glial integrity is critical to
maintenance of cognitive function (Nave, 2010). Previously, we
demonstrated that selective disruption of white matter integrity
in response to hypoperfusion results in impairment of spatial
working memory (Coltman et al., 2011). Although these distinct
changes to the protein architecture at a subcellular level might
appear subtle, they might be sufficient to explain the previously
described cognitive dysfunction. In development, conduction ve-
locities are significantly increased with clustering of Nav1.6 so-
dium channels at the node of Ranvier (Rasband et al., 1999) and
disrupted paranodes lead to changes in electrophysiological mea-
surements (Susuki et al., 2007). Disruption of nodal structures
would be expected to result in changes in action potential prop-
agation and thus could lead to functionally impaired connections
between different brain regions.
We propose that the axon– glial connection at the paran-
odes and internodes in white matter tracts are rapidly dis-
rupted in response to hypoperfusion relevant to the aging
brain. The onset of this disruption is fast, which may indicate
a narrow window of opportunity to prevent damage from
occurring. However, in future studies, it will be important to
determine whether this damage is reversible. In our model, the
underlying axon remains intact, as does the compact myelin in
the myelin sheaths. Although it is not clear whether long-term
axonal degeneration and myelin sheath loss occurs with pro-
gressive hypoperfusion, there is emerging evidence that it
leads to neuronal cell loss (Nishio et al., 2010). The complexity
of the molecular mechanisms elicited by hypoperfusion sug-
gests that there is no single molecular target. However, stabi-
lizing the axon– glial connection at the early onset of
disruption to myelinated axons could be crucial to prevent
further degenerative processes and cognitive impairment.
Notes
Supplemental material for this article is available at http://www.cnr.
ed.ac.uk/Research/horsburgh.html. Supplemental Table 1: Genes regu-
lated by hypoperfusion in white matter-enriched microsamples. This
material has not been peer reviewed.
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